You are cordially invited to
attend a special meeting of the stockholders of The Valspar Corporation, a Delaware corporation (Valspar, the Company, we, our or us), which we will hold at
[ ], on [ ], at [ ], local time
(such meeting, including any adjournment or postponement thereof, the special meeting).
At the special meeting, holders of
our common stock, par value $0.50 per share (common stock), will be asked to consider and vote on (1) a proposal to adopt the Agreement and Plan of Merger (as it may be amended from time to time, the merger agreement),
dated as of March 19, 2016, by and among the Company, The Sherwin-Williams Company, an Ohio corporation (Sherwin-Williams), and Viking Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Sherwin-Williams
(Merger Sub), pursuant to which Merger Sub will be merged with and into the Company (the merger), (2) a proposal to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to
the Companys named executive officers in connection with the merger, and (3) a proposal to adjourn the special meeting, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of
the special meeting to approve the proposal to adopt the merger agreement or in the absence of a quorum. If the merger agreement is adopted and the merger is completed, the Company will become a wholly owned subsidiary of Sherwin-Williams and, at
the effective time, each share of common stock issued and outstanding immediately prior to the effective time of the merger (other than dissenting shares and shares owned by the Company, Sherwin-Williams or any of their respective subsidiaries,
except for shares of common stock held on behalf of third parties) will be cancelled and converted into the right to receive the merger consideration.
The merger consideration will be $113.00 per share in cash, without interest, and subject to any applicable withholding taxes. However, if
Sherwin-Williams is required, in order to obtain the necessary regulatory approvals, to commit to any divestiture, license, hold separate, sale or other disposition of or with respect to assets, businesses or product lines of Valspar,
Sherwin-Williams or their subsidiaries representing, in the aggregate, in excess of $650 million of net sales, as described in the section entitled
The Merger Agreement Efforts to Complete the Merger Divestitures and
Triggering Divestiture
(which commitment we refer to as a triggering divestiture, with a triggering event deemed to occur when Sherwin-Williams is required pursuant to the regulatory efforts covenant in the merger
agreement to take, or cause to be taken, or commit to take, or cause to commit to be taken, an action constituting a triggering divestiture), then the merger consideration will be $105.00 per share in cash, without interest, and subject to any
applicable withholding taxes.
There can be no assurance that a triggering divestiture will not occur, and accordingly there can be no assurance that holders of Valspar common stock will receive $113.00 per share in cash instead of $105.00 per
share in cash. See the section entitled
The Merger (Proposal 1) Regulatory Approvals
.
The
Valspar board of directors has unanimously determined that the merger agreement, the merger and the other transactions contemplated by the merger agreement are advisable, fair to and in the best interests of the Company and its stockholders and has
unanimously approved the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Valspar board of directors unanimously recommends that the stockholders of the Company vote (1)
FOR
the proposal to adopt the merger agreement, (2)
FOR
the advisory (non-binding) proposal to approve certain compensation that may be paid or become payable to the named executive officers of the Company in connection with the
merger, and (3)
FOR
the proposal to adjourn the special meeting, if necessary or appropriate, including to solicit additional proxies or in the absence of a quorum.
The enclosed proxy statement describes the merger agreement, the merger and the compensation that
may be paid or become payable to the named executive officers of the Company in connection with the merger and provides specific information concerning the special meeting and the parties involved. A copy of the merger agreement is attached as
Annex A
to the proxy statement. We urge you to, and you should, read the entire proxy statement carefully, including its annexes and the documents incorporated by reference in the proxy statement, as it sets forth the details of the merger
agreement and other important information related to the merger. In addition, you may obtain information about us from documents filed with the Securities and Exchange Commission (the SEC). See
Where You Can Find Additional
Information
.
If you have any questions or need assistance in voting your
shares, please contact our proxy solicitor, MacKenzie Partners, Inc., at (800) 322-2885 or via email at proxy@mackenziepartners.com.
Gary E. Hendrickson
Certain Valspar Unaudited Prospective Financial Information
In connection with the merger, Valspars management prepared financial projections of revenue, adjusted EBITDA and adjusted earnings per
share for fiscal years 2016 through 2020 (the Valspar Projections). The Valspar Projections were prepared for internal use and provided to Valspars board of directors, for the purposes of considering, analyzing and evaluating the
Companys strategic and financial alternatives, including the merger. The Valspar Projections were also provided to the Financial Advisors in connection with rendering their respective fairness opinions to the Valspar board of directors and in
performing the related analyses. The Valspar Projections were also provided to Sherwin-Williams and Sherwin-Williams financial advisor in connection with their respective consideration and evaluation of a merger with Valspar. Valspar does not
as a matter of course make public projections as to future performance due to, among other reasons, the inherent difficulty of accurately predicting financial performance for future periods and the uncertainty of underlying assumptions and
estimates. However, Valspar is including in this proxy statement a summary of certain limited unaudited prospective financial information for Valspar on a stand-alone basis, without giving effect to the merger, to give Valspar stockholders access to
certain nonpublic information provided to Valspars board of directors and Financial Advisors and to Sherwin-Williams for purposes of considering and evaluating the merger. The inclusion of the Valspar Projections should not be regarded as an
indication that the Valspar board of directors, Valspar, the Sherwin-Williams board of directors, Sherwin-Williams, Merger Sub, Goldman Sachs, BofA Merrill Lynch, Citi or any other recipient of this information considered, or now considers, it to be
an assurance of the achievement of future results or an accurate prediction of future results, and they should not be relied on as such.
The Valspar Projections and the underlying assumptions upon which the Valspar Projections were based are subjective in many respects, and
subject to multiple interpretations and frequent revisions attributable to the cyclicality of Valspars industry and based on actual experience and business developments. The Valspar Projections reflect numerous assumptions with respect to
company performance, industry performance, general business, economic, regulatory, market and financial conditions and other matters, many of which are difficult to predict, subject to significant economic and competitive uncertainties and beyond
Valspars control. Multiple factors, including those described in the section entitled
Cautionary Statement Concerning Forward-Looking Statements
, could cause the Valspar Projections or the underlying assumptions to be
inaccurate. As a result, there can be no assurance that the Valspar Projections will be realized or that actual results will not be significantly higher or lower than projected. Because the Valspar Projections cover multiple years, such information
by its nature becomes less reliable with each successive year. The Valspar Projections do not take into account any circumstances or events occurring after the date on which they were prepared. Economic and business environments can and do change
quickly, which adds an additional significant level of uncertainty as to whether the results portrayed in the Valspar Projections will be achieved. As a result, the inclusion of the Valspar Projections in this proxy statement does not constitute an
admission or representation by Valspar or any other person that the information is material. The summary of the Valspar Projections is not provided to influence Valspar stockholders decisions regarding whether to vote for the merger proposal
or any other proposal.
The Valspar Projections were not prepared with a view toward public disclosure or toward compliance with United
States generally accepted accounting principles (GAAP), published guidelines of the SEC or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial
information. Neither Ernst & Young LLP (Ernst & Young), Valspars independent registered public accounting firm, nor any other accounting firm, has examined, compiled or performed any procedures with respect to the
Valspar Projections, and accordingly, Ernst & Young does not express an opinion or any other form of assurance with respect thereto. The Ernst & Young report incorporated by reference in this proxy statement relates to
Valspars historical financial information. It does not extend to the prospective financial information contained herein and should not be read to do so.
-36-
The following is a summary of the Valspar Projections:
Summary of the Valspar Projections
(dollars in millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected Fiscal Year
|
|
|
|
2016
|
|
|
2017
|
|
|
2018
|
|
|
2019
|
|
|
2020
|
|
Revenue
|
|
$
|
4,397
|
|
|
$
|
4,701
|
|
|
$
|
4,952
|
|
|
$
|
5,220
|
|
|
$
|
5,513
|
|
Adjusted EBITDA
(1)
|
|
$
|
745
|
|
|
$
|
810
|
|
|
$
|
877
|
|
|
$
|
942
|
|
|
$
|
1,015
|
|
Adjusted Earnings Per Share
(2)
|
|
$
|
4.90
|
|
|
$
|
5.59
|
|
|
$
|
6.44
|
|
|
$
|
7.32
|
|
|
$
|
8.42
|
|
(1)
|
Earnings before interest, income taxes and depreciation and amortization (EBITDA) is a non-GAAP measure consisting of net income plus interest expense, provision for income taxes and depreciation and
amortization. Projected adjusted EBITDA for fiscal years 2016 through 2020 excludes certain restructuring and acquisition-related charges that have occurred, or may occur, in those fiscal years.
|
(2)
|
Projected adjusted earnings per share for fiscal years 2016 through 2020 excludes certain restructuring and acquisition-related charges that have occurred, or may occur, in those fiscal years.
|
The Valspar Projections do not take into account the possible financial and other effects on Valspar of the merger and do not attempt to
predict or suggest future results of the combined company. The Valspar Projections do not give effect to the merger, including the impact of negotiating or executing the merger agreement, the expenses that may be incurred in connection with
consummating the merger, the potential synergies that may be achieved by the combined company as a result of the merger, the effect on Valspar of any business or strategic decision or action that has been or will be taken as a result of the merger
agreement having been executed, or the effect of any business or strategic decisions or actions that would likely have been taken if the merger agreement had not been executed, but that were instead altered, accelerated, postponed or not taken in
anticipation of the merger. Further, the Valspar Projections do not take into account the effect on Valspar of any possible failure of the merger to occur.
For the foregoing reasons, and considering that the special meeting will be held several months after the Valspar Projections were prepared,
as well as the uncertainties inherent in any forecasting information, readers of this proxy statement are cautioned not to place unwarranted reliance on the Valspar Projections set forth above. No one has made or makes any representation to any
stockholder regarding the information included in the Valspar Projections. Valspar urges all Valspar stockholders to review its most recent SEC filings for a description of its reported financial results. See the section entitled
Where You
Can Find Additional Information
.
In addition, the Valspar Projections have not been updated or revised to reflect
information or results after the date the Valspar Projections were prepared or as of date of this proxy statement, and except as required by applicable securities laws, Valspar does not intend to update or otherwise revise the Valspar Projections or
the specific portions presented to reflect circumstances existing after the date when made or to reflect the occurrence of future events, even in the event that any or all of the assumptions are shown to be in error.
-37-
Opinion of Valspars Financial Advisors
Opinion of BofA Merrill Lynch
On March 19, 2016, at the meeting of the Valspar board of directors, BofA Merrill Lynch rendered to the Valspar board of directors its
oral opinion, subsequently confirmed in writing, to the effect that, as of March 19, 2016 and based upon and subject to the assumptions made, procedures followed, factors considered and limitations and qualifications on the review undertaken
described in BofA Merrill Lynchs written opinion, the per share price, whether or not a triggering event (as described in the section entitled
The Merger Agreement Efforts to Complete the Merger Divestitures and
Triggering Divestiture
) occurs, to be received in the merger by the holders of shares of Valspar common stock (other than dissenting shares and shares owned by the Company, Sherwin-Williams or any of their respective subsidiaries (except
for shares of common stock held on behalf of third parties), which will be cancelled), was fair, from a financial point of view, to such holders.
The full text of the written opinion of BofA Merrill Lynch, dated March 19, 2016, to the Valspar board of directors, which describes,
among other things, the assumptions made, procedures followed, factors considered and limitations and qualifications on the review undertaken in connection with the opinion, is attached as Annex B to this proxy statement. BofA Merrill Lynch
delivered its opinion for the benefit and use of the Valspar board of directors (in its capacity as such) in connection with and for purposes of its evaluation of the merger. BofA Merrill Lynchs opinion did not address any other term or aspect
of the merger and no opinion or view was expressed by BofA Merrill Lynch as to the relative merits of the merger in comparison to other strategies or transactions that might be available to Valspar or in which Valspar might engage or as to the
underlying business decision of Valspar to proceed with or effect the merger. BofA Merrill Lynch expressed no opinion or recommendation as to how any Valspar stockholder should vote or act in connection with the merger or any related matter.
In connection with its opinion, BofA Merrill Lynch, among other things:
|
|
|
reviewed certain publicly available business and financial information relating to Valspar;
|
|
|
|
reviewed certain internal financial and operating information with respect to the business, operations and prospects of Valspar furnished by or discussed with the management of Valspar, including certain financial
forecasts relating to Valspar prepared by the management of Valspar, including the Valspar Projections (the Valspar Forecasts);
|
|
|
|
discussed the past and current business, operations, financial condition and prospects of Valspar with members of senior management of Valspar;
|
|
|
|
reviewed the trading history for shares of Valspar common stock and a comparison of that trading history with the trading histories of other companies BofA Merrill Lynch deemed relevant;
|
|
|
|
compared certain financial and stock market information of Valspar with similar information of other companies BofA Merrill Lynch deemed relevant;
|
|
|
|
compared certain financial terms of the merger to financial terms, to the extent publicly available, of other transactions BofA Merrill Lynch deemed relevant;
|
|
|
|
reviewed a draft, dated March 19, 2016, of the merger agreement; and
|
|
|
|
performed such other analyses and studies and considered such other information and factors as BofA Merrill Lynch deemed appropriate.
|
In arriving at its opinion, BofA Merrill Lynch assumed and relied upon, without independent verification, the accuracy and completeness of the
financial and other information and data publicly available or provided to
-38-
or otherwise reviewed by or discussed with BofA Merrill Lynch and relied upon the assurances of the management of Valspar that they were not aware of any facts or circumstances that would make
such information or data inaccurate or misleading in any material respect. With respect to the Valspar Forecasts, BofA Merrill Lynch was advised by the management of Valspar, and assumed, that the Valspar Forecasts had been reasonably prepared on
bases reflecting the best currently available estimates and good faith judgments of the management of Valspar as to the future financial performance of Valspar.
BofA Merrill Lynch did not make and was not provided with any independent evaluation or appraisal of the assets or liabilities (contingent or
otherwise) of Valspar, nor did BofA Merrill Lynch make any physical inspection of the properties or assets of Valspar. BofA Merrill Lynch did not evaluate the solvency or fair value of Valspar under any state, federal or other laws relating to
bankruptcy, insolvency or similar matters. BofA Merrill Lynch assumed, at the direction of Valspar, that the merger would be consummated in accordance with its terms, without waiver, modification or amendment of any material term, condition or
agreement and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases and waivers for the merger, no delay, limitation, restriction or condition, including any divestiture requirements or
amendments or modifications, would be imposed that would have an adverse effect on Valspar or the contemplated benefits to Valspar of the merger in any way meaningful to BofA Merrill Lynchs analysis.
BofA Merrill Lynch expressed no view or opinion as to any terms or other aspects of the proposed transaction (other than the per share price,
whether or not a triggering event occurs, to the extent expressly specified in its written opinion), including, without limitation, the form or structure of the merger. BofA Merrill Lynchs opinion was limited to the fairness, from a financial
point of view, of the per share price, whether or not a triggering event occurs, to be received by holders of Valspar common stock, and no opinion or view was expressed with respect to any consideration received in connection with the merger by the
holders of any other class of securities, creditors or other constituencies of any party. In addition, no opinion or view was expressed with respect to the fairness (financial or otherwise) of the amount, nature or any other aspect of any
compensation to any of the officers, directors or employees of any party to the merger, or class of such persons, relative to the per share price, whether or not a triggering event occurs. Furthermore, no opinion or view was expressed as to the
relative merits of the proposed transaction in comparison to other strategies or transactions that might be available to Valspar or in which Valspar might engage or as to the underlying business decision of Valspar to proceed with or effect the
merger. In addition, BofA Merrill Lynch expressed no opinion or recommendation as to how any stockholder should vote or act in connection with the proposed merger or any related matter.
BofA Merrill Lynchs opinion was necessarily based on financial, economic, monetary, market and other conditions and circumstances as in
effect on, and the information made available to BofA Merrill Lynch as of, the date of its opinion. It should be understood that subsequent developments may affect BofA Merrill Lynchs opinion, and BofA Merrill Lynch does not have any
obligation to update, revise, or reaffirm its opinion. The issuance of BofA Merrill Lynchs opinion was approved by BofA Merrill Lynchs Americas Fairness Opinion Review Committee.
In connection with BofA Merrill Lynchs services as Valspars financial advisor, assuming a per share price of $113, BofA Merrill
Lynch will receive a fee for its services of approximately $32,000,000, approximately $30,000,000 of which is contingent upon consummation of the merger. In the event that the per share price is $105, BofA Merrill Lynch will receive a fee for its
services of approximately $30,000,000, approximately $28,000,000 of which is contingent upon consummation of the merger. In addition, Valspar has agreed to reimburse BofA Merrill Lynch for its expenses and to indemnify BofA Merrill Lynch against
certain liabilities arising out of BofA Merrill Lynchs engagement.
BofA Merrill Lynch and its affiliates comprise a full
service securities firm and commercial bank engaged in securities, commodities and derivatives trading, foreign exchange and other brokerage activities, and principal investing as well as providing investment, corporate and private banking, asset
and investment management, financing and financial advisory services and other commercial services and products to a wide range of
-39-
companies, governments and individuals. In the ordinary course of their businesses, BofA Merrill Lynch and its affiliates may invest on a principal basis or on behalf of customers or manage funds
that invest, make or hold long or short positions, finance positions or trade or otherwise effect transactions in equity, debt or other securities or financial instruments (including derivatives, bank loans or other obligations) of Valspar,
Sherwin-Williams and certain of their respective affiliates.
BofA Merrill Lynch and its affiliates in the past have provided, currently
are providing and in the future may provide, investment banking, commercial banking and other financial services to Valspar and have received or in the future may receive compensation for the rendering of these services, including (i) having
acted or acting as joint lead arranger, joint bookrunner for, and/or a lender under, certain term loans, letters of credit, leasing and other credit facilities of Valspar (including acquisition financing), (ii) having acted or acting as joint
bookrunner and underwriter in connection with various debt offerings of Valspar and (iii) having provided or providing certain treasury and trade management services and products to Valspar. From February 1, 2014 through January 31,
2016, BofA Merrill Lynch and/or its affiliates received aggregate revenues from Valspar and certain of its affiliates of approximately $3,000,000 for corporate, commercial and investment banking services.
In addition, BofA Merrill Lynch and its affiliates in the past have provided, currently are providing, and in the future may provide,
investment banking, commercial banking and other financial services to Sherwin-Williams and have received or in the future may receive compensation for the rendering of these services, including (i) having acted or acting as administrative
agent, joint lead arranger, joint bookrunner for, and/or a lender under, certain leasing and other credit facilities of Sherwin-Williams, (ii) having acted or acting as joint bookrunner, underwriter and/or dealer manager for certain debt
offerings of, and share repurchases by, Sherwin-Williams, (iii) having provided or providing certain treasury and trade management services and products to Sherwin-Williams and (iv) having provided or providing certain derivatives and
foreign exchange trading services to Sherwin-Williams. From February 1, 2014 through January 31, 2016, BofA Merrill Lynch and/or its affiliates received aggregate revenues from Sherwin-Williams and certain of its affiliates of
approximately $8,000,000 for corporate, commercial and investment banking services.
BofA Merrill Lynch is an internationally recognized
investment banking firm which is regularly engaged in providing financial advisory services in connection with mergers and acquisitions. Valspar selected BofA Merrill Lynch as its financial advisor in connection with the proposed transaction on the
basis of BofA Merrill Lynchs experience in similar transactions, its reputation in the investment community and its familiarity with Valspar and its business.
Opinion of Goldman Sachs
On March 19, 2016, at a meeting of the Valspar board of directors, Goldman Sachs rendered to the Valspar board of directors its oral
opinion, subsequently confirmed in writing, to the effect that, as of March 19, 2016 and based upon and subject to the assumptions made, procedures followed, factors considered and limitations and qualifications on the review undertaken
described in Goldman Sachs written opinion, the per share price, whether or not a triggering event occurs, to be paid to holders (other than Sherwin-Williams and its affiliates) of Valspar common stock pursuant to the merger agreement was fair
from a financial point of view to such holders.
The full text of the written opinion of Goldman Sachs, dated March 19, 2016,
which sets forth the assumptions made, procedures followed, factors considered and limitations and qualifications on the review undertaken in connection with the opinion, is attached as Annex C to this proxy statement. The summary of the Goldman
Sachs opinion contained in this proxy statement is qualified in its entirety by reference to the full text of Goldman Sachs written opinion. Goldman Sachs advisory services and opinion were provided for the information and assistance of
the Valspar board of directors in connection with its consideration of the merger, and the opinion does not constitute a recommendation as to how any holder of Valspar common stock should vote with respect to the merger or any other matter.
-40-
In connection with rendering the opinion described above and performing its related financial
analyses, Goldman Sachs reviewed, among other things:
|
|
|
annual reports to stockholders and Annual Reports on Form 10-K of Valspar for the five fiscal years ended October 30, 2015;
|
|
|
|
certain interim reports to stockholders and Quarterly Reports on Form 10-Q of Valspar;
|
|
|
|
certain other communications from Valspar to its stockholders;
|
|
|
|
certain publicly available research analyst reports for Valspar; and
|
|
|
|
the Valspar Forecasts, which were approved by Valspar for use by Goldman Sachs.
|
Goldman Sachs
also held discussions with members of the senior management of Valspar regarding their assessment of the past and current business operations, financial condition and future prospects of Valspar; reviewed the reported price and trading activity for
the shares of Valspar common stock; compared certain financial and stock market information for Valspar with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent
business combinations in the coatings industry and in other industries; and performed such other studies and analyses and considered such other factors, as Goldman Sachs deemed appropriate.
For purposes of rendering its opinion, Goldman Sachs, with the consent of Valspar, relied upon and assumed the accuracy and completeness of
all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, Goldman Sachs, without assuming any responsibility for independent verification thereof. In that regard, Goldman Sachs
assumed, with the consent of Valspar, that the Valspar Forecasts had been reasonably prepared on a basis reflecting the best then currently available estimates and judgment of Valspar management. Goldman Sachs did not make an independent evaluation
or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of Valspar, and Goldman Sachs was not furnished with any such evaluation or appraisal. Goldman Sachs assumed that all
governmental, regulatory or other consents and approvals necessary for the consummation of the merger would be obtained, without any adverse effect on the expected benefits of the merger in any way meaningful to its analysis. Goldman Sachs assumed
that the merger would be consummated on the terms set forth in the merger agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to its analysis.
Goldman Sachs opinion did not address the underlying business decision of Valspar to engage in the merger or the relative merits of the
merger as compared to any strategic alternatives that may have been available to Valspar, nor did it address any legal, regulatory, tax or accounting matters. Goldman Sachs opinion addresses only the fairness from a financial point of view to
the holders (other than Sherwin-Williams and its affiliates) of shares of Valspar common stock, as of March 19, 2016, of the per share price, whether or not a triggering event occurs, to be paid to such holders pursuant to the merger agreement.
Goldman Sachs did not express any view on, and its opinion did not address, any other term or aspect of the merger agreement or the merger, or any term or aspect of any other agreement or instrument contemplated by the merger agreement or entered
into or amended in connection with the merger, including the fairness of the merger to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors or other constituencies of Valspar, nor as to
the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of Valspar, or class of such persons, in connection with the merger, whether relative to the per share price, whether or
not a triggering event occurs, to be paid to the holders (other than Sherwin-Williams and its affiliates) of shares of Valspar common stock pursuant to the merger agreement or otherwise. Goldman Sachs did not express any opinion as to the solvency
or viability of Valspar or Sherwin-Williams or the ability of Valspar or Sherwin-Williams to pay their respective obligations when they come due. Goldman Sachs opinion was necessarily based on economic, monetary, market and other conditions as
in effect on, and the information made available to Goldman Sachs as of,
-41-
March 19, 2016, the date of its opinion, and Goldman Sachs assumed no responsibility for updating, revising or reaffirming its opinion based on circumstances, developments or events
occurring after March 19, 2016. Goldman Sachs opinion was approved by a fairness committee of Goldman Sachs.
Goldman Sachs and
its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs
and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in
securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of Valspar, Sherwin-Williams, any of their respective affiliates and third parties, or any currency or commodity that may be involved in
the merger. Goldman Sachs has acted as a financial advisor to Valspar in connection with, and participated in certain of the negotiations leading to, the merger. Goldman Sachs has provided certain financial advisory and/or underwriting services to
Valspar and/or its affiliates from time to time, for which its Investment Banking Division has received, and may receive, compensation, including having acted as bookrunner in connection with the issuance of Valspars 3.30% Senior Notes due
February 2025 (aggregate principal amount $250,000,000) and 4.40% Senior Notes due February 2045 (aggregate principal amount $250,000,000) in January 2015; co-manager in connection with the issuance of Valspars 3.95% Senior Notes due January
2026 (aggregate principal amount $350,000,000) in July 2015; and dealer in Valspars $450 million commercial paper program. During the two-year period ended March 19, 2016, Goldman Sachs has received compensation for financial advisory
and/or underwriting services provided to Valspar and/or its affiliates of approximately $775,000.
Goldman Sachs also has provided certain
financial advisory and/or underwriting services to Sherwin-Williams and/or its affiliates from time to time, including acting as Sherwin-Williams financial advisor in connection with its announced acquisition of Consorcio Comex S.A. de C.V. in
September 2013 (which was subsequently terminated). During the two-year period ended March 19, 2016, the Investment Banking Division of Goldman Sachs has not been engaged by Sherwin-Williams or its affiliates to provide financial advisory or
underwriting services for which Goldman Sachs has received compensation.
Goldman Sachs may also in the future provide financial advisory
and/or underwriting services to Valspar, Sherwin-Williams and their respective affiliates for which Goldman Sachs Investment Banking Division may receive compensation.
Valspar selected Goldman Sachs as its financial advisor because it is an internationally recognized investment banking firm that has
substantial experience in transactions similar to the transaction contemplated by the merger agreement. Under an engagement letter between Valspar and Goldman Sachs and assuming a per share price of $113, Valspar has agreed to pay Goldman Sachs a
transaction fee of approximately $33,800,000, $5,000,000 of which became payable upon Valspars entry into the merger agreement and the remainder of which is payable upon consummation of the merger. In the event that the per share price is
$105, Valspar has agreed to pay Goldman Sachs a transaction fee of approximately $31,800,000, $5,000,000 of which became payable upon Valspars entry into the merger agreement and the remainder of which is payable upon consummation of the
merger. In addition, Valspar has agreed to reimburse certain of Goldman Sachs expenses arising, and indemnify Goldman Sachs against certain liabilities that may arise, out of Goldman Sachs engagement.
Summary of Material Financial Analyses
The following is a summary of the material financial analyses contained in the joint presentation that was made by BofA Merrill Lynch and
Goldman Sachs (which we refer to collectively in this proxy statement as the Financial Advisors) on March 19, 2016 to the Valspar board of directors in connection with the rendering of their respective opinions described above. The
following summary, however, does not purport to be a complete description of the financial analyses performed by either of the Financial Advisors, nor does the order of analyses described represent relative importance or weight given to those
analyses by either of the Financial Advisors.
-42-
The financial analyses summarized below, including the per share price references below, are
based on the per share price of $105, which would be the per share price if a triggering event occurs, not because it is the expected per share price but because it represents the lower of the two possible per share price outcomes contemplated by
the merger agreement. Each of the Financial Advisors determined that, taking into account its financial analysis, a per share price of $105 or, if no triggering event occurs, a per share price of $113, is fair from a financial point of view to the
holders of Valspar common stock.
The financial analyses summarized below include information presented in tabular format. In order to
fully understand the financial analyses performed by the Financial Advisors, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses performed by either of
the Financial Advisors. Considering the data set forth in the tables below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading
or incomplete view of the financial analyses performed by the Financial Advisors. Except as otherwise noted, the following quantitative information is based on data as such data existed, or were publicly available, on or before March 18, 2016,
and are not necessarily indicative of current market conditions.
Implied Multiples and Premiums Analysis
The Financial Advisors calculated the premium represented by the per share price in relation to:
|
|
|
the closing price per share of Valspar common stock as of March 18, 2016;
|
|
|
|
the highest intraday price per share of Valspar common stock over the 52-week period ended March 18, 2016;
|
|
|
|
the lowest intraday price per share of Valspar common stock over the 52-week period ended March 18, 2016;
|
|
|
|
the volume weighted average price (VWAP) for the shares of Valspar common stock over the 30-day period ended March 18, 2016;
|
|
|
|
the VWAP for the shares of Valspar common stock over the 60-day period ended March 18, 2016;
|
|
|
|
the VWAP for the shares of Valspar common stock over the 90-day period ended March 18, 2016; and
|
|
|
|
the VWAP for the shares of Valspar common stock over the 52-week period ended March 18, 2016.
|
The results of these calculations are as follows:
|
|
|
|
|
|
|
Premium
|
|
March 18, 2016
|
|
|
25.3
|
%
|
52-Week Intraday High
|
|
|
19.1
|
%
|
52-Week Intraday Low
|
|
|
48.8
|
%
|
30-Day VWAP
|
|
|
30.7
|
%
|
60-Day VWAP
|
|
|
32.3
|
%
|
90-Day VWAP
|
|
|
30.4
|
%
|
52-Week VWAP
|
|
|
30.4
|
%
|
In addition, the Financial Advisors calculated an implied equity value for Valspar using the per share price
(Implied Transaction Equity Value) by multiplying the $105 per share price by the number of diluted outstanding shares of Valspar common stock, calculated using information provided by Valspar management. The Financial Advisors also
calculated an implied enterprise value (EV) for Valspar using the $105 per share price (Implied Transaction Enterprise Value) by adding to the Implied Transaction Equity Value the amount of Valspars net debt (defined as
total debt less cash and cash equivalents) as of January 29, 2016, as reflected in Valspars quarterly report on Form 10-Q for the quarterly period ended January 29, 2016.
-43-
Using the foregoing, the Financial Advisors calculated the following implied multiples for
Valspar:
|
|
|
Implied Transaction Enterprise Value as a multiple of:
|
|
|
|
Valspars adjusted EBITDA for the four-quarter period ended January 29, 2016 (LTM adjusted EBITDA) as provided by Valspar management;
|
|
|
|
the estimate of Valspars 2016 adjusted EBITDA, calendarized to Valspars fiscal year end, which ends on the Friday on or immediately preceding October 31 of each year (Fiscal Year), reflected
in the Valspar Forecasts;
(1)
|
|
|
|
the estimate of Valspars Fiscal Year 2016 adjusted EBITDA, using the Institutional Broker Estimate System, which we refer to as IBES, consensus estimates;
|
|
|
|
the estimate of Valspars Fiscal Year 2017 adjusted EBITDA, reflected in the Valspar Forecasts;
(2)
|
|
|
|
the estimate of Valspars Fiscal Year 2017 adjusted EBITDA, using IBES consensus estimates; and
|
|
|
|
$105 per share price as a multiple of:
|
|
|
|
Valspars diluted earnings per share (EPS) for the four-quarter period ended January 29, 2016 (LTM EPS), as provided by Valspar management;
|
|
|
|
the estimate of Valspars Fiscal Year 2016 adjusted EPS, reflected in the Valspar Forecasts;
(3)
|
|
|
|
the estimate of Valspars Fiscal Year 2016 adjusted EPS, using IBES consensus estimates;
|
|
|
|
the estimate of Valspars Fiscal Year 2017 adjusted EPS, reflected in the Valspar Forecasts;
(4)
and
|
|
|
|
the estimate of Valspars Fiscal Year 2017 adjusted EPS, using IBES consensus estimates.
|
(1)
|
Projected adjusted EBITDA for fiscal year 2016 excludes certain restructuring and acquisition-related charges that have occurred, or may occur, in that fiscal year.
|
(2)
|
Projected adjusted EBITDA for fiscal years 2017 through 2020 excludes certain restructuring and acquisition-related charges that have occurred, or may occur, in those fiscal years.
|
(3)
|
Projected adjusted EPS for fiscal year 2016 excludes certain restructuring and acquisition-related charges that have occurred, or may occur, in that fiscal year.
|
(4)
|
Projected adjusted EPS for fiscal years 2017 through 2020 excludes certain restructuring and acquisition-related charges that have occurred, or may occur, in those fiscal years.
|
The results of these calculations are as follows:
|
|
|
|
|
|
|
|
|
|
|
Management
|
|
|
IBES
|
|
Implied Transaction Enterprise Value / EBITDA
|
|
|
|
|
|
|
|
|
LTM (1/29/2016)
|
|
|
15.2x
|
|
|
|
|
|
Fiscal Year 2016E
|
|
|
14.2x
|
|
|
|
14.2x
|
|
Fiscal Year 2017E
|
|
|
13.0x
|
|
|
|
13.4x
|
|
Per Share Price / EPS
|
|
|
|
|
|
|
|
|
LTM (1/29/2016)
|
|
|
23.7x
|
|
|
|
|
|
Fiscal Year 2016E
|
|
|
21.4x
|
|
|
|
21.6x
|
|
Fiscal Year 2017E
|
|
|
18.8x
|
|
|
|
19.6x
|
|
-44-
Selected Publicly Traded Companies Analysis
Using publicly available information and consensus estimates published by IBES and FactSet, each as of March 18, 2016, the Financial
Advisors compared financial information and ratios for Valspar with the corresponding information for a selected group of publicly traded companies. For purposes of these analyses, the Financial Advisors selected five publicly traded companies in
the coatings industry that, in the professional judgment of the Financial Advisors, have businesses that for purposes of analysis may be considered similar to those of Valspar. The selected companies were:
|
|
|
The Sherwin-Williams Company
|
|
|
|
Axalta Coatings Systems, LLC
|
The Financial Advisors calculated an implied equity value for
each of these companies using their respective closing share prices as of March 18, 2016 and the number of diluted shares of each, calculated using its most recent publicly available SEC filings. The Financial Advisors calculated an implied EV
for each company by adding the amount of each such companys net debt and non-controlling interest as reflected in its most recent publicly available balance sheet to the calculated implied equity value for each such company.
Using IBES consensus estimates calendarized to Valspars fiscal year end for each of Fiscal Year 2016 and Fiscal Year 2017 adjusted
EBITDA and the implied EVs the Financial Advisors calculated for each company as described above, the Financial Advisors calculated the following implied multiples for each of the selected companies and Valspar:
|
|
|
implied EV as a multiple of Fiscal Year 2016 estimated adjusted EBITDA (EV/Fiscal Year 2016 adjusted EBITDA Multiple); and
|
|
|
|
implied EV as a multiple of Fiscal Year 2017 estimated adjusted EBITDA (EV/Fiscal Year 2017 adjusted EBITDA Multiple).
|
Using IBES consensus estimates calendarized to Valspars fiscal year end for each of Fiscal Year 2016 and Fiscal Year 2017 adjusted EPS
and each companys closing share price as of March 18, 2016, the Financial Advisors calculated the following implied multiples for each of the selected companies and Valspar:
|
|
|
the closing share price as a multiple of Fiscal Year 2016 estimated adjusted EPS (Fiscal Year 2016 P/E Multiple); and
|
|
|
|
the closing share price as a multiple of Fiscal Year 2017 estimated adjusted EPS (Fiscal Year 2017 P/E Multiple).
|
A summary of the results of these calculations are reflected in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EV/Fiscal Year 2016
Adjusted EBITDA
Multiple
|
|
|
EV/Fiscal Year 2017
Adjusted EBITDA
Multiple
|
|
|
Fiscal Year 2016
P/E Multiple
|
|
|
Fiscal Year 2017
P/E Multiple
|
|
High
|
|
|
15.0x
|
|
|
|
14.0x
|
|
|
|
23.5x
|
|
|
|
20.7x
|
|
Mean
(1)
|
|
|
11.3x
|
|
|
|
10.6x
|
|
|
|
19.2x
|
|
|
|
17.1x
|
|
Low
|
|
|
7.4x
|
|
|
|
7.2x
|
|
|
|
14.0x
|
|
|
|
13.2x
|
|
Valspar
|
|
|
11.8x
|
|
|
|
11.1x
|
|
|
|
17.3x
|
|
|
|
15.7x
|
|
-45-
Finally, using publicly available information, IBES consensus estimates and FactSet, each as of
March 18, 2016, the Financial Advisors calculated various EV to next 12-months (NTM) adjusted EBITDA multiples for Valspar and the selected publicly traded companies. The Financial Advisors calculated EV to NTM Adjusted EBITDA
multiples for each day during the ten-year period ended March 18, 2016, using the closing share price, outstanding shares, net debt and non-controlling interest as reflected in the most recently publicly available balance sheet and estimated
NTM EBITDA as of each respective day. Based on such calculations, the Financial Advisors calculated the following multiples:
|
|
|
the EV to NTM adjusted EBITDA multiple on March 18, 2016;
|
|
|
|
the average EV to NTM adjusted EBITDA multiple over the 1-year period ended March 18, 2016;
|
|
|
|
the average EV to NTM adjusted EBITDA multiple over the 3-year period ended March 18, 2016;
|
|
|
|
the average EV to NTM adjusted EBITDA multiple over the 5-year period ended March 18, 2016; and
|
|
|
|
the average EV to NTM adjusted EBITDA multiple over the 10-year period ended March 18, 2016.
|
The results of this analysis are summarized in the table below:
Average EV/NTM Adjusted EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valspar Multiple
|
|
|
Average Selected Public
Companies Multiple
(1)
|
|
|
% Premium /Discount
|
|
Current
|
|
|
11.5x
|
|
|
|
10.8x
|
|
|
|
6.2
|
%
|
1-Year
|
|
|
10.7x
|
|
|
|
11.1x
|
|
|
|
(3.3
|
%)
|
3-Year
|
|
|
10.6x
|
|
|
|
10.9x
|
|
|
|
(2.4
|
%)
|
5-Year
|
|
|
9.8x
|
|
|
|
9.9x
|
|
|
|
(0.1
|
%)
|
10-Year
|
|
|
9.0x
|
|
|
|
8.6x
|
|
|
|
4.3
|
%
|
10-Year High
|
|
|
11.8x
|
|
|
|
|
|
|
|
|
|
10-Year Low
|
|
|
6.4x
|
|
|
|
|
|
|
|
|
|
(1)
|
Excludes Axalta Coating Systems, LLC for uniformity of data set over time.
|
BofA Merrill
Lynch
Using the foregoing and BofA Merrill Lynchs analyses of the selected companies and its professional judgment and
experience, BofA Merrill Lynch applied a reference range of EV to Fiscal Year estimated adjusted EBITDA Multiples of 10.0x to 12.0x to Valspars Fiscal Year 2016 estimated adjusted EBITDA, derived from the Valspar Forecasts, to calculate a
range of implied EVs for Valspar. BofA Merrill Lynch subtracted from the range of implied EVs the amount of Valspars net debt as of January 29, 2016, and divided the result by the number of diluted shares of Valspar common stock
outstanding as of March 18, 2016, calculated using information provided by Valspar management, to derive a reference range of implied per share values for Valspar of $68.10 to $85.80 (each, rounded to the nearest $0.05).
Using the foregoing, BofA Merrill Lynchs analyses of the selected companies and BofA Merrill Lynchs professional judgment and
experience, BofA Merrill Lynch applied a reference range of Fiscal Year 2017 P/E Multiples of 13.5x to 16.5x to Valspars Fiscal Year 2017 estimated adjusted EPS, which were derived from the Forecasts, to calculate a range of implied per share
values for Valspar of $75.50 to $92.30 (each, rounded to the nearest $0.05).
-46-
Present Value of Future Stock Price and Dividends
The Financial Advisors derived illustrative ranges of implied present values per share of Valspar common stock as of March 18, 2016, using
(1) theoretical future values for the Valspar common stock as of October 31, 2016, and each subsequent year through 2020, calculated using the Valspar Forecasts and (2) the dividends per share forecasted to be paid through each such
October 31, as reflected in the Valspar Forecasts.
The Financial Advisors derived a range of theoretical future values for shares of
Valspar common stock as of October 31, 2016 and each subsequent year through 2020, by:
|
|
|
applying, with respect to each October 31, illustrative one-year forward EV to adjusted EBITDA multiples ranging from 9.5x to 11.5x to estimates of Valspars adjusted EBITDA for the following year, as
reflected in the Valspar Forecasts, to derive a range of implied EVs for Valspar as of such October 31;
|
|
|
|
subtracting estimated net debt as of each such October 31, as reflected in the Valspar Forecasts, from the resulting range of implied EVs, to yield a range of implied equity values for Valspar as of each such
October 31; and
|
|
|
|
dividing the resulting range of implied equity values by the estimated fully diluted shares of Valspar common stock outstanding for each such October 31, as reflected in the Valspar Forecasts.
|
The future stock price was then discounted based on year-end convention, and the cumulative future dividends per share were discounted based
on mid-year convention.
BofA Merrill Lynch
By applying an illustrative discount rate of 10%, which reflected the approximate mid-point of BofA Merrill Lynchs estimated range for
Valspars cost of equity, BofA Merrill Lynch discounted to present value as of January 29, 2016 the range of theoretical future values it derived, as of October 31 of each of 2016 through 2020, and the dividends per share forecasted
to be paid through each such October 31, as reflected in the Valspar Forecasts, to yield a range of each years illustrative present values per share of Valspar common stock (rounded to the nearest $0.05). The results of this analysis are
summarized in the table below:
Present Value of Future Stock Price and Dividends
|
|
|
|
|
|
|
Valspar Valuation Range
|
|
Fiscal Year 2016E
|
|
$
|
69 to $88
|
|
Fiscal Year 2017E
|
|
$
|
73 to $93
|
|
Fiscal Year 2018E
|
|
$
|
77 to $96
|
|
Fiscal Year 2019E
|
|
$
|
80 to $101
|
|
Fiscal Year 2020E
|
|
$
|
82 to $103
|
|
-47-
Goldman Sachs
By applying an illustrative discount rate of 8.2%, which reflected Goldman Sachs estimate of Valspars cost of equity, Goldman Sachs
discounted to present value as of January 29, 2016 the range of theoretical future values it derived, as of October 31 of each of 2016 through 2020, and the dividends per share forecasted to be paid through each such October 31, as
reflected in the Valspar Forecasts, to yield a range of each years illustrative present values per share of Valspar common stock. The results of this analysis are summarized in the table below:
Present Value of Future Stock Price and Dividends
|
|
|
|
|
|
|
Valspar Valuation Range
|
|
Fiscal Year 2016E
|
|
$
|
70 to $89
|
|
Fiscal Year 2017E
|
|
$
|
76 to $95
|
|
Fiscal Year 2018E
|
|
$
|
80 to $101
|
|
Fiscal Year 2019E
|
|
$
|
85 to $107
|
|
Fiscal Year 2020E
|
|
$
|
89 to $111
|
|
Discounted Cash Flow Analysis
Using the Valspar Forecasts, each of the Financial Advisors performed a discounted cash flow analysis of Valspar to derive a range of
illustrative present values per share of Valspar common stock.
BofA Merrill Lynch
Using discount rates ranging from 7.50% to 9.50%, which reflected BofA Merrill Lynchs estimate of Valspars weighted average cost of
capital (WACC), BofA Merrill Lynch discounted to present value as of January 29, 2016, (1) estimates of the unlevered free cash flow for Valspar during the period from January 30, 2016 through October 31, 2020, such
estimates as approved by Valspar management after being calculated by BofA Merrill Lynch using information set forth in the Valspar Forecasts, and (2) a range of illustrative terminal values for Valspar as of October 31, 2020, which was
calculated by applying perpetuity growth rates ranging from 1.5% to 2.5% to estimated terminal year normalized free cash flow for Valspar, as reflected in the Valspar Forecasts. BofA Merrill Lynch derived ranges of illustrative EVs for Valspar by
adding the ranges of present values it derived in (1) and (2) above. BofA Merrill Lynch then subtracted from the range of illustrative EVs it derived, Valspars net debt as of January 29, 2016, as provided by Valspar management,
and divided the results by the number of diluted shares of Valspar common stock outstanding as of March 18, 2016, calculated using information provided by Valspar management, to derive a range of illustrative present values per share of Valspar
common stock ranging from $67.40 to $118.05 (each, rounded to the nearest $0.05).
Goldman Sachs
Using discount rates ranging from 6.75% to 8.25%, which reflected Goldman Sachs estimate of Valspars WACC, Goldman Sachs discounted
to present value as of January 31, 2016, (1) estimates of the unlevered free cash flow for Valspar during the period from January 30, 2016 through October 31, 2020, such estimates as approved by Valspar management after being
calculated by Goldman Sachs using information set forth in the Valspar Forecasts, and (2) a range of illustrative terminal values for Valspar as of October 31, 2020, which were calculated by applying perpetuity growth rates ranging from
1.5% to 2.5% to estimated terminal year normalized free cash flow for Valspar, as reflected in the Valspar Forecasts. Goldman Sachs derived ranges of illustrative EVs for Valspar by adding the ranges of present values it derived in (1) and
(2) above. Goldman Sachs then subtracted from the range of illustrative EVs it derived, Valspars net debt as of January 29, 2016, as provided by Valspar management, and divided the results by the number of diluted shares of Valspar
common stock outstanding as of March 18, 2016, calculated using information provided by Valspar management, to derive a range of illustrative present values per share of Valspar common stock ranging from $84 to $143.
-48-
Selected Precedent Transactions Analysis
The Financial Advisors analyzed certain publicly available information relating to the selected coatings industry acquisition transactions
listed below. Goldman Sachs performed its analysis with respect to all companies below (which we refer to as the Goldman Sachs selected transactions). BofA Merrill Lynch considered all of the companies below and focused its analysis on
the BofA Merrill Lynch selected transactions, which are indicated below.
|
|
|
|
|
Date Announced
|
|
Acquiror
|
|
Target
|
June 2014
|
|
PPG Industries, Inc.
*
|
|
Consorcio Comex, S.A. de C.V.
|
Nov. 2012
|
|
The Sherwin-Williams Company
|
|
Consorcio Comex, S.A. de C.V.
|
Oct. 2012
|
|
Advent International Corporation
|
|
Cytec Coatings Resins
|
Aug. 2012
|
|
The Carlyle Group
|
|
DuPont Performance Coatings
|
Aug. 2007
|
|
Akzo Nobel N.V.
*
|
|
Imperial Chemical Industries PLC
|
July 2007
|
|
PPG Industries, Inc.
*
|
|
SigmaKalon Group
|
Feb. 2006
|
|
Wendel Investissement
|
|
Materis SAS
|
Oct. 2004
|
|
Cytec Industries Inc.
|
|
UCB Surface Specialties
|
Nov. 2000
|
|
Berkshire Hathaway Inc.
|
|
Benjamin Moore & Co.
|
(*)
|
BofA Merrill Lynch selected transactions.
|
The Financial Advisors calculated the EV for each target company by multiplying the amount of the announced per share consideration paid or
payable in the applicable transaction by the number of diluted outstanding shares of the target company, and adding to the result the amount of the target companys net debt and non-controlling interest as of the date of the target
companys most recent balance sheet prior to the announcement of the transaction, in each case, which were based upon publicly available information for the target company. (If the necessary information to perform this calculation was not
available for a particular transaction, the Financial Advisors instead used the respective transaction value for each transaction as publicly disclosed as each target companys EV).
Using the EV for each of the transactions, the Financial Advisors calculated the EV as a multiple of last 12-month EBITDA of the target
company (LTM EBITDA Multiple). The LTM EBITDA Multiples for the BofA Merrill Lynch selected transactions ranged from approximately 10.0x to 11.7x. The mean for the BofA Merrill Lynch selected transactions was 11.1x. The LTM EBITDA
Multiples for the Goldman Sachs selected transactions ranged from approximately 6.8x to 14.5x. The median for the Goldman Sachs selected transactions was 10.0x.
Although none of the selected transactions are directly comparable to the proposed merger, the target companies in the selected transactions
were companies with operations that, for the purposes of analysis, may be considered similar to certain of Valspars operations, and as such, for purposes of the Financial Advisors analysis, the selected transactions may be considered
similar to the merger.
BofA Merrill Lynch
Using the foregoing, BofA Merrill Lynchs analyses of the BofA Merrill Lynch selected transactions and BofA Merrill Lynchs
professional judgment and experience, BofA Merrill Lynch applied a reference range of LTM EBITDA Multiples of 9.5x to 12.5x to Valspars LTM adjusted EBITDA to derive a range of implied EVs for Valspar. BofA Merrill Lynch subtracted from the
range of implied EVs the amount of Valspars net debt as of January 29, 2016 and divided the result by the number of diluted shares of Valspar common stock outstanding as of March 18, 2016, which were calculated using information
provided by Valspar management, to derive a reference range of implied per share values for Valspar of $57.70 to $82.55 (rounded to the nearest $0.05).
-49-
Goldman Sachs
Using the foregoing, Goldman Sachs analyses of the Goldman Sachs selected transactions and Goldman Sachs professional judgment and
experience, Goldman Sachs applied a reference range of LTM EBITDA Multiples of 6.8x to 14.5x to Valspars LTM adjusted EBITDA to derive a range of implied EVs for Valspar. Goldman Sachs subtracted from the range of implied EVs the amount of
Valspars net debt as of January 29, 2016 and divided the result by the number of diluted shares of Valspar common stock outstanding as of March 18, 2016, which was calculated using information provided by Valspar management, to
derive a reference range of implied per share values for Valspar of $34 to $99.
Acquisition Premium for United States Cash Transactions
Goldman Sachs
Using
Thomson Financial Securities Data as of March 18, 2016, Goldman Sachs calculated the median premium paid in completed deals for each year from 2010 to 2015 that were valued over $1 billion, and involved 100% cash consideration for publicly
traded U.S. targets in which the acquirer held no ownership in the target prior to the acquisition. Goldman Sachs calculated each premium using the targets price one day before the announcement of the acquisition. These calculations resulted
in a range of median acquisition premia for the selected transactions of 26% to 37%. Applying these acquisition premia to the closing share price of Valspar common stock on March 18, 2016, Goldman Sachs calculated a range of implied per share
values of Valspar common stock of $106 to $115.
General
The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description.
Selecting portions of the analyses or of the summary set forth above, without considering the analyses as a whole, could create an incomplete view of the processes underlying the Financial Advisors respective opinions. In arriving at their
respective fairness determinations, each of the Financial Advisors considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis considered by it. Rather, each Financial Advisor made its
determination as to fairness on the basis of its experience and professional judgment after considering the results of all of its analyses.
No company or transaction used in the above analyses as a comparison is directly comparable to Valspar or the merger.
The analyses by the Financial Advisors do not purport to be appraisals, nor do they necessarily reflect the prices at which businesses or
securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses. Because these analyses are
inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties or their respective advisors, none of Valspar, BofA Merrill Lynch, Goldman Sachs, Sherwin-Williams, the Sherwin-Williams board of
directors, Sherwin-Williams financial advisor or any other person assumes responsibility if future results are materially different from those forecasts.
Financing
In connection with execution of the merger agreement, Sherwin-Williams received debt financing commitments in the amount of $9.3 billion from
Citigroup Global Markets Inc., Citibank, N.A. and certain of their affiliates. The merger, however, is not conditioned upon receipt of this or other financing by Sherwin-Williams. See the section entitled
The Merger Agreement
Financing and Financing Cooperation
.
-50-
Interests of the Companys Directors and Executive Officers in the Merger
In considering the recommendation of the Valspar board of directors that you vote to adopt the merger agreement, you should be aware
that aside from their interests as stockholders of the Company, the Valspar directors and executive officers may have interests in the merger that are different from, or in addition to, those of other stockholders of the Company generally. The
members of the Valspar board of directors were aware of and considered these interests, among other matters, in evaluating and negotiating the merger agreement and the merger, and in recommending to the stockholders of the Company that the merger
agreement be adopted. The Companys stockholders should take these interests into account in deciding whether to vote
FOR
the proposal to adopt the merger agreement. These interests are described in more detail below, and
certain of them are quantified within the narrative disclosure and the table below. The transactions contemplated by the merger agreement will constitute a change in control, change of control or term of similar meaning for
purposes of the Companys executive compensation and benefit plans and agreements described below. Since the Companys named executive officers are its only executive officers, the disclosure set forth below relates to the Companys
directors and named executive officers.
Certain Assumptions
Except as otherwise specifically noted, for purposes of quantifying the potential payments and benefits described in this section, the
following assumptions were used:
|
|
|
The relevant price per share of the Company common stock is $113, which is the amount of the cash merger consideration if a triggering divestiture does not occur;
|
|
|
|
The effective time is April 13, 2016, which is the assumed date of the closing of the merger solely for purposes of the disclosure in this section;
|
|
|
|
Each named executive officer of the Company experiences a qualifying termination, including a termination by the Company without cause or resignation by the named executive officer for good
reason, as such terms are defined in the relevant Company plans and agreements as in effect on the date hereof, immediately following the assumed effective time of April 13, 2016.
|
Equity Compensation
Treatment
of Stock Options
At the effective time, each Company stock option granted prior to the date of the merger agreement, including each
such Company stock option held by a named executive officer or non-employee director of the Company, that is outstanding as of the effective time, whether vested or unvested, will be cancelled in consideration for the right to receive a cash payment
(without interest and less applicable withholding taxes) equal to the product of (1) the number of shares of Company common stock subject to such option as of the effective time and (2) the excess, if any, of the merger consideration over
the exercise price per share of Company common stock subject to such option as of the effective time. No Company stock options have been granted to the named executive officers after the date of the merger agreement and prior to the date of this
proxy statement, and the Company does not expect to grant any Company stock options to the named executive officers after the date of this proxy statement and prior to the effective time of the merger.
Treatment of Time-Based and Performance-Based Restricted Stock Units
At the effective time, each Company time-based restricted stock unit award and each Company performance-based restricted stock unit award,
including each such award held by a named executive officer of the Company, that is outstanding as of the effective time will, if granted prior to the date of the merger agreement, be cancelled in consideration for the right to receive a cash
payment (without interest and less applicable withholding taxes) equal to the product of (1) the number of shares of Company common stock subject to such award as of the effective time (with respect to each performance-based restricted stock
unit
-51-
award, determined by assuming the actual level of achievement of the applicable performance goals in respect of fiscal years completed prior to the effective time and the target level of
achievement of the applicable performance goals in respect of all other fiscal years) and (2) the merger consideration. At the effective time, each Company time-based restricted stock unit award granted after the date of the merger agreement,
including each such award that is granted to a named executive officer of the Company, that is outstanding as of immediately prior to the effective time will be converted into a Sherwin-Williams restricted stock unit award, on the same terms and
conditions applicable to such Company time-based restricted stock unit award immediately prior to the effective time (including vesting and any applicable accelerated vesting) relating to the number of shares of Sherwin-Williams common stock
(rounded up to the nearest whole number of shares) equal to the product of (a) the equity award exchange ratio, multiplied by (b) the number of shares of Company common stock subject to such award as of immediately prior to the effective
time. The equity award exchange ratio means the quotient (rounded to four decimal places) obtained by dividing the merger consideration by the volume weighted average trading price of Sherwin-Williams common stock for the five
consecutive trading days ending with, and including, the trading day immediately prior to the closing date. Company time-based restricted stock unit awards granted after the date of the merger agreement, including any Company time-based restricted
stock unit awards granted to the named executive officers, will vest (1) in full upon the holders qualifying termination of employment after the end of fiscal year 2017, and (2) pro-rata upon the holders qualifying termination
of employment prior to the end of fiscal year 2017, based on the number of days worked by the holder in fiscal year 2017. As of the date of this proxy statement, no such Company time-based restricted stock unit awards have been granted to any named
executive officer.
Treatment of Restricted Shares
At the effective time, each share of Company common stock subject to vesting, repurchase or other lapse restrictions pursuant to an award
granted by the Company, including each such award held by a named executive officer or non-employee director, that is outstanding as of the effective time shall vest in full and become free of restrictions and shall be cancelled and converted
automatically into the right of the holder to receive the merger consideration (less applicable withholding taxes).
Quantification of
Equity Compensation
See the section entitled
Interests of the Companys Directors and Executive Officers in the Merger
Quantification of Potential Payments and Benefits to the Companys Named Executive Officers in Connection with the Merger
for an estimate of the value of the unvested equity awards held by each of the Companys named
executive officers that will become vested at the effective time based on the assumptions described above under
Certain Assumptions
. Also based on those assumptions, the estimated aggregate value of the unvested
restricted shares held by four of the Companys ten non-employee directors that will become vested at the effective time is $729,980; the remaining non-employee directors do not hold unvested equity awards. For more information on equity
holdings of the Companys non-employee directors and named executive officers, see the table entitled
Security Ownership of Certain Beneficial Owners and Management
.
Change in Control Employment Agreements
The Company has entered into a change in control employment agreement (a CIC Agreement) with each named executive officer providing
for the continued employment of such officer for a period of up to two years following a change in control of the Company. Each CIC Agreement provides that, for so long as the named executive officer remains employed during such two-year period, his
position, compensation and benefits will be commensurate with his position, compensation and benefits in effect prior to the change in control. Under each CIC Agreement, upon a termination of the named executive officers employment by the
Company other than for cause, death or disability, or due to the named executive officers resignation for good reason, in each case within two years following a change in control, the officer is entitled to receive: (1) a lump sum cash
severance payment equal to a multiple (three times in the case of Messrs. Hendrickson and Engh and two times in the case of
-52-
Messrs. Muehlbauer, Heckes and Ireland) of the sum of (a) the officers annual base salary (defined as 12 times the highest monthly base salary paid or payable to the officer in the
one-year period preceding the month in which a change in control occurs) and (b) the officers target annual bonus (defined as the target annual cash incentive bonus for the fiscal year during which the qualifying termination of employment
occurs), (2) a prorated cash bonus payment equal to the officers target annual cash incentive bonus multiplied by a fraction, the numerator of which is the number of days in the fiscal year through the date of the qualifying termination
of employment and the denominator of which is 365, (3) for three years following such termination of employment, health care and life insurance benefits at least equal to, and at the same after-tax cost, as those which would have been provided
absent a termination of employment or, if more favorable to the officer, as in effect generally from time to time with respect to other peer executives of the Company and its affiliates, and (4) at the Companys sole expense, outplacement
services substantially similar to those available to the officer immediately before the qualifying termination of employment.
In
addition, each CIC Agreement provides that the Company will pay all legal fees and expenses that the named executive officer reasonably incurs as a result of any contest (regardless of the outcome thereof) respecting the validity or enforceability
of, or liability under, any provision of the officers CIC Agreement or any guarantee of performance thereof (including as a result of any contest by the officer about the amount of any payment pursuant to the CIC Agreement), plus interest.
The CIC Agreement with each of Messrs. Hendrickson, Engh and Heckes provides for a gross-up of the excise tax imposed on the payments and
benefits to each such named executive officer in connection with a change in control by reason of Sections 4999 and 280G of the Code. The CIC Agreement with each of Messrs. Muehlbauer and Ireland provides that if the payments and benefits to each
such named executive officer in connection with a change in control would be subject to an excise tax by reason of Sections 4999 and 280G of the Code, the payments and benefits under the CIC Agreement will be reduced to the extent necessary to
prevent any portion of the officers change in control-related payments and benefits from becoming subject to such excise tax, but only if, by reason of that reduction, the net after-tax benefit received by the officer exceeds the net after-tax
benefit that the officer would receive if no reduction was made.
The CIC Agreements include a perpetual confidentiality covenant with
respect to the confidential information of the Company and its affiliates. In addition, the CIC Agreement with each of Messrs. Muehlbauer and Ireland includes non-compete, employee non-solicit and no-hire and customer non-solicit and
non-interference
covenants that apply for three years following the officers termination of employment. In addition, each named executive officer has entered into a separate restrictive covenant agreement in
connection with the receipt of equity awards from the Company that includes (1) with respect to Messrs. Ireland and Muehlbauer, non-compete and customer non-solicit covenants that apply for three years following termination of employment,
(2) with respect to Messrs. Engh and Heckes, a non-compete covenant that applies for three years following termination of employment and (3) with respect to Mr. Hendrickson, a perpetual confidentiality covenant and non-compete,
employee non-solicit and no-hire and customer non-solicit and non-interference covenants that apply for three years following termination of employment.
See the section entitled
Interests of the Companys Directors and Executive Officers in the Merger Quantification of
Potential Payments and Benefits to the Companys Named Executive Officers in Connection with the Merger
for an estimate of the value of the severance benefits payable to each of the Companys named executive officers upon a
qualifying termination immediately following the effective time.
Rights to Post-Retirement Medical Coverage
The Company may amend its officer retiree medical plan effective immediately prior to, and contingent upon, the closing of the merger, to
provide that (1) each of Messrs. Muehlbauer, Ireland and Heckes shall be deemed to have satisfied all eligibility requirements provided by the plan from and after the closing, so long as he remains actively employed as an officer of the Company
through the closing or, if earlier, the time at which he
-53-
actually satisfies all eligibility requirements provided by the plan (Messrs. Hendrickson and Engh have already satisfied all eligibility requirements), (2) for any named executive officer
who becomes entitled to healthcare continuation coverage under the terms of a CIC Agreement, such officers coverage under the retiree medical plan will commence at the expiration of such continuation coverage period, and (3) the right of
the named executive officers to participate in the officer retiree medical plan from and after the closing shall be nonforfeitable. See the section entitled
Interests of the Companys Directors and Executive Officers in the Merger
Quantification of Potential Payments and Benefits to the Companys Named Executive Officers in Connection with the Merger
for an estimate of the potential value of the retiree medical coverage for each of Messrs. Muehlbauer,
Ireland and Heckes as a result of the deemed satisfaction of the applicable eligibility requirements under the Companys officer retiree medical plan.
Indemnification and Insurance
Pursuant to the terms of the merger agreement, the Company non-employee directors and executive officers will be entitled to certain ongoing
indemnification and coverage under certain directors and officers liability insurance policies following the merger. Such indemnification and insurance coverage is further described in the section entitled
The Merger Agreement
Indemnification and Insurance
.
Quantification of Potential Payments and Benefits to the Companys Named Executive Officers in
Connection with the Merger
The information set forth in the table below is intended to comply with Item 402(t) of the
SECs Regulation S-K, which requires disclosure of information about certain compensation for each named executive officer of the Company that is based on, or otherwise relates to, the merger. The amounts shown in the table below are estimates
based on multiple assumptions that may or may not actually occur or be accurate on the relevant date, including the assumptions described below and in the footnotes to the table, and do not reflect certain compensation actions that may occur before
completion of the merger. For purposes of calculating such amounts, the following assumptions were used:
|
|
|
The relevant price per share of the Company common stock is $113, which is the amount of the cash merger consideration if a triggering divestiture does not occur;
|
|
|
|
The effective time is April 13, 2016, which is the assumed date of the closing of the merger solely for purposes of the disclosure in this section; and
|
|
|
|
Each named executive officer of the Company experiences a qualifying termination, including a termination by the Company without cause or resignation by the named executive officer for good
reason as such terms are defined in the relevant Company plans and agreements as in effect on the date hereof, immediately following the assumed effective time of April 13, 2016.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Cash ($)(1)
|
|
|
Equity($)(2)
|
|
|
Perquisites/
Benefits($)(3)
|
|
|
Tax
Reimbursement
($)(4)
|
|
|
Total ($)
|
|
Gary E. Hendrickson
|
|
|
7,712,301
|
|
|
|
30,341,459
|
|
|
|
91,000
|
|
|
|
0
|
|
|
|
38,144,760
|
|
James L. Muehlbauer
|
|
|
2,419,748
|
|
|
|
8,255,859
|
|
|
|
460,000
|
|
|
|
N/A
|
|
|
|
11,135,607
|
|
Rolf Engh
|
|
|
2,639,972
|
|
|
|
2,280,258
|
|
|
|
85,000
|
|
|
|
0
|
|
|
|
5,005,230
|
|
Howard C. Heckes
|
|
|
2,179,040
|
|
|
|
4,963,079
|
|
|
|
502,000
|
|
|
|
0
|
|
|
|
7,644,119
|
|
Les H. Ireland
|
|
|
1,957,911
|
|
|
|
3,050,996
|
|
|
|
500,000
|
|
|
|
N/A
|
|
|
|
5,508,907
|
|
(1)
|
Cash
. Includes (a) a lump sum cash severance payment equal to a multiple (three times in the case of
Messrs. Hendrickson and Engh and two times in the case of Messrs. Muehlbauer, Heckes and Ireland) of the sum of (i) the officers annual base salary (defined as 12 times the highest monthly base salary paid or payable to the executive in
the one-year period preceding the month in which a change in control occurs) and (ii) the officers target annual bonus (defined as the target annual cash incentive bonus for the fiscal
|
-54-
|
year during which the qualifying termination of employment occurs), and (b) a prorated cash bonus payment equal to the officers target annual cash incentive bonus multiplied by a
fraction, the numerator of which is the number of days in the fiscal year through the date of the qualifying termination of employment and the denominator of which is 365. Such payments are double trigger and payable only upon a
qualifying termination of employment on or during the two-year period immediately following the effective time of the merger. The estimated amount of each such payment is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Severance ($)
|
|
|
Prorated Bonus ($)
|
|
|
Total ($)
|
|
Gary E. Hendrickson
|
|
|
7,107,000
|
|
|
|
605,301
|
|
|
|
7,712,301
|
|
James L. Muehlbauer
|
|
|
2,206,050
|
|
|
|
213,698
|
|
|
|
2,419,748
|
|
Rolf Engh
|
|
|
2,485,740
|
|
|
|
154,232
|
|
|
|
2,639,972
|
|
Howard C. Heckes
|
|
|
1,986,600
|
|
|
|
192,440
|
|
|
|
2,179,040
|
|
Les H. Ireland
|
|
|
1,785,000
|
|
|
|
172,911
|
|
|
|
1,957,911
|
|
(2)
|
Equity
. Includes unvested stock options, unvested restricted stock, unvested time-based restricted stock units, and unvested performance-based restricted stock units, in each case that are outstanding as of the
assumed closing date of April 13, 2016. All such awards are single trigger and will become vested in full at the effective time. The amounts reflected exclude the estimated value of Company equity awards held by named executive
officers who are retirement eligible as of the assumed closing date of April 13, 2016 ($8,951,777 for Mr. Hendrickson and $1,436,660 for Mr. Engh) that would vest upon retirement in the ordinary course and independent of the merger,
pursuant to the terms of such awards as in effect on the grant date. The Company and Sherwin-Williams have agreed that time-based restricted stock unit awards granted after the date of the merger agreement as part of the Companys ordinary
annual compensation cycle relating to fiscal year 2017, including those granted to the named executive officers, will be double trigger and will vest following the effective time, either (1) in full, upon the holders
qualifying termination of employment after the end of fiscal year 2017, or (2) pro-rata, upon the holders qualifying termination of employment prior to the end of fiscal year 2017, based on the number of days worked by the holder in
fiscal year 2017. As of the date of this proxy statement, no such double trigger awards have been granted to named executive officers and therefore no estimated value is included with respect to such awards. For further details regarding the
treatment of the Company equity awards in connection with the merger, see above under
Interests of the Companys Directors and Executive Officers in the Merger Equity Compensation
. The estimated value of the single
trigger awards is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Stock Options
($)
|
|
|
Restricted Stock
($)
|
|
|
Restricted Stock
Units ($)
|
|
|
Performance-
Based
Restricted
Stock Units
($)
|
|
|
Total ($)
|
|
Gary E. Hendrickson
|
|
|
7,775,041
|
|
|
|
N/A
|
|
|
|
16,658,686
|
|
|
|
5,907,732
|
|
|
|
30,341,459
|
|
James L. Muehlbauer
|
|
|
3,410,906
|
|
|
|
1,348,881
|
|
|
|
1,997,275
|
|
|
|
1,498,797
|
|
|
|
8,255,859
|
|
Rolf Engh
|
|
|
1,013,404
|
|
|
|
N/A
|
|
|
|
506,240
|
|
|
|
760,614
|
|
|
|
2,280,258
|
|
Howard C. Heckes
|
|
|
1,742,290
|
|
|
|
731,110
|
|
|
|
1,424,026
|
|
|
|
1,065,653
|
|
|
|
4,963,079
|
|
Les H. Ireland
|
|
|
1,027,300
|
|
|
|
670,090
|
|
|
|
540,140
|
|
|
|
813,466
|
|
|
|
3,050,996
|
|
(3)
|
Perquisites/Benefits
. Includes (a) for three years following termination of employment, health care
and life insurance benefits at least equal to, and at the same after-tax cost, as those which would have been provided absent a termination of employment or, if more favorable to the officer, as in effect generally from time to time with respect to
other peer executives of the Company and its affiliates, and (b) at the Companys sole expense, outplacement services substantially similar to those available to the officer immediately before the qualifying termination of employment. Such
benefits are double trigger and are provided only upon a qualifying termination of employment on or during the two-year period immediately following the effective time of the merger. Also includes, with respect to Messrs. Muehlbauer,
Heckes and Ireland, an estimate of the potential value of the retiree medical coverage as a result of the deemed satisfaction of the applicable eligibility requirements under the Companys officer retiree medical plan, as described above under
|
-55-
|
Interests of the Companys Directors and Executive Officers in the MergerRights to Post-Retirement Medical Coverage
. Such waiver of the eligibility requirements
under the Companys officer retiree medical plan is single trigger. In accordance with applicable SEC rules, the estimated value of (i) for each named executive officer, the health care and life insurance benefits, and (ii) for
Messrs. Muehlbauer, Heckes and Ireland, the potential value of the retiree medical coverage, was calculated based on the same assumptions used for financial reporting purposes. The estimated value of these benefits is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Healthcare and Life
Insurance Benefits
($)
|
|
|
Outplacement
Services ($)
|
|
|
Retiree Medical -
Waiver of
Eligibility
Requirements ($)
|
|
|
Total ($)
|
|
Gary E. Hendrickson
|
|
|
61,000
|
|
|
|
30,000
|
|
|
|
N/A
|
|
|
|
91,000
|
|
James L. Muehlbauer
|
|
|
63,000
|
|
|
|
30,000
|
|
|
|
367,000
|
|
|
|
460,000
|
|
Rolf Engh
|
|
|
55,000
|
|
|
|
30,000
|
|
|
|
N/A
|
|
|
|
85,000
|
|
Howard C. Heckes
|
|
|
56,000
|
|
|
|
30,000
|
|
|
|
416,000
|
|
|
|
502,000
|
|
Les H. Ireland
|
|
|
58,000
|
|
|
|
30,000
|
|
|
|
412,000
|
|
|
|
500,000
|
|
(4)
|
Tax Reimbursements
. Each of Messrs. Hendrickson, Engh and Heckes is entitled to receive, under the terms of such officers CIC Agreement, a gross-up payment for the excise tax imposed on the payments and
benefits to such officer in connection with a change in control by reason of Sections 4999 and 280G of the Code. Based on the estimated values of such payments and benefits as described in this proxy statement, no gross-up payment would be due to
any such officer. Messrs. Muehlbauer and Ireland are not entitled to receive a gross-up payment under the terms of their CIC Agreements.
|
Material U.S. Federal Income Tax Consequences of the Merger
The following is a general discussion of the material U.S. federal income tax consequences of the merger to U.S. holders (as defined below) of
common stock whose shares are exchanged for cash pursuant to the merger. This discussion does not address U.S. federal income tax consequences with respect to holders other than U.S. holders. This discussion is based on the provisions of the Code,
applicable U.S. Treasury Regulations, judicial opinions and administrative rulings and published positions of the Internal Revenue Service (the IRS), each as in effect as of the date hereof. These authorities are subject to change or
differing interpretations, possibly on a retroactive basis, and any such change or interpretation could affect the accuracy of the statements and conclusions set forth in this discussion. This discussion is for general information purposes only and
does not purport to be a complete analysis of all potential tax consequences. This discussion does not address any tax consequences arising under the unearned income Medicare contribution tax pursuant to the Health Care and Education Reconciliation
Act of 2010, nor does it address any tax considerations under state, local or foreign laws or U.S. federal laws other than those pertaining to the U.S. federal income tax. This discussion is not binding on the IRS or the courts and, therefore, could
be subject to challenge, which could be sustained. No ruling is intended to be sought from the IRS with respect to the merger.
For
purposes of this discussion, the term U.S. holder means a beneficial owner of common stock that is for U.S. federal income tax purposes:
|
|
|
a citizen or individual resident of the United States;
|
|
|
|
a corporation, or other entity classified as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States, any state thereof, or the District of Columbia;
|
|
|
|
a trust if (1) a court within the United States is able to exercise primary supervision over the trusts administration, and one or more U.S. persons are authorized to control all substantial decisions of the
trust or (2) such trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person; or
|
|
|
|
an estate the income of which is subject to U.S. federal income tax regardless of its source.
|
-56-
This discussion applies only to U.S. holders of shares of common stock who hold such shares as a
capital asset within the meaning of Section 1221 of the Code (generally, property held for investment). Further, this discussion does not purport to consider all aspects of U.S. federal income taxation that may be relevant to a U.S. holder in
light of its particular circumstances, or that may apply to U.S. holders subject to special treatment under U.S. federal income tax laws (including, for example, insurance companies, dealers or brokers in securities or foreign currencies, traders in
securities who elect the mark-to-market method of accounting, holders subject to the alternative minimum tax, U.S. holders that have a functional currency other than the U.S. dollar, tax-exempt organizations, tax-qualified retirement plans, banks
and other financial institutions, mutual funds, certain expatriates, partnerships (or other entities or arrangements treated as partnerships for U.S. federal income tax purposes), S corporations, or other pass-through entities, or investors in such
partnerships, S corporations or other pass-through entities, real estate investment trusts, regulated investment companies, U.S. holders who hold shares of common stock as part of a hedge, straddle, constructive sale, conversion or other integrated
transaction, U.S. holders who will hold (actually or constructively) an equity interest in the surviving corporation immediately after the merger, and U.S. holders who acquired their shares of common stock through the exercise of employee stock
options or other compensation arrangements). This discussion also does not address the U.S. federal income tax consequences to holders of shares of common stock who exercise appraisal rights in connection with the merger under the DGCL.
If a partnership (including for this purpose any entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds
shares of common stock, the tax treatment of a partner in such partnership will generally depend on the status of the partners and the activities of the partnership. If you are, for U.S. federal income tax purposes, a partner in a partnership
holding shares of common stock, you should consult your tax advisor.
This summary of material U.S. federal income tax consequences is
for general information purposes only and is not tax advice. Holders of common stock are urged to consult their own tax advisors to determine the particular tax consequences to them of the merger, including the applicability and effect of the
alternative minimum tax, the unearned income Medicare contribution tax and any other U.S. federal, or state, local, foreign or other tax laws.
The receipt of cash by U.S. holders in exchange for shares of common stock pursuant to the merger will be a taxable transaction for U.S.
federal income tax purposes. In general, for U.S. federal income tax purposes, a U.S. holder who receives cash in exchange for shares of common stock pursuant to the merger will recognize capital gain or loss in an amount equal to the difference, if
any, between (1) the amount of cash received and (2) the U.S. holders adjusted tax basis in such shares.
Any such gain or
loss will be long-term capital gain or loss if a U.S. holders holding period in the shares of common stock surrendered in the merger is greater than one year as of the date of the merger. Long-term capital gains of certain non-corporate
holders, including individuals, are generally subject to U.S. federal income tax at preferential rates. The deductibility of capital losses is subject to limitations. If a U.S. holder acquired different blocks of common stock at different times and
different prices, such U.S. holder must determine its adjusted tax basis, gain or loss and holding period separately with respect to each block of common stock.
Information Reporting and Backup Withholding
Payments made in exchange for shares of common stock pursuant to the merger may be subject, under certain circumstances, to information
reporting and backup withholding (currently at a rate of 28%). To avoid backup withholding, a U.S. holder that does not otherwise establish an exemption should complete and return to the applicable withholding agent a properly completed and executed
IRS Form W-9, certifying that such U.S. holder is a U.S. person, that the taxpayer identification number provided is correct, and that such U.S. holder is not subject to backup withholding.
-57-
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding
rules may be refunded or credited against a holders U.S. federal income tax liability, if any, provided that such holder furnishes the required information to the IRS in a timely manner.
Regulatory Approvals
Under the HSR Act and related rules, certain transactions, including the merger, may not be completed until notifications have been given and
information furnished to the Antitrust Division and the FTC and all statutory waiting period requirements have been satisfied. Completion of the merger is subject to the expiration or termination of the applicable waiting period under the HSR Act.
On April 8, 2016, both the Company and Sherwin-Williams filed their respective Notification and Report Forms with the Antitrust Division and the FTC. On May 9, 2016, the FTC issued a Second Request to each of Sherwin-Williams and Valspar
in connection with the FTCs regulatory review of the transaction. The Second Request extends the waiting period for 30 calendar days following the date both parties have substantially complied with the Second Request, unless the waiting period
is terminated earlier by the FTC or extended by agreement or court order.
Completion of the merger is further subject to notification or
receipt of certain regulatory approvals, including notification, clearance and/or approval in Australia, Brazil, Canada, China, Ecuador, the European Union, Mexico and Russia.
At any time before or after the expiration of the statutory waiting periods under the HSR Act, the Antitrust Division or the FTC may take
action under the antitrust laws, including seeking to enjoin the completion of the merger, to rescind the merger or to conditionally permit completion of the merger subject to regulatory conditions or other remedies. In addition, non-U.S. regulatory
bodies and U.S. state attorneys general could take action under the antitrust laws as they deem necessary or desirable in the public interest, including, without limitation, seeking to enjoin the completion of the merger or permitting completion
subject to regulatory conditions. Private parties may also seek to take legal action under the antitrust laws under some circumstances. Although neither Valspar nor Sherwin-Williams believes that the merger will violate the antitrust laws, there can
be no assurance that a challenge to the merger on antitrust grounds will not be made or, if such a challenge is made, that it would not be successful.
If necessary to obtain the requisite antitrust clearances, Sherwin-Williams has agreed, among other things, to take or commit to the sale,
divestiture, license, holding separate or other disposition of, or restriction on, the businesses, assets, properties, product lines or equity interests of, or changes to the conduct of business of, Valspar, Sherwin-Williams and their respective
subsidiaries (including the surviving corporation and its subsidiaries). However, Sherwin-Williams will not be required to sell, divest, license, hold separate or otherwise dispose of businesses, assets, properties, product lines and equity
interests (1) representing, in the aggregate, more than $1.5 billion of net sales or (2) of Sherwin-Williams Sherwin-Williams, Krylon or Ronseal trademark or trade name, or any businesses or
product lines using any such trademarks or trade names, in any jurisdiction other than Australia. See the section entitled
The Merger Agreement Efforts to Complete the Merger Divestitures and Triggering Divestiture
.
However, if Sherwin-Williams is required, in order to obtain the necessary regulatory approvals, to commit to a triggering divestiture, as described in the section entitled
The Merger Agreement Efforts to Complete the Merger
Divestitures and Triggering Divestiture
, then the merger consideration will be $105.00 per share in cash, without interest, and subject to any applicable withholding taxes. See the section entitled
The Merger (Proposal 1)
Regulatory Approvals
.
For purposes of the regulatory approvals provisions of the merger agreement, the calculation of net sales
with respect to any asset, business or product line will be measured by reference to the net sales of Valspars corresponding asset, business or product line for the fiscal year ended October 30, 2015, regardless of which asset, business
or product line is actually divested. However, the net sales associated with any asset, business or product line of Valspar or its subsidiaries involved in the manufacture, distribution or sale of architectural
-58-
coatings in Australia will not count toward calculating the $650 million when determining whether a triggering divestiture has occurred or toward calculating the $1.5 billion in net sales that
represents the limit of Sherwin-Williams divestiture obligations. The net sales associated with any asset, business or product line of Sherwin-Williams or its subsidiaries involved in the manufacture, distribution or sale of architectural
coatings in Australia will count toward the aforesaid $650 million and $1.5 billion calculations.
If any governmental entity requires
Sherwin-Williams to take action in order to obtain necessary approvals under the antitrust laws that amount to a triggering divestiture, as described in the section entitled
The Merger Agreement Efforts to Complete the Merger
Divestitures and Triggering Divestiture
, holders of Valspar common stock will receive $105.00 per share in cash, and not $113.00 per share in cash. Regulatory authorities may impose conditions that will lead to a triggering
divestiture, or impose conditions on the completion of the merger or require changes to the terms of the transaction.
Delisting and Deregistration of Company Common Stock
If the merger is completed, the Company common stock will be delisted from the NYSE and deregistered under the Exchange Act.
-59-
THE MERGER AGREEMENT
The following is a summary of the material provisions of the merger agreement, a copy of which is attached to this proxy statement as
Annex A
and which is incorporated by reference into this proxy statement. This summary does not purport to be complete and may not contain all of the information about the merger agreement that is important to you. We encourage
you to read carefully the merger agreement in its entirety, as the rights and obligations of the parties thereto are governed by the express terms of the merger agreement and not by this summary or any other information contained in this proxy
statement.
Explanatory Note Regarding the Merger Agreement
The following summary of the merger agreement, and the copy of the merger agreement attached as
Annex A
to this proxy statement,
are intended to provide information regarding the terms of the merger agreement and are not intended to provide any factual information about Valspar or modify or supplement any factual disclosures about Valspar in its public reports filed with the
SEC. In particular, the merger agreement and the related summary are not intended to be, and should not be relied upon as, disclosures regarding any facts and circumstances relating to Valspar. The merger agreement contains representations and
warranties by and covenants of Valspar, Sherwin-Williams and Merger Sub which were made only for purposes of that agreement and as of specified dates. The representations, warranties and covenants in the merger agreement were made solely for the
benefit of the parties to the merger agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to
the merger agreement instead of establishing these matters as facts, and may be subject to contractual standards of materiality or material adverse effect applicable to the contracting parties that generally differ from those applicable to
investors. In addition, information concerning the subject matter of the representations, warranties and covenants may change after the date of the merger agreement, which subsequent information may or may not be fully reflected in Valspars
public disclosures. The representations, warranties and covenants in the merger agreement and any descriptions thereof should be read in conjunction with the disclosures in Valspars periodic and current reports, proxy statements and other
documents filed with the SEC. See the section entitled
Where You Can Find Additional Information
. Moreover, the description of the merger agreement below does not purport to describe all of the terms of such agreement and is
qualified in its entirety by reference to the full text of such agreement, a copy of which is attached hereto as
Annex A
and is incorporated herein by reference.
Additional information about Valspar may be found elsewhere in this proxy statement and Valspars other public filings. See the section
entitled
Where You Can Find Additional Information
.
Structure of the Merger; Certificate of
Incorporation; Bylaws; Directors and Officers
At the effective time, Merger Sub will merge with and into Valspar, and the separate
corporate existence of Merger Sub will cease. Valspar will be the surviving corporation in the merger and will continue its corporate existence as a Delaware corporation and a wholly owned subsidiary of Sherwin-Williams. The certificate of
incorporation and bylaws of Merger Sub that are in effect immediately before the effective time will become the certificate of incorporation and bylaws of the surviving corporation, although the certificate of incorporation and bylaws will be
amended to reflect the name of the surviving corporation as The Valspar Corporation.
The individuals holding positions as
directors and officers of Merger Sub immediately before the effective time will become the initial directors and officers of the surviving corporation.
When the Merger Becomes Effective
The closing of the merger will take place at 10:00 a.m. local time at the offices of Wachtell, Lipton, Rosen & Katz, 51 West 52nd
Street, New York, New York, 10019 on the third business day following the day on
-60-
which the last of the conditions set forth in the merger agreement to be satisfied or waived (other than those conditions that by their nature are to be satisfied at the closing of the merger,
but subject to the satisfaction or waiver of such conditions) shall be satisfied or waived in accordance with the merger agreement, or at such other place, date and time as Valspar and Sherwin-Williams may agree in writing.
On the closing date, Valspar and Merger Sub will file a certificate of merger with the Secretary of State of the State of Delaware. The merger
will become effective at such time as the certificate of merger has been filed with the Secretary of State of the State of Delaware, or at such time as is agreed between the parties and specified in the certificate of merger.
As of the date of this proxy statement, we expect to complete the merger by the end of the first quarter of 2017. However, completion of the
merger is subject to the satisfaction or waiver of the conditions to the completion of the merger, which are described below and include various regulatory clearances and approvals, and it is possible that factors outside the control of Valspar or
Sherwin-Williams could delay the completion of the merger, or prevent it from being completed at all. There may be a substantial amount of time between the special meeting and the completion of the merger. We expect to complete the merger promptly
following the receipt of all required approvals.
Effect of the Merger on the Common Stock
At the effective time, each share of Company common stock outstanding immediately before the effective time (other than shares owned by
Valspar, Sherwin-Williams or Merger Sub or any of their subsidiaries, which will be cancelled, and other than dissenting shares) will be converted into the right to receive the merger consideration.
The merger consideration will be $113.00 per share in cash, without interest, and subject to any applicable withholding taxes. However, if
Sherwin-Williams is required, in order to obtain the necessary antitrust approvals, to commit to a triggering divestiture, as described in the section entitled
The Merger Agreement Efforts to Complete the Merger Divestitures
and Triggering Divestiture
, then the merger consideration will be $105.00 per share in cash, without interest, and subject to any applicable withholding taxes. See the section entitled
The Merger Agreement Efforts to
Complete the Merger Divestitures and Triggering Divestiture
.
For purposes of the regulatory approval provisions of the
merger agreement, the calculation of net sales with respect to any asset, business or product line will be measured by reference to the net sales of Valspars corresponding asset, business or product line for the fiscal year ended
October 30, 2015, regardless of which asset, business or product line is actually divested. However, the net sales associated with any asset, business or product line of Valspar or its subsidiaries involved in the manufacture, distribution or
sale of architectural coatings in Australia will not count toward calculating the $650 million when determining whether a triggering divestiture has occurred or toward calculating the $1.5 billion in net sales that represents the limit of
Sherwin-Williams divestiture obligations. The net sales associated with any asset, business or product line of Sherwin-Williams or its subsidiaries involved in the manufacture, distribution or sale of architectural coatings in Australia will
count toward the aforesaid $650 million and $1.5 billion calculations.
Sherwin-Williams has agreed to use its reasonable best efforts to
satisfy the applicable closing conditions without taking, or committing to take, any action that would constitute a triggering divestiture, unless and until (1) Valspar has requested that Sherwin-Williams offer a triggering divestiture or
(2) Sherwin-Williams reasonably determines, after communications between Sherwin-Williams and a governmental entity (to which Valspar was a participant) and after further consultation with Valspar, that a triggering divestiture is necessary in
order to permit the satisfaction of the applicable closing conditions by the end date, as described in the section entitled
The Merger Agreement Efforts to Complete the Merger Divestitures and Triggering Divestiture
.
There can be no assurance that a triggering divestiture will not occur, and accordingly there can be no assurance that holders of
Valspar common stock will receive $113.00 per share in cash instead of
-61-
$105.00 per share in cash. See the section entitled
The Merger (Proposal 1) Regulatory Approvals
.
At the effective time, each share of Company common
stock outstanding immediately before the effective time that is owned or held in treasury by Valspar or any of its direct or indirect subsidiaries and any shares of Company common stock owned by Sherwin-Williams, Merger Sub or any other direct or
indirect subsidiary of Sherwin-Williams other than, in each case, shares of Company common stock held on behalf of third parties, will be cancelled, and no consideration will be delivered in exchange for such cancellation.
At the effective time, each share of common stock, par value $0.50 per share, of Merger Sub issued and outstanding immediately prior to the
effective time will be converted into and become one validly issued, fully paid and nonassessable share of common stock, par value $0.50 per share, of the surviving corporation, and such shares will constitute the only outstanding shares of capital
stock of the surviving corporation.
Treatment of Company Equity Awards; Stock Purchase Program
Stock Options
. At the effective time, each Company stock option that is outstanding as of the effective time, whether vested or
unvested, will, if granted prior to the date of the merger agreement, be cancelled in consideration for the right to receive a cash payment (without interest and less applicable withholding taxes) equal to the product of (1) the number of
shares of Company common stock subject to such option as of the effective time and (2) the excess, if any, of the merger consideration over the exercise price per share of Company common stock subject to such option as of the effective time.
All Company stock options granted prior to the date of the merger agreement with an exercise price equal to, or in excess of, the merger consideration will be cancelled as of immediately prior to the effective time for no consideration. At the
effective time, each Company stock option, if granted after the date of the merger agreement, that is outstanding as of the effective time, whether vested or unvested, will be converted into an option to acquire, on the same terms and conditions
applicable to such Company stock option immediately prior to the effective time (including vesting and any applicable accelerated vesting), a number of shares of Sherwin-Williams common stock equal to the product (rounded down to the nearest whole
number of shares) of (a) the number of shares of Company common stock subject to such option immediately prior to the effective time, multiplied by (b) the equity award exchange ratio, at a price per share (rounded up to the nearest whole
cent) equal to the price per share of such option immediately prior to the effective time divided by the equity award exchange ratio. The equity award exchange ratio means the quotient (rounded to four decimal places) obtained by
dividing the merger consideration by the volume weighted average trading price of Sherwin-Williams common stock for the five consecutive trading days ending with, and including, the trading day immediately prior to the closing date.
Time-Based and Performance-Based Restricted Stock Unit Awards
. At the effective time, each Company time-based restricted stock unit
award and each Company performance-based restricted stock unit award that is outstanding as of the effective time will, if granted prior to the date of the merger agreement, be cancelled in consideration for the right to receive a cash payment
(without interest and less applicable withholding taxes) equal to the product of (1) the number of shares of Company common stock subject to such award as of the effective time (with respect to each performance-based restricted stock unit
award, determined by assuming the actual level of achievement of the applicable performance goals in respect of fiscal years completed prior to the effective time and the target level of achievement of the applicable performance goals in respect of
all other fiscal years) and (2) the merger consideration. At the effective time, each Company time-based restricted stock unit award granted after the date of the merger agreement that is outstanding as of immediately prior to the effective
time will be converted into a Sherwin-Williams restricted stock unit award, on the same terms and conditions applicable to such Company time-based restricted stock unit award immediately prior to the effective time (including vesting and any
applicable accelerated vesting), relating to the number of shares of Sherwin-Williams common stock (rounded up to the nearest whole number of shares) equal to the product of (a) the equity award exchange ratio, multiplied by (b) the number
of shares of Company common stock subject to such award as of immediately prior to the effective time.
-62-
Restricted Shares
. At the effective time, each share of Company common stock subject to
vesting, repurchase or other lapse restrictions pursuant to an award granted by the Company that is outstanding as of the effective time shall vest in full and become free of restrictions and shall be cancelled and converted automatically into the
right of the holder to receive the merger consideration (less applicable withholding taxes).
Company Stock Purchase Program
.
Effective immediately prior to the effective time, the Companys Stock Purchase Program provided through Computershare Shareowner Services will be terminated and all accumulated employee payroll deductions held pursuant to such program as of
the effective time will be refunded to employees.
Payment for Common Stock in the Merger
Prior to the effective time, Sherwin-Williams will deposit, or cause to be deposited, with a paying agent (reasonably acceptable to Valspar),
in trust for the benefit of the holders of Company common stock, cash sufficient to pay the aggregate merger consideration. As promptly as practicable (and no later than the third business day) after the effective time, Sherwin-Williams will cause
the paying agent to mail to each holder of record of shares of Company common stock whose shares were converted into the right to receive the merger consideration (1) a letter of transmittal and (2) instructions for use in effecting the
surrender of certificates or book-entry shares formerly representing shares of the common stock in exchange for payment of the merger consideration. Upon surrender of certificates or book-entry shares, as applicable, to the paying agent together
with the letter of transmittal, duly completed and validly executed, and such other documents as may reasonably be required by the paying agent, the holder of such certificates or book-entry shares will be entitled to receive the merger
consideration (less any amount that may be withheld with respect to any applicable withholding taxes).
Representations and
Warranties
The merger agreement contains representations and warranties of Valspar, subject to certain exceptions in the merger
agreement, in the disclosure schedules delivered in connection with the merger agreement and in Valspars public filings, as to, among other things:
|
|
|
organization, good standing and qualification to do business;
|
|
|
|
capital stock and indebtedness;
|
|
|
|
corporate authority, consents and approvals relating to the execution, delivery and performance of the merger agreement;
|
|
|
|
the reports, forms, documents and financial statements of Valspar required by the SEC;
|
|
|
|
the establishment and maintenance of certain disclosure controls and procedures and internal control over financial reporting;
|
|
|
|
the absence of undisclosed liabilities;
|
|
|
|
compliance with applicable laws and permits;
|
|
|
|
the absence of lawsuits against Valspar pertaining to environmental laws and Valspars compliance with such laws;
|
|
|
|
certain details with respect to the employee benefit plans and other agreements, plans and policies with or concerning employees of Valspar and its subsidiaries;
|
|
|
|
the absence of certain material changes or events in the business of Valspar, including that there has not been a material adverse effect with respect to Valspar;
|
|
|
|
the receipt of notice or pendency of any investigations or litigation;
|
|
|
|
the accuracy and completion of the information supplied for the purposes of this proxy statement;
|
|
|
|
certain details pertaining to Valspars and its subsidiaries tax returns, filings and other tax matters;
|
-63-
|
|
|
certain details with respect to Valspars and its subsidiaries employee relations, labor matters and compliance with workplace safety and workers compensation laws;
|
|
|
|
certain details pertaining to Valspars and its subsidiaries intellectual property;
|
|
|
|
the receipt by the Valspar board of directors of the opinion from each of Goldman Sachs and BofA Merrill Lynch as to the fairness from a financial point of view, as of the date of each such opinion, of the consideration
to be received by the holders of shares of Valspar common stock pursuant to the merger;
|
|
|
|
brokers and finders fees;
|
|
|
|
state takeover statutes;
|
|
|
|
warranties and products liability; and
|
|
|
|
Valspars top customers and suppliers.
|
The merger agreement also contains
representations and warranties of Sherwin-Williams and Merger Sub, subject to certain exceptions in the merger agreement and the disclosure schedules delivered in connection with the merger agreement, as to, among other things:
|
|
|
organization, good standing and qualification to do business;
|
|
|
|
corporate authority, consents and approvals relating to the execution, delivery and performance of the merger agreement;
|
|
|
|
the absence of changes or events that would have a material adverse effect with respect to Sherwin-Williams;
|
|
|
|
the reports, forms, documents and financial statements of Sherwin-Williams required by the SEC;
|
|
|
|
compliance with applicable laws;
|
|
|
|
the accuracy and completion of the information supplied for the purposes of this proxy statement;
|
|
|
|
brokers and finders fees;
|
|
|
|
the delivery to Valspar by Sherwin-Williams of evidence of debt commitments for the financing required to consummate the transaction and the enforceability of such commitments;
|
|
|
|
the ownership and operations of Merger Sub;
|
|
|
|
any ownership of Valspar common stock; and
|
|
|
|
the absence of a need for a vote of Sherwin-Williams stockholders on the merger.
|
Some of the
representations and warranties in the merger agreement are qualified by materiality qualifications or a material adverse effect qualification with respect to either Valspar or Sherwin-Williams, as discussed below.
For purposes of the merger agreement, a material adverse effect with respect to Valspar means any change, fact, effect, event,
occurrence or development that has a material adverse effect on the business, operations or financial condition of Valspar and its subsidiaries taken as a whole. However, a material adverse effect is not deemed to include the impact of:
|
|
|
any changes or developments in domestic or any foreign market or domestic, foreign or global economic conditions
generally, including (1) any changes or developments in or affecting the domestic
|
-64-
|
or any foreign securities, equity, credit or financial markets or (2) any changes or developments in or affecting domestic or any foreign interest or exchange rates;
|
|
|
|
changes in GAAP or any official interpretation or enforcement thereof;
|
|
|
|
changes in applicable laws or any changes or developments in the official interpretation or enforcement thereof by governmental entities;
|
|
|
|
changes in domestic, foreign or global political conditions (including the outbreak or escalation of war, military actions, or acts of terrorism), including any worsening of such conditions threatened or existing on the
date of the merger agreement;
|
|
|
|
changes or developments in the business or regulatory conditions affecting the industries in which Valspar or any of its subsidiaries operate;
|
|
|
|
the announcement of the merger agreement or the transactions contemplated hereby (including the impact thereof on the relationships, contractual or otherwise, of Valspar or any of its subsidiaries with employees, labor
unions, financing sources, customers, suppliers or partners);
|
|
|
|
weather conditions or other acts of God (including storms, earthquakes, tornados, floods or other natural disasters);
|
|
|
|
the loss of business with customers that are or become major customers of Sherwin-Williams or its subsidiaries;
|
|
|
|
a decline in the trading price or trading volume of Valspar common stock or any change in the ratings or ratings outlook for Valspar or any of its subsidiaries, but not, in any case, the underlying causes thereof;
|
|
|
|
the failure to meet any projections, guidance, budgets, forecasts or estimates, but not, in any case, including the underlying causes thereof;
|
|
|
|
any action taken or omitted to be taken by Valspar or any of its subsidiaries at the written request of Sherwin-Williams; and
|
|
|
|
any actions or claims made or brought by any of the current or former stockholders of Valspar (or on their behalf or on behalf of Valspar) against Valspar or any of its directors, officers or employees arising out of
the merger agreement or the merger;
|
however, with respect to the matters described in the foregoing first, second, third, fourth, fifth and
seventh bullet points above, such impact will be taken into account to the extent that it is disproportionately adverse to Valspar and its subsidiaries, taken as a whole, relative to others in the industry or industries in which Valspar and its
subsidiaries operate.
For the purpose of the merger agreement, a material adverse effect with respect to Sherwin-Williams
means any fact, change, event, occurrence or development that has a material adverse effect on Sherwin-Williams ability to timely consummate the transactions contemplated by the merger agreement (including the merger and obtaining the
financing necessary to pay the merger consideration or any other merger amount).
Conduct of Business Pending the Merger
The merger agreement provides that, during the period from March 19, 2016 until the earlier of the termination of the merger
agreement in accordance with its terms and the effective time, except as required by applicable law, with Sherwin-Williams prior written consent (which shall not be unreasonably withheld, conditioned or delayed), as required by the merger
agreement or as set forth in the disclosure schedules to the merger agreement, Valspar will, and will cause each of its subsidiaries to, conduct its business in all material respects in the ordinary course consistent with past practice, will use
commercially reasonable efforts to maintain
-65-
and preserve intact, in all material respects, its business organization, assets, key employees, present lines of business, rights, franchises, permits and business relationships with customers
(generally) and suppliers and will not, and will not permit any of its subsidiaries to take, any of the following actions:
|
|
|
amend its governing organizational documents or otherwise take any action to exempt any person from any provision of its governing organizational documents or the governing organizational documents of any of the
Companys significant subsidiaries;
|
|
|
|
split, including a reverse stock split, combine, exchange, reclassify or take any similar action with respect to any of its capital stock, voting securities or other equity interests;
|
|
|
|
make, declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase or otherwise acquire, any shares of its capital stock, or any other securities or obligations convertible
(whether currently convertible or convertible only after the passage of time or the occurrence of certain events) into or exchangeable for any shares of its capital stock, except (1) dividends paid by any of the subsidiaries of Valspar to
Valspar or any of their wholly owned subsidiaries, respectively, (2) the acceptance of shares of Company common stock as payment for the exercise price of company options, or (3) the acceptance of shares of Company common stock, or
withholding of shares of Company common stock otherwise deliverable, to satisfy withholding taxes incurred in connection with the exercise, vesting and/or settlement of Company equity awards, except that Valspar may make, declare and pay quarterly
cash dividends (and, with respect to Company equity awards, as and if applicable, dividends or dividend equivalents) in an amount per share not in excess of $0.33 per quarter for dividends declared in the fiscal year ending October 28, 2016,
and not in excess of $0.37 per quarter for dividends declared in the fiscal year ending October 27, 2017, and not in excess of $0.42 per quarter thereafter, and with record dates consistent with the record dates customarily used by Valspar for
the payment of quarterly cash dividends, including with respect to the quarter in which the effective time occurs, unless the effective time precedes the record date for such quarter;
|
|
|
|
grant any Company equity awards or other equity-based awards or interests, or grant any individual, corporation or other entity any right to acquire any shares of its capital stock;
|
|
|
|
issue, sell or otherwise permit to become outstanding any additional shares of its capital stock or securities convertible or exchangeable into, or exercisable for, any shares of its capital stock or any options,
warrants, or other rights of any kind to acquire any shares of its capital stock, except pursuant to the due exercise, vesting and/or settlement of Company equity awards outstanding as of March 19, 2016 in accordance with their terms, or enter
into any agreement, understanding or arrangement with respect to the sale or voting of its capital stock or equity interests;
|
|
|
|
adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization, other than the merger;
|
|
|
|
incur, assume, endorse, guarantee or otherwise become liable for or modify in any material respects the terms of any indebtedness for borrowed money or issue or sell any debt securities or any rights to acquire any debt
securities, except for (1) any indebtedness for borrowed money among Valspar and/or its wholly owned subsidiaries or among wholly owned subsidiaries of Valspar, (2) guarantees by Valspar of indebtedness for borrowed money of subsidiaries
of Valspar or guarantees by subsidiaries of Valspar of indebtedness for borrowed money of Valspar or any of its subsidiaries, which indebtedness is incurred in compliance with the terms of this bullet point or is outstanding on March 19, 2016,
(3) indebtedness for commercial paper, (4) indebtedness incurred from time to time pursuant to agreements entered into by Valspar or any subsidiary of Valspar in effect prior to the execution of the merger agreement, and
(5) additional indebtedness for borrowed money incurred by Valspar or any of its subsidiaries not to exceed $100 million in aggregate principal amount outstanding;
|
|
|
|
except as otherwise permitted or required by the merger agreement or for transactions between or among Valspar
and/or its wholly owned subsidiaries, prepay, redeem, repurchase, defease, cancel or
|
-66-
|
otherwise terminate any indebtedness for borrowed money of Valspar or any subsidiary, other than (1) indebtedness under Valspars revolving credit facilities, receivables facilities,
commercial paper arrangements and any other working capital facilities and (2) any prepayment, redemption, repurchase, defeasance, cancellation or other termination of indebtedness made within 90 days of the same becoming due;
|
|
|
|
other than in accordance with contracts or agreements in effect on March 19, 2016, sell, transfer, mortgage, encumber or otherwise dispose of any of its properties or assets having a value in excess of $10 million
individually or $50 million in the aggregate to any person (other than to Valspar or a wholly owned subsidiary of Valspar and other than (1) sales of inventory, (2) sales of obsolete or worthless equipment, or (3) commodity, purchase,
sale or hedging agreements that can be terminated upon 90 days or less notice without penalty, and power contracts in each case in the ordinary course of business consistent with past practice, or other than in accordance with contracts or
agreements in effect on March 19, 2016, cancel, release or assign any material indebtedness for borrowed money of any such person owed to it or any claims held by it against any such person other than indebtedness by Valspar or any wholly owned
subsidiary to any other wholly owned subsidiary, or by any wholly owned subsidiary to Valspar;
|
|
|
|
acquire any assets (other than acquisitions of assets in the ordinary course of business consistent with past practice) or any other person or business of any other person (whether by merger or consolidation,
acquisition of stock or assets or by formation of a joint venture or otherwise) or make any investment in any person, in each case other than a wholly owned subsidiary of Valspar (or any assets thereof), either by purchase of stock or securities,
contributions to capital, property transfers or purchase of property or assets of any person other than a wholly owned subsidiary of Valspar, if such acquisition or investment is in excess of $20 million individually or $100 million in the
aggregate;
|
|
|
|
make any capital expenditures in excess of $125 million in any fiscal year or that materially deviate from Valspars categories of capital expenditures (
i.e.
, Growth, Maintenance/HSE and Productivity);
|
|
|
|
except as required by any collective bargaining agreement in effect as of March 19, 2016, or the terms of any company benefit plan existing as of March 19, 2016, (1) establish, adopt, amend or terminate
any material collective bargaining agreement or company benefit plan or create or enter into any plan, agreement, program, policy, trust, fund or other arrangement that would be a company benefit plan if it were in existence as of March 19,
2016, except for adoptions, amendments or terminations in the ordinary course of business that do not materially increase the cost of such collective bargaining agreement or benefit plan to Valspar and its subsidiaries, taken as a whole,
(2) grant any new awards under any company benefit plan, (3) amend or modify any outstanding award under any company benefit plan, (4) enter into any third-party contract with respect to a company benefit plan (including contracts for
the provision of services to such company benefit plan, including benefits administration) having a term of greater than one year that is not terminable on 90 calendar days notice or less, (5) increase in any manner the compensation
(including bonus, incentive, severance, change-in-control and retention compensation) or benefits (including pension, welfare, fringe or other benefits) of any current or former directors, officers, employees or consultants (who are natural persons)
of Valspar or its subsidiaries, (6) pay or award, or commit to pay or award, any bonuses or incentive compensation, other than pursuant to the currently existing terms of any company benefit plan, (7) accelerate any rights or benefits
under, or, other than in the ordinary course of business consistent with past practice, make any material determinations or interpretations with respect to, any company benefit plan, (8) accelerate the time of funding or payment of, or increase
the amount required to fund, any company benefit plan, or fund any rabbi trust or similar arrangement associated with or intended to satisfy liabilities under any company benefit plan, (9) enter into any collective bargaining agreement or other
agreement with a labor union, works council or similar organization, other than in connection with the expiration of any existing collective bargaining agreement to which Valspar or any of its subsidiaries is a party that is scheduled to expire
during the 18-month period beginning on March 19, 2016, or (10) forgive any loans, or issue any loans (other than routine travel advances issued in the ordinary course of business) to any of its or its subsidiaries directors,
officers, contractors or employees;
|
-67-
|
|
|
implement or adopt any change in its financial accounting principles or its methods, other than as may be required by GAAP or applicable law;
|
|
|
|
except as otherwise provided in the merger agreement, settle or compromise any litigation, claim, suit, action or proceeding (other than any litigation, claim, suit, action or proceeding in respect of taxes or tax
matters or in which Valspar or one of its subsidiaries is the plaintiff), except for (1) settlements or compromises that involve monetary remedies with a value not in excess of, with respect to any individual litigation, claim, suit, action or
proceeding, $2 million or, in the aggregate with respect to all litigation, claims, suits, actions and proceedings, $10 million, and do not impose any material restriction on the business of Valspar or the business of its subsidiaries,
(2) settlements of any workers compensation or U.S. Equal Employment Opportunity Commission charges or ordinary course of business consistent with past practice U.S. Department of Labor matters, or (3) the commencement of any
litigation, claim, suit, action or proceeding in the ordinary course of business;
|
|
|
|
make, change or revoke any material tax election, other than in the ordinary course of business, enter into any closing agreement within the meaning of Section 7121 of the Internal Revenue Code (or any similar
provision of state, local or foreign tax law) with respect to a material amount of taxes for an amount materially in excess of the amount reserved therefor, in accordance with GAAP, by Valspar, settle or compromise any material tax litigation,
claim, suit action or proceeding for an amount materially in excess of the amount reserved therefor, in accordance with GAAP, by Valspar, or consent to any extension or waiver of the statute of limitations for any U.S. federal income tax return,
obtain any material tax ruling that would be binding on Sherwin-Williams for any tax period (or portion thereof) beginning after the closing date, or file any material amended tax return;
|
|
|
|
except in the ordinary course of business consistent with past practice, enter into any contract that falls within certain categories of contracts specified in the merger agreement, or materially amend any contract in
effect as of March 19, 2016 that falls within such categories, or
|
|
|
|
agree to take, or make any commitment to take, any of the foregoing actions.
|
Sherwin-Williams
has also agreed that, during the period from March 19, 2016 until the earlier of the termination of the merger agreement in accordance with its terms and the effective time, Sherwin-Williams will not, and will not permit any of its subsidiaries
to knowingly take any action that would prevent, materially delay or materially impede the consummation of the financing to fund the merger consideration.
Both Valspar and Sherwin-Williams agreed that, during the period from March 19, 2016 until the earlier of the termination of the merger
agreement in accordance with its terms and the effective time, both Sherwin-Williams and Valspar will not, and will not permit any of their subsidiaries to, acquire or agree to acquire by merging or consolidating with, or by purchasing a material
portion of the assets of or equity in, any person or enter into any new line of business, if such acquisition, agreement or entry would reasonably be expected to (1) prevent, materially delay or materially impede the obtaining of, or adversely
affect in any material respect the ability of Sherwin-Williams or Valspar to procure, any authorizations, consents, orders, declarations or approvals of any governmental entity or the expiration or termination of any applicable waiting period
necessary to consummate the transactions contemplated hereby, (2) materially increase the risk of any governmental entity entering an order, ruling, judgment or injunction prohibiting the consummation of the transactions contemplated by the
merger agreement, or (3) result in Sherwin-Williams or Valspar being required pursuant to the terms of the merger agreement to take, or cause to be taken, or commit to take, or commit to cause to be taken, any action constituting a triggering
divestiture, as described in the section entitled
Efforts to Complete the Merger Divestitures and Triggering Divestiture
.
Access
Subject to certain exceptions and limitations, during the period from March 19, 2016 until the earlier of the termination of the merger
agreement in accordance with its terms and the effective time, Valspar must afford
-68-
Sherwin-Williams and its controlled affiliates, and its and their respective representatives, reasonable access during normal business hours to Valspars and its subsidiaries
personnel, properties, contracts, commitments, tax returns, books and records and such other information concerning its business, properties and personnel (other than certain highly confidential information or information that would jeopardize the
attorney-client privilege or conflict with any law or contract to which Valspar or its subsidiaries are bound).
Alternative
Proposals; No Solicitation
Except as permitted by the merger agreement, Valspar will, will cause each of its subsidiaries and its and
their respective officers, directors, employees and agents, and will direct each of its financial advisors, investment bankers, attorneys, accountants and other representatives, to:
|
|
|
not, directly or indirectly, solicit, initiate, or knowingly encourage or facilitate any inquiries regarding, or the making of any proposal or offer, including any proposal or offer to its stockholders, that
constitutes, or could reasonably be expected to lead to, a company takeover proposal (as defined below);
|
|
|
|
not, directly or indirectly, engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any other person any information in connection with or for the purpose of encouraging
or facilitating, any inquiry, proposal or offer that constitutes, or could reasonably be expected to lead to, a company takeover proposal (although, solely in response to an unsolicited company takeover proposal, the Valspar board of directors may
take such action to ascertain facts from the person making such company takeover proposal for the sole purpose of informing itself about such proposal), or approve, recommend or enter into, or propose to approve, recommend or enter into, any letter
of intent or similar document, agreement, commitment, or agreement in principle with respect to a company takeover proposal; or
|
|
|
|
immediately cease and cause to be terminated any discussions or negotiations with any persons (other than Sherwin-Williams and Merger Sub) that may be ongoing with respect to a company takeover proposal.
|
Pursuant to the merger agreement, a company takeover proposal means any
bona fide
proposal or offer made
by any person or group of related persons (other than Sherwin-Williams and its subsidiaries), and whether involving a transaction or series of related transactions, for (1) a merger, reorganization, share exchange, consolidation, business
combination, recapitalization, dissolution, liquidation or similar transaction involving Valspar, (2) the acquisition by any person or group of related persons (other than Sherwin-Williams and its subsidiaries) of more than 20% of the assets of
Valspar and its subsidiaries, on a consolidated basis (in each case, including securities of the subsidiaries of Valspar), or (3) the direct or indirect acquisition by any person or group of related persons (other than Sherwin-Williams and its
subsidiaries) of more than 20% of the shares of Company common stock then issued and outstanding.
Existing Discussions or Negotiations
Under the terms of the merger agreement, Valspar has agreed to use reasonable best efforts to enforce to the fullest extent, and not release
any third party from, or waive, amend or modify any provision of, or grant permission under, any standstill provision in any agreement to which Valspar is a party or any confidentiality provision in any agreement to which Valspar is a party.
However, if the Valspar board of directors determines in good faith, after consultation with its outside legal counsel that the failure to take such action would be inconsistent with the directors fiduciary duties under applicable law, Valspar
may waive any such standstill provision solely to the extent necessary to permit a third party to make a company takeover proposal to the Valspar board of directors.
-69-
Receipt of Company Takeover Proposals
Notwithstanding the provisions of the merger agreement described above, if at any time after March 19, 2016 and prior to the time the
requisite company vote is obtained, Valspar receives a
bona fide
written company takeover proposal from a third party (that did not result from a breach of the non-solicitation provisions of the merger agreement), and if the Valspar board of
directors determines in good faith, after consultation with its independent financial advisors and outside legal counsel, that such company takeover proposal constitutes or could reasonably be expected to lead to a company superior proposal (as
defined below), then Valspar and its representatives may take the following actions:
|
|
|
furnish, pursuant to an acceptable confidentiality agreement, information (including non-public information) with respect to Valspar and its subsidiaries to the person that has made such company takeover proposal and
its representatives; provided that Valspar must substantially concurrently provide to Sherwin-Williams any non-public information concerning Valspar or any of its subsidiaries that is provided or made available to such person or its representatives,
unless such non-public information has been previously provided to Sherwin-Williams; and
|
|
|
|
engage in or otherwise participate in discussions or negotiations with the person making such company takeover proposal and its representatives regarding such proposal.
|
Valspar will promptly (and in any event within 24 hours) notify Sherwin-Williams in writing if Valspar furnishes such information or engages
or otherwise participates in discussions or negotiations with a person making a company takeover proposal or such persons representatives regarding such company takeover proposal.
Pursuant to the merger agreement, a company superior proposal means any
bona fide
proposal or offer made by any person or
group of related persons (other than Sherwin-Williams and its subsidiaries), and whether involving a transaction or series of related transactions, for (1) a merger, reorganization, share exchange, consolidation, business combination,
recapitalization, dissolution, liquidation or similar transaction involving Valspar, (2) the acquisition by any person or group of related persons (other than Sherwin-Williams and its subsidiaries) of more than 50% of the assets of Valspar and
its subsidiaries, on a consolidated basis (in each case, including securities of the subsidiaries of Valspar), or (3) the direct or indirect acquisition by any person or group of related persons (other than Sherwin-Williams and its
subsidiaries) of more than 50% of the shares of Company common stock then issued and outstanding, which the Valspar board of directors determines in good faith, after consultation with Valspars independent financial advisors and outside legal
counsel, taking into account the timing, likelihood of consummation, legal, financial, regulatory and other aspects of such proposal, including the financing terms thereof, and such other factors as the Valspar board of directors considers to be
appropriate, to be more favorable to Valspar and its stockholders than the transactions contemplated by the merger agreement.
Valspar
will promptly (and in no event later than 48 hours) notify Sherwin-Williams in writing in the event that Valspar or any of its representatives receives a company takeover proposal or any offer, proposal, inquiry or request for information or
discussions relating to Valspar or its subsidiaries that would be reasonably likely to lead to or that contemplates a company takeover proposal, including the identity of the person making the company takeover proposal, offer, proposal, inquiry or
request and the material terms and conditions thereof. Valspar will keep Sherwin-Williams reasonably informed, on a reasonably current basis (but in no event more often than once every 48 hours), as to the status of (including any material
developments related thereto) such company takeover proposal, offer, proposal, inquiry or request, and provide Sherwin-Williams with copies of any draft agreements to the extent that any such drafts are or would reasonably be expected to be material
to Sherwin-Williams ability to exercise its rights to propose revisions to the merger agreement as described in the section entitled
Alternative Proposals; No Solicitation
Changes in Board Recommendation.
Valspar has agreed to not enter into any agreement with any person after March 19, 2016, that prohibits Valspar from providing any information to Sherwin-Williams in accordance with, or otherwise complying with, these obligations.
-70-
Changes in Board Recommendation
The Valspar board of directors has unanimously recommended that Valspar stockholders vote
FOR
the proposal to adopt the
merger agreement. The merger agreement permits the Valspar board of directors to make a company adverse recommendation change only in certain limited circumstances, as described below.
Except as expressly permitted by the merger agreement, neither the Valspar board of directors nor any committee thereof, nor any group of
directors, formally or informally, acting intentionally and publicly, either directly or indirectly, in a manner that is materially inconsistent with the recommendation of the Valspar board of directors that stockholders adopt the merger agreement
(which we refer to as the company recommendation in this proxy statement), will:
|
|
|
change, qualify, withhold, withdraw or modify, or authorize or resolve to or publicly propose or announce its intention to change, qualify, withhold, withdraw or modify, in each case in any manner adverse to
Sherwin-Williams, the company recommendation;
|
|
|
|
approve or recommend to the stockholders of Valspar, or resolve to or publicly propose or announce its intention to approve or recommend to the stockholders of Valspar, a company takeover proposal;
|
|
|
|
authorize, cause or permit Valspar or any of its subsidiaries to enter into any letter of intent, memorandum of understanding, agreement (including an acquisition agreement, merger agreement, joint venture agreement or
other agreement), commitment or agreement in principle with respect to, or that is intended or could reasonably be expected to lead to, any company takeover proposal (any such agreement referred to in this proxy statement as a company
acquisition agreement); or
|
|
|
|
resolve, publicly propose or agree to do any of the foregoing.
|
The actions described in the
first and second bullet points above are referred to in this proxy statement as a company adverse recommendation change.
However, at any time after March 19, 2016 and prior to the time the requisite company vote is obtained, the Valspar board of directors
may make a company adverse recommendation change in response to an intervening event if prior to taking such action, the Valspar board of directors has determined in good faith, after consultation with outside legal counsel, that the failure to take
such action would be inconsistent with its fiduciary duties under applicable law. Prior to making a company adverse recommendation change in response to an intervening event, Valspar must have given Sherwin-Williams at least four business days
prior written notice of its intention to take such action, and at the end of such notice period, the Valspar board of directors must have considered in good faith any revisions to the terms of the merger agreement proposed in writing by
Sherwin-Williams, and have determined, after consultation with independent financial advisors and outside legal counsel, that the failure to make a company adverse recommendation change would continue to be inconsistent with its fiduciary duties
under applicable law. Under the merger agreement, an intervening event means any material change, event, effect, occurrence, consequence or development relating to Valspar that is unknown and not reasonably foreseeable as of
March 19, 2016, and does not relate to any company takeover proposal.
Further, at any time after March 19, 2016 and prior to
the time the requisite company vote is obtained, if the Valspar board of directors determines in good faith, after consultation with independent financial advisors and outside legal counsel, that a written company takeover proposal made after
March 19, 2016 (that did not result from a breach of the non-solicitation provision of the merger agreement) constitutes a company superior proposal, then the Valspar board of directors may (1) make a company adverse recommendation change
or (2) cause Valspar to terminate the merger agreement in order to enter into a definitive agreement relating to such company superior proposal, subject to paying the $300 million termination fee due to Sherwin-Williams under the terms of the
merger agreement. Prior to making any such company adverse recommendation change or terminating the merger agreement to enter into a definitive agreement relating to a company superior proposal, (1) Valspar must have given Sherwin-Williams at
least four business days prior written notice of its intention to take such action, and have provided Sherwin-Williams the material terms and conditions of, and the identity of
-71-
the person making, any such company superior proposal and copies of the company superior proposal and any proposed company acquisition agreements and (2) at the end of such notice period,
the Valspar board of directors must have considered in good faith any revisions to the terms of the merger agreement proposed in writing by Sherwin-Williams, and have determined, after consultation with its independent financial advisors and outside
legal counsel, that the company superior proposal would nevertheless continue to constitute a company superior proposal if the revisions proposed by Sherwin-Williams were to be given effect.
In the event of any change to any of the financial terms (including the form, amount and timing of payment of consideration) or any other
material terms and conditions of the company superior proposal, Valspar must satisfy the notice requirement described above with a new written notice to Sherwin-Williams, and comply with the negotiation requirements described above (provided that
any such subsequent notice period will only be two business days).
The non-solicitation provisions of the merger agreement do not
prohibit Valspar or the Valspar board of directors from taking and disclosing to the stockholders of Valspar a position contemplated by Rule 14e-2(a) or Rule 14d-9 promulgated under the Exchange Act. However, if such disclosure does not reaffirm the
company recommendation or state that the company recommendation remains unchanged, such disclosure will be deemed to be a company adverse recommendation change. Any stop, look and listen disclosure in and of itself will not be considered
a company adverse recommendation change.
Valspar Stockholders Meeting
Subject to Valspars right to terminate the merger agreement to enter into a definitive agreement relating to a company superior proposal,
as described in the section entitled
Changes in Board Recommendation,
(1) Valspar will take, in accordance with applicable law and its certificate of incorporation and bylaws, all action necessary to convene a
meeting of holders of Valspar common stock as promptly as reasonably practicable after the date of mailing of this proxy statement (and in any event no more than 25 business days) to consider and vote upon the adoption of the merger agreement (which
meeting, and any adjournment or postponement thereof, is referred to in this proxy statement as the Valspar stockholders meeting) and (2) unless Valspar has made a company adverse recommendation change, the Valspar board of
directors will use its reasonable best efforts to solicit the requisite company vote at the Valspar stockholders meeting.
Prior to
the mailing of this proxy statement, Valspar will engage a proxy solicitor that is reasonably satisfactory to Sherwin-Williams. Valspar will keep Sherwin-Williams reasonably informed regarding its solicitation efforts and proxy tallies following the
mailing of this proxy statement, including by allowing Sherwin-Williams and its representatives to participate in any substantive meeting or discussion with such proxy solicitor, in each case, to the extent practicable, except that Sherwin-Williams
and its representatives will not have a right to participate in meetings or discussions from and after the time the Valspar board of directors makes a company adverse recommendation change.
Valspar may only postpone or adjourn the Valspar stockholders meeting (1) to solicit additional proxies for the purpose of
obtaining the requisite company vote, (2) for the absence of a quorum, (3) to allow reasonable additional time for the filing and/or mailing of any supplemental or amended disclosure that Valspar has determined after consultation with
outside legal counsel is necessary under applicable law, and for such supplemental or amended disclosure to be disseminated and reviewed by Valspars stockholders prior to the Valspar stockholders meeting, or (4) with the written
consent of Sherwin-Williams, which may be withheld in Sherwin-Williams sole discretion.
Financing and Financing
Cooperation
In connection with signing the merger agreement, Sherwin-Williams delivered to Valspar a true, complete and correct copy
of the fully executed debt commitment letter, dated as of March 19, 2016, pursuant to which,
-72-
upon the terms and subject to the conditions set forth therein, Citigroup Global Markets Inc., Citibank, N.A. and certain of their affiliates agreed to lend Sherwin-Williams a total of $9.3
billion for the purpose of funding the merger consideration and related amounts. Sherwin-Williams has agreed to use its reasonable best efforts to take, or cause to be taken, all actions and do, or cause to be done, all things necessary, advisable
or proper, in each case, regardless of whether the merger consideration is $113.00 per share or $105.00 per share, to obtain the financing contemplated by the commitment letter on or prior to the closing date. Valspar will, and will cause its
subsidiaries to, use reasonable best efforts to provide all customary cooperation reasonably requested by Sherwin-Williams that is necessary, proper or advisable in connection with the financing. The merger agreement permits Sherwin-Williams to
conduct offers to purchase or exchange, and consent solicitations with respect to, Valspars outstanding senior notes and requires Valspar to use its reasonable best efforts to cooperate with Sherwin-Williams in connection therewith.
Employee Matters
The merger agreement provides that, effective as of the effective time and during the one-year period immediately following the effective time
(the continuation period), Sherwin-Williams will provide, or will cause the surviving corporation to provide, to each employee of Valspar or its subsidiaries who continues to be employed by Sherwin-Williams or the surviving corporation
or any of their respective subsidiaries following the effective time (collectively, the Company employees), (1) an annual base salary or wage rate, target and maximum short-term annual incentive compensation opportunities and target
equity-based incentive compensation opportunities that, in each case, are no less than those provided to such Company employee immediately prior to the effective time and (2) employee benefits that are substantially similar in the aggregate to
the employee benefits provided to such Company employee immediately prior to the effective time.
Pursuant to the merger agreement,
(1) during the continuation period, the non-discretionary matching contribution opportunity in effect for each Company employee under any 401(k) plan maintained by Sherwin-Williams or any of its subsidiaries (including the surviving corporation
and its subsidiaries) (a Sherwin-Williams 401(k) plan) in which such Company employee participates will be no less favorable than that in effect for such Company employee immediately prior to the effective time under the applicable
401(k) plan maintained by the Company or any of its subsidiaries (a Company 401(k) plan), (2) a profit sharing contribution will be made to the applicable Sherwin-Williams 401(k) plan for each Company employee participant in respect
of (a) calendar year 2016, if the effective time occurs in such calendar year, and (b) calendar year 2017, in each case based on a percentage of eligible compensation equal to 8%, and (3) any amounts calculated in accordance with the
preceding item (2) that cannot be contributed to the applicable Sherwin-Williams 401(k) plan due to applicable limitations under the Code will instead be paid to the applicable Company employee in a manner consistent with the Companys
past practice regarding such excess amounts. Further, during the continuation period, Sherwin-Williams has agreed to continue to maintain or cause to be maintained, without amendment, the merger-related severance plan adopted by the Company prior to
the effective time in accordance with the terms agreed to between the Company and Sherwin-Williams (the Company severance plan), and to provide, or cause to be provided in accordance with the terms of the Company severance plan, to each
Company employee who experiences a severance-qualifying termination under such Company severance plan, the severance benefits specified in the Company severance plan. However, if any such Company employee is entitled to severance benefits under an
individual severance, employment or similar agreement, such Company employee will receive the severance benefits provided under the terms of such agreement and not the severance benefits set forth in the Company severance plan.
Under the merger agreement, following the closing date, Sherwin-Williams will, or will cause the surviving corporation to, cause any employee
benefit plans sponsored or maintained by Sherwin-Williams or the surviving corporation or their subsidiaries in which the Company employees are eligible to participate following the closing date (collectively, the post-closing plans) to
recognize the service of each Company employee with the Company and its subsidiaries (and any predecessor thereto) prior to the closing date for purposes of eligibility, vesting and level of benefits under such post-closing plans. However, such
recognition of service will not
-73-
(1) apply for purposes of any post-closing plan that is a defined benefit retirement plan or any post-closing plan that provides retiree welfare benefits, (2) operate to duplicate any
benefits of a Company employee with respect to the same period of service, or (3) apply for purposes of any plan, program or arrangement (a) under which similarly situated employees of Sherwin-Williams and its subsidiaries do not receive
credit for prior service or (b) that is grandfathered or frozen, either with respect to level of benefits or participation. With respect to any post-closing plan that provides medical, dental or vision insurance benefits, for the plan year in
which such Company employee is first eligible to participate during the continuation period, Sherwin-Williams has agreed to use reasonable best efforts to (A) cause any preexisting condition limitations or eligibility waiting periods under such
plan to be waived with respect to such Company employee to the extent such limitation would have been waived or satisfied under the Company benefit plan in which such Company employee participated immediately prior to the effective time and
(B) credit each Company employee for any co-payments or deductibles incurred by such Company employee in such plan year for purposes of any applicable deductible and annual out-of-pocket expense requirements under any such post-closing plan,
and such credited expenses will also count toward any annual or lifetime limits, treatment or visit limits or similar limitations that apply under the terms of the applicable plan.
Efforts to Complete the Merger
Valspar and Sherwin-Williams have agreed that prior to the closing of the merger, Sherwin-Williams, Merger Sub and Valspar will use their
respective reasonable best efforts to obtain all regulatory approvals needed to complete the merger as promptly as practicable, including (1) preparing and filing all forms, registrations and notifications required (whether by law or in order
to satisfy the condition that the waiting periods under the HSR Act or receipt of specified notices, approvals or clearances, have been satisfied or waived) to be filed to consummate the merger, (2) using reasonable best efforts to satisfy the
conditions to consummating the merger, (3) using reasonable best efforts to obtain (and to cooperate with each other in obtaining) any consent, authorization, expiration or termination of a waiting period, permit, order or approval of, waiver
or any exemption by, any governmental entity required to be obtained or made by Sherwin-Williams, Merger Sub, Valspar or any of their respective subsidiaries in connection with the merger, (4) defending any lawsuits or other legal proceedings,
whether judicial or administrative, challenging the merger agreement or the consummation of the merger, (5) using reasonable best efforts to obtain (and to cooperate with each other in obtaining) any consent, approval of, waiver or any
exemption by, any non-governmental third party, in each case, to the extent necessary, proper or advisable to consummate the merger, and (6) the execution and delivery of any reasonable additional instruments necessary to consummate the merger
and to fully carry out the purposes of the merger agreement.
Valspar and Sherwin-Williams will each keep the other apprised of the status
of matters relating to the completion of the merger and work cooperatively to obtain all required consents, authorizations, orders or approvals of, or any exemptions by, any governmental entity that are required under the merger agreement. Valspar
and Sherwin-Williams have each agreed that, prior to the closing, each will promptly (1) consult with the other parties to the merger agreement with respect to and provide any necessary information and assistance as the other parties may
reasonably request with respect to all notices, submissions or filings made by or on behalf of such party with any governmental entity and (2) inform the other parties to the merger agreement of any substantive communication from or to any
governmental entity regarding the merger, and permit the other parties to review and discuss in advance, and consider in good faith the views of the other parties in connection with, any proposed communication or submission with any such
governmental entity.
Valspar and Sherwin-Williams have also agreed to use reasonable best efforts to make or file with the appropriate
governmental entity all filings, forms, registrations and notifications required to consummate the merger under any applicable antitrust law, and to furnish all requested information and documentary material under the HSR Act or any other antitrust
law. Sherwin-Williams is entitled to devise and implement the antitrust strategy, but must keep Valspar informed of any substantive communications from any governmental entity and allow Valspar to participate in any meeting or substantive
communications with any governmental entity. In the
-74-
event that the parties receive a Request for Additional Information and Documentary Material (which we refer to in this proxy statement as a Second Request) pursuant to the HSR Act,
Sherwin-Williams must certify compliance with such second request by October 20, 2016.
For purposes of the merger agreement, a
substantive communication means any communication relating to merits, remedies (including divestitures and potential divestiture buyers, any consent decree or other settlement agreement or any regulatory commission vote), timing
agreement or timing of any significant decision or significant action in connection with any regulatory approval or clearance.
Divestitures and
Triggering Divestiture
If necessary to obtain the requisite antitrust clearances, Sherwin-Williams has agreed to (1) propose,
negotiate, commit to, effect and agree to the sale, divestiture, license, holding separate, and other disposition of and restriction on the businesses, assets, properties, product lines, and equity interests of, or changes to the conduct of business
of, Valspar, Sherwin-Williams and their respective subsidiaries (including the surviving corporation and its subsidiaries) and take such action or actions that would in the aggregate have a similar effect, (2) create, terminate, or divest
relationships, ventures, contractual rights or obligations of Valspar, Sherwin-Williams and their respective subsidiaries, and (3) otherwise take or commit to take any action that would limit Sherwin-Williams freedom of action with
respect to, or its ability to retain or hold, directly or indirectly, any businesses, assets, equity interests, product lines or properties of Valspar, Sherwin-Williams and their respective subsidiaries. However, Sherwin-Williams will not be
required to divest, license, hold separate or otherwise dispose of businesses, assets, properties, product lines and equity interests:
|
|
|
representing, in the aggregate, more than $1.5 billion of net sales (as defined below); or
|
|
|
|
Sherwin-Williams Sherwin-Williams, Krylon or Ronseal trademark or trade name, or any businesses or product lines using any such trademarks or trade names, in any jurisdiction
other than Australia.
|
Sherwin-Williams also has agreed to use its reasonable best efforts to satisfy the conditions to
closing pertaining to regulatory approvals. Prior to the earlier of December 19, 2016 and the commencement of any litigation by a governmental entity to prohibit the merger, Sherwin-Williams cannot offer, propose, or commit to take, any action
that constitutes a triggering divestiture (as defined below), unless and until Valspar has requested that Sherwin-Williams offer a triggering divestiture. Thereafter, Sherwin-Williams may offer, propose, or commit to take, any action that
constitutes a triggering divestiture if (1) Valspar requests that Sherwin-Williams offer a triggering divestiture, or (2) Sherwin-Williams reasonably determines, after communications between Sherwin-Williams and a government entity (in
which Valspar participates) and further consultation with Valspar, that a triggering divestiture would be necessary to satisfy such closing conditions. In addition, Sherwin-Williams cannot agree to any arrangement that would prevent the parties from
completing the merger before February 20, 2017.
Under the merger agreement, a triggering divestiture is the divestiture,
license, hold separate, sale or other disposition of the assets, businesses or product lines of Valspar, Sherwin-Williams or any of their respective subsidiaries representing, in the aggregate, in excess of $650 million of net sales to fulfill the
conditions pertaining to regulatory approvals. A triggering event is deemed to occur when Sherwin-Williams is required pursuant to the regulatory efforts covenant in the merger agreement to take, or cause to commit to be taken, or commit
to take, or cause to be taken, an action constituting a triggering divestiture. For purposes of the regulatory approvals provisions of the merger agreement, the calculation of net sales with respect to any asset, business or product line
will be measured by reference to the net sales of Valspars corresponding asset, business or product line for the fiscal year ended October 30, 2015, regardless of which asset, business or product line is actually divested. However, the
net sales associated with any asset, business or product line of Valspar or its subsidiaries involved in the manufacture, distribution or sale of architectural coatings in Australia will not count toward calculating the $650 million when determining
whether a triggering divestiture has occurred or toward
-75-
calculating the $1.5 billion in net sales that represents the limit of Sherwin-Williams divestiture obligations. The net sales associated with any asset, business or product line of
Sherwin-Williams or its subsidiaries involved in the manufacture, distribution or sale of architectural coatings in Australia will count toward the aforesaid $650 million and $1.5 billion calculations.
If a triggering divestiture occurs, the merger consideration will be $105.00 per share in cash and not $113.00 per share in cash (in each
case, without interest, and subject to any applicable withholding taxes). There can be no assurance that a triggering divestiture will not occur, and accordingly there can be no assurance that holders of Valspar common stock will receive $113.00 per
share in cash instead of $105.00 per share in cash. See the section entitled
The Merger (Proposal 1) Regulatory Approvals
.
Indemnification and Insurance
Sherwin-Williams and Merger Sub have agreed that all rights to exculpation and indemnification for acts or omissions occurring at or prior to
the effective time, whether asserted or claimed prior to, at or after the effective time (including any matters arising in connection with the transactions contemplated by the merger agreement), now existing in favor of the current or former
directors, officers or employees, as the case may be, of Valspar or any of its subsidiaries (which we refer to as the indemnified parties) as provided in Valspars governing organizational documents and the certificate of
incorporation, bylaws, limited partnership agreement, limited liability company agreement or comparable constituent or organizational documents for each subsidiary of Valspar or in any agreement set forth in the disclosure schedule in the merger
agreement, each as in effect on March 19, 2016, will survive the merger and continue in full force and effect in accordance with their terms. For a period of not less than six years after the effective time, Sherwin-Williams will cause the
surviving corporation to indemnify, defend and hold harmless, and advance expenses to, the indemnified parties with respect to all acts or omissions by them in their capacities as such at any time prior to the effective time, to the fullest extent
provided by: (1) the Valspar organizational documents or the certificate of incorporation, bylaws, limited partnership agreement, limited liability company agreement or comparable constituent or organizational documents for each subsidiary of
Valspar as in effect on March 19, 2016, (2) any such agreement between any such indemnified party, on the one hand, and Valspar or any of its subsidiaries, on the other hand, as in effect on March 19, 2016 and (3) applicable law.
In addition, Sherwin-Williams will obtain, or cause the surviving corporation to obtain, for a period of not less than six years after
the effective time, for the indemnified parties who are insured under Valspars directors and officers insurance and indemnification policy, an insurance and indemnification policy that provides coverage for events occurring at or
prior to the effective time that is no less favorable than the existing policy of Valspar, with certain qualifications.
Coordination on Litigation
Valspar and Sherwin-Williams have agreed to coordinate with respect to litigation relating to the merger. Each party will, subject to the
preservation of privilege and confidential information, give the other parties to the merger agreement the opportunity to participate in (but not control) its defense or settlement of any stockholder litigation or other litigation or proceeding
against it and/or its directors or executive officers or representatives relating to the merger agreement, the merger and/or the other transactions contemplated by the merger agreement, and will give due consideration to such other parties
advice with respect to such litigation or proceeding. No party will cease to defend, consent to the entry of any judgment, settle or offer to settle or take any other material action with respect to such litigation or proceeding commenced without
the prior written consent of the other parties to the merger agreement (which cannot be unreasonably withheld, conditioned or delayed).
-76-
Other Covenants and Agreements
The merger agreement also contains additional covenants, including, among others, covenants relating to the filing of this proxy statement,
covenants relating to regulatory filings and approvals (which are described under the section entitled
The Merger (Proposal 1) Regulatory Approvals
), reporting requirements under Section 16 of the Exchange Act, the
treatment of certain indebtedness and delisting and deregistration of the Valspar common stock, and public announcements with respect to the transactions contemplated by the merger agreement.
Conditions to Completion of the Merger
Each partys obligation to complete the merger is subject to the satisfaction or waiver of the following conditions:
|
|
|
the adoption of the merger agreement by the requisite company vote;
|
|
|
|
no injunction by any court or other tribunal of competent jurisdiction having been entered and continuing to be in effect and no law having been adopted that remains in effect or be effective, in each case that
prevents, enjoins, prohibits or makes illegal the consummation of the merger; and
|
|
|
|
all waiting periods applicable to the merger under the HSR Act having expired or been terminated and all other specified filings, notices, approvals and clearances having been obtained or filed or shall have occurred.
|
The respective obligations of Sherwin-Williams and Merger Sub to complete the merger are subject to the satisfaction or
waiver (in writing) of the following additional conditions:
|
|
|
the accuracy of the representations and warranties of the Company both at and as of March 19, 2016 and at and as of the closing date (except for any such representations and warranties made as of a particular date
or period, which representations and warranties must be true and correct only as of that date or period), subject to a material adverse effect or other materiality standard provided in the merger agreement;
|
|
|
|
the Company having performed and complied in all material respects with all covenants required by the merger agreement to be performed or complied with by it prior to the closing date; and
|
|
|
|
Sherwin-Williams receipt of a certificate signed on behalf of the Company by the Chief Executive Officer or Chief Financial Officer of the Company to the effect that each of the conditions described in the two
preceding bullet points have been satisfied.
|
The obligation of the Company to complete the merger is subject to the
satisfaction or waiver (in writing) of the following additional conditions:
|
|
|
the accuracy of the representations and warranties of Sherwin-Williams and Merger Sub both at and as of March 19, 2016 and at and as of the closing date (except for any such representations and warranties made as
of a particular date or period, which representations and warranties must be true and correct only as of that date or period), subject to a material adverse effect or other materiality standard provided in the merger agreement;
|
|
|
|
each of Sherwin-Williams and Merger Sub having performed and complied in all material respects with all covenants required by the merger agreement to be performed or complied with by it prior to the closing date; and
|
|
|
|
the Companys receipt of a certificate signed on behalf of Sherwin-Williams by a senior executive officer of Sherwin-Williams to the effect that each of the conditions described in the two preceding bullet points
have been satisfied.
|
-77-
Termination
The merger agreement may be terminated and abandoned at any time prior to the effective time in the following circumstances:
|
|
|
by the mutual written consent of Valspar and Sherwin-Williams;
|
|
|
|
by either Valspar or Sherwin-Williams, if:
|
|
|
|
the merger has not been completed by March 21, 2017 (referred to in this proxy statement as the end date), provided that (1) if all of the conditions to closing, other than those pertaining to an
injunction under antitrust laws, waiting periods under the HSR Act or receipt of specified notices, approvals or clearances, have been satisfied or waived at such time, the end date may be extended by either Valspar or Sherwin-Williams to
June 21, 2017 and (2) following the initial extension of the end date, if all of the conditions to closing, other than those pertaining to an injunction under antitrust laws, waiting periods under the HSR Act or receipt of specified
notices, approvals or clearances, have been satisfied or waived at such time, the end date may be extended further by either Valspar or Sherwin-Williams to September 21, 2017;
|
|
|
|
an order by a governmental entity of competent jurisdiction has been issued permanently restraining, enjoining or otherwise prohibiting the consummation of the merger, and such order has become final and nonappealable,
except that a party will not have the right to terminate if such order resulted due to the intentional material breach by such party of any representation, warranty, covenant or other agreement of such party set forth in the merger agreement; or
|
|
|
|
if the requisite company vote has not been obtained at the Valspar stockholders meeting or at any adjournment or postponement of the Valspar stockholders meeting; or
|
|
|
|
Sherwin-Williams or Merger Sub has breached or there is any inaccuracy in any of its representations or warranties, or has breached or failed to perform any of its covenants or other agreements contained in the merger
agreement, which (1) would result in a failure of a condition to the obligations of Valspar to effect the merger and (2) is either not curable or is not cured by the earlier of the end date and the date that is 30 days following written
notice from Valspar to Sherwin-Williams describing such breach or failure; or
|
|
|
|
at any time prior to the time the requisite company vote is obtained, in accordance with the provisions relating to Valspars right to terminate the merger agreement to enter into a company superior proposal; or
|
|
|
|
by Sherwin-Williams, if:
|
|
|
|
Valspar has breached or there is any inaccuracy in any of its representations or warranties, or has breached or failed to perform any of its covenants or other agreements contained in the merger agreement (with certain
exceptions), which (1) would result in a failure of a condition to the obligations of Sherwin-Williams and Merger Sub to effect the merger and (2) is either not curable or is not cured by the earlier of the end date and the date that is 30
days following written notice from Sherwin-Williams to Valspar describing such breach or failure; or
|
|
|
|
the Valspar board of directors has effected a company adverse recommendation change; or
|
|
|
|
Valspar has breached (except for any
de minimis
breach) any of its obligations under the non-solicitation provisions of the merger agreement or specified provisions of the merger agreement related to preparing
this proxy statement and obtaining the requisite company vote.
|
-78-
Termination Fee
Valspar will pay Sherwin-Williams a termination fee in an amount equal to $300 million in immediately available funds if the merger agreement
is terminated in the following circumstances:
|
|
|
if the merger agreement is terminated by Valspar in accordance with the provisions regarding its right to terminate the merger agreement to enter into a definitive agreement relating to a company superior proposal;
|
|
|
|
if the merger agreement is terminated by Sherwin-Williams because (1) the Valspar board of directors has effected a company adverse recommendation change or (2) Valspar has breached (except for any
de
minimis
breach) any of its obligations under the non-solicitation provisions of the merger agreement or specified provisions of the merger agreement related to preparing this proxy statement and obtaining the requisite company vote; or
|
|
|
|
(1) after March 19, 2016, a qualifying transaction (as defined below) has been publicly made and not withdrawn, (2) the merger agreement is thereafter terminated by Valspar or Sherwin-Williams (as applicable)
because (i) the merger agreement has not been completed by the end date (if Valspar is in material breach of its regulatory efforts obligations under the merger agreement), (ii) Valspar breached or there was any inaccuracy in any of its
representations or warranties, leading to a termination right, or (iii) the requisite company vote was not obtained, and (3) at any time on or before the 12-month anniversary of such termination, Valspar or any of its subsidiaries enters
into a definitive agreement with respect to any qualifying transaction or completes a qualifying transaction.
|
Pursuant to
the merger agreement, a qualifying transaction is deemed to occur if Valspar receives a
bona fide
proposal or offer made by any person or group of related persons (other than Sherwin-Williams and its subsidiaries), and whether
involving a transaction or series of related transactions, for (1) a merger, reorganization, share exchange, consolidation, business combination, recapitalization, dissolution, liquidation or similar transaction involving Valspar, (2) the
acquisition by any person or group of related persons (other than Sherwin-Williams and its subsidiaries) of more than 50% of the assets of Valspar and its subsidiaries, on a consolidated basis (in each case, including securities of the subsidiaries
of Valspar), or (3) the direct or indirect acquisition by any person or group of related persons (other than Sherwin-Williams and its subsidiaries) of more than 50% of the shares of Company common stock then issued and outstanding.
Limitation on Remedies
In the event of the termination of the merger agreement pursuant to the provisions described in the section entitled
Termination
, the merger agreement will be terminated, and there will be no further liability on the part of Valspar, Sherwin-Williams or Merger Sub, except that the confidentiality agreement, certain provisions of the
merger agreement relating to the financing, the sections of the merger agreement relating to termination and Article VIII of the merger agreement (which contains miscellaneous provisions) will survive termination. However, no such termination will
relieve any party from any liability for failure to consummate the transactions contemplated by the merger agreement, including the merger, of from liability for a willful breach of its covenants or agreements prior to such termination.
If the termination fee is due and payable, from and after the termination of the agreement and payment of the termination fee in full pursuant
to the merger agreement, Valspar will have no further liability of any kind for any reason in connection with the merger agreement or its termination, except for any liability arising from a willful breach of the merger agreement. In no event will
Sherwin-Williams be entitled to payment of the termination fee on more than one occasion.
Expenses; Transfer Taxes
Except as otherwise provided in the merger agreement, whether or not the merger is consummated, all costs and expenses incurred in connection
with the merger, the merger agreement and the transactions contemplated in
-79-
the merger agreement will be paid by the party incurring or required to incur such expenses. Except as otherwise provided in the merger agreement, all transfer, documentary, sales, use, stamp,
registration and other such similar non-income taxes imposed with respect to the transfer of Company common stock pursuant to the merger will be borne by Sherwin-Williams or Merger Sub and expressly are not a liability of holders of Company common
stock.
Amendment and Modification
At any time prior to the effective time, any provision of the merger agreement may be amended or waived if, and only if, such amendment or
waiver is in writing and signed, in the case of an amendment, by Valspar, Sherwin-Williams and Merger Sub, except that certain provisions in the merger agreement relating to the financing may not be amended, supplemented, waived or otherwise
modified in a manner adverse to the financing sources without their prior written consent.
Jurisdiction; Specific
Enforcement
The parties have agreed that irreparable damage would occur in the event that any of the provisions of the merger
agreement are not performed, or are threatened to be not performed, and that money damages would not be an adequate remedy in such a situation. Accordingly, the parties have agreed that, in addition to any other remedy available, including monetary
damages, each of the parties will be entitled to an injunction or injunctions to prevent breaches or threatened breaches of the merger agreement and to enforce specifically the terms and provisions of the merger agreement exclusively in the Delaware
Court of Chancery and any state appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware).
Pursuant to the merger agreement, the parties irrevocably waived, and agreed not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding with respect to the merger agreement, (1) any claim that it is
not personally subject to the jurisdiction of the above named courts, (2) any claim that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts, and (3) to the fullest
extent permitted by applicable law, any claim that the suit, action or proceeding in such court is brought in an inconvenient forum, the venue of such suit, action or proceeding is improper or the merger agreement, or the subject matter thereof, may
not be enforced in or by such courts.
-80-
THIS PROXY STATEMENT DOES NOT CONSTITUTE THE SOLICITATION OF A PROXY IN ANY
JURISDICTION TO OR FROM ANY PERSON TO WHOM OR FROM WHOM IT IS UNLAWFUL TO MAKE SUCH PROXY SOLICITATION IN THAT JURISDICTION. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE INTO THIS PROXY STATEMENT TO VOTE YOUR SHARES
AT THE SPECIAL MEETING. NO PERSONS HAVE BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROXY STATEMENT, AND, IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS
HAVING BEEN AUTHORIZED BY US OR ANY OTHER PERSON. THIS PROXY STATEMENT IS DATED [ ], 2016. YOU SHOULD NOT ASSUME THAT THE
INFORMATION CONTAINED IN THIS PROXY STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE, AND THE MAILING OF THIS PROXY STATEMENT TO STOCKHOLDERS DOES NOT AND WILL NOT CREATE ANY IMPLICATION TO THE CONTRARY.
-92-
Annex A
EXECUTION VERSION
AGREEMENT AND PLAN OF MERGER
by and among
THE
VALSPAR CORPORATION,
THE SHERWIN-WILLIAMS COMPANY
and
VIKING MERGER SUB,
INC.
Dated as of March 19, 2016
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I.
|
|
THE MERGER
|
|
|
A-1
|
|
|
|
|
Section 1.1
|
|
The Merger
|
|
|
A-1
|
|
Section 1.2
|
|
Closing
|
|
|
A-1
|
|
Section 1.3
|
|
Effective Time
|
|
|
A-2
|
|
Section 1.4
|
|
Effects of the Merger
|
|
|
A-2
|
|
Section 1.5
|
|
Organizational Documents of the Surviving Company
|
|
|
A-2
|
|
Section 1.6
|
|
Directors
|
|
|
A-2
|
|
Section 1.7
|
|
Officers
|
|
|
A-2
|
|
|
|
|
ARTICLE II.
|
|
CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES
|
|
|
A-2
|
|
|
|
|
Section 2.1
|
|
Effect on Capital Stock
|
|
|
A-2
|
|
Section 2.2
|
|
Exchange of Certificates
|
|
|
A-4
|
|
Section 2.3
|
|
Treatment of Company Equity Awards; Stock Purchase Program
|
|
|
A-5
|
|
Section 2.4
|
|
Further Assurances
|
|
|
A-7
|
|
|
|
|
ARTICLE III.
|
|
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
|
|
|
A-7
|
|
|
|
|
Section 3.1
|
|
Organization
|
|
|
A-7
|
|
Section 3.2
|
|
Capital Stock and Indebtedness
|
|
|
A-8
|
|
Section 3.3
|
|
Corporate Authority Relative to this Agreement; Consents and Approvals; No Violation
|
|
|
A-9
|
|
Section 3.4
|
|
Reports and Financial Statements
|
|
|
A-10
|
|
Section 3.5
|
|
Internal Controls and Procedures
|
|
|
A-10
|
|
Section 3.6
|
|
No Undisclosed Liabilities
|
|
|
A-11
|
|
Section 3.7
|
|
Compliance with Law; Permits
|
|
|
A-11
|
|
Section 3.8
|
|
Environmental Laws and Regulations
|
|
|
A-12
|
|
Section 3.9
|
|
Employee Benefit Plans
|
|
|
A-13
|
|
Section 3.10
|
|
Absence of Certain Changes or Events
|
|
|
A-15
|
|
Section 3.11
|
|
Investigations; Litigation
|
|
|
A-15
|
|
Section 3.12
|
|
Company Information
|
|
|
A-15
|
|
Section 3.13
|
|
Tax Matters
|
|
|
A-16
|
|
Section 3.14
|
|
Employment and Labor Matters
|
|
|
A-17
|
|
Section 3.15
|
|
Intellectual Property
|
|
|
A-18
|
|
Section 3.16
|
|
Opinion of Financial Advisor
|
|
|
A-19
|
|
Section 3.17
|
|
Material Contracts
|
|
|
A-19
|
|
Section 3.18
|
|
Finders or Brokers
|
|
|
A-20
|
|
Section 3.19
|
|
State Takeover Statutes
|
|
|
A-20
|
|
Section 3.20
|
|
Insurance
|
|
|
A-20
|
|
Section 3.21
|
|
Warranties/Product Liability
|
|
|
A-21
|
|
Section 3.22
|
|
Customers and Suppliers
|
|
|
A-21
|
|
Section 3.23
|
|
No Other Representations
|
|
|
A-22
|
|
|
|
|
ARTICLE IV.
|
|
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
|
|
|
A-22
|
|
|
|
|
Section 4.1
|
|
Organization
|
|
|
A-22
|
|
Section 4.2
|
|
Corporate Authority Relative to this Agreement; Consents and Approvals; No Violation
|
|
|
A-22
|
|
Section 4.3
|
|
Absence of Certain Changes or Events
|
|
|
A-23
|
|
Section 4.4
|
|
Reports and Financial Statements
|
|
|
A-23
|
|
Section 4.5
|
|
Compliance with Law
|
|
|
A-24
|
|
Section 4.6
|
|
Parent and Merger Sub Information
|
|
|
A-24
|
|
Section 4.7
|
|
Finders or Brokers
|
|
|
A-24
|
|
-i-
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Section 4.8
|
|
Financing
|
|
|
A-24
|
|
Section 4.9
|
|
Merger Sub
|
|
|
A-25
|
|
Section 4.10
|
|
Ownership of Company Common Stock
|
|
|
A-25
|
|
Section 4.11
|
|
No Vote of Parent Stockholders
|
|
|
A-26
|
|
Section 4.12
|
|
No Other Representations
|
|
|
A-26
|
|
|
|
|
ARTICLE V.
|
|
COVENANTS AND AGREEMENTS
|
|
|
A-26
|
|
|
|
|
Section 5.1
|
|
Conduct of Business
|
|
|
A-26
|
|
Section 5.2
|
|
Access
|
|
|
A-30
|
|
Section 5.3
|
|
No Solicitation
|
|
|
A-30
|
|
Section 5.4
|
|
Proxy Filing; Information Supplied
|
|
|
A-32
|
|
Section 5.5
|
|
Stockholders Meeting
|
|
|
A-33
|
|
Section 5.6
|
|
Employee Matters
|
|
|
A-34
|
|
Section 5.7
|
|
Regulatory Approvals; Efforts
|
|
|
A-35
|
|
Section 5.8
|
|
Takeover Statutes
|
|
|
A-38
|
|
Section 5.9
|
|
Public Announcements
|
|
|
A-38
|
|
Section 5.10
|
|
Indemnification and Insurance
|
|
|
A-38
|
|
Section 5.11
|
|
Section 16 Matters
|
|
|
A-39
|
|
Section 5.12
|
|
Financing and Financing Cooperation
|
|
|
A-40
|
|
Section 5.13
|
|
Treatment of Certain Indebtedness
|
|
|
A-43
|
|
Section 5.14
|
|
Transaction Litigation
|
|
|
A-43
|
|
Section 5.15
|
|
Additional Agreements
|
|
|
A-43
|
|
Section 5.16
|
|
Obligations of Merger Sub
|
|
|
A-44
|
|
Section 5.17
|
|
Stock Exchange Delisting; Deregistration
|
|
|
A-44
|
|
|
|
|
ARTICLE VI.
|
|
CONDITIONS TO THE MERGER
|
|
|
A-44
|
|
|
|
|
Section 6.1
|
|
Conditions to Each Partys Obligation to Effect the Merger
|
|
|
A-44
|
|
Section 6.2
|
|
Conditions to Obligations of Parent and Merger Sub
|
|
|
A-44
|
|
Section 6.3
|
|
Conditions to Obligation of the Company
|
|
|
A-45
|
|
|
|
|
ARTICLE VII.
|
|
TERMINATION
|
|
|
A-45
|
|
|
|
|
Section 7.1
|
|
Termination or Abandonment
|
|
|
A-45
|
|
Section 7.2
|
|
Effect of Termination
|
|
|
A-46
|
|
Section 7.3
|
|
Termination Fee
|
|
|
A-47
|
|
|
|
|
ARTICLE VIII.
|
|
MISCELLANEOUS
|
|
|
A-48
|
|
|
|
|
Section 8.1
|
|
No Survival
|
|
|
A-48
|
|
Section 8.2
|
|
Expenses; Transfer Taxes
|
|
|
A-48
|
|
Section 8.3
|
|
Counterparts; Effectiveness
|
|
|
A-48
|
|
Section 8.4
|
|
Governing Law
|
|
|
A-48
|
|
Section 8.5
|
|
Jurisdiction; Specific Enforcement
|
|
|
A-48
|
|
Section 8.6
|
|
WAIVER OF JURY TRIAL
|
|
|
A-49
|
|
Section 8.7
|
|
Notices
|
|
|
A-50
|
|
Section 8.8
|
|
Assignment; Binding Effect
|
|
|
A-51
|
|
Section 8.9
|
|
Severability
|
|
|
A-51
|
|
Section 8.10
|
|
Entire Agreement
|
|
|
A-51
|
|
Section 8.11
|
|
Amendments; Waivers
|
|
|
A-51
|
|
Section 8.12
|
|
Headings
|
|
|
A-51
|
|
Section 8.13
|
|
No Third-Party Beneficiaries
|
|
|
A-51
|
|
Section 8.14
|
|
Interpretation
|
|
|
A-51
|
|
Section 8.15
|
|
Liability of Financing Sources
|
|
|
A-52
|
|
Section 8.16
|
|
Definitions
|
|
|
A-52
|
|
-ii-
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (this
Agreement
), dated as of March 19, 2016, is by and among The Valspar
Corporation, a Delaware corporation (the
Company
), The Sherwin-Williams Company, an Ohio corporation (
Parent
), and Viking Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent
(
Merger Sub
).
WITNESSETH
:
WHEREAS, Parent desires to acquire the Company on the terms and subject to the conditions set forth in this Agreement;
WHEREAS, in furtherance of such acquisition of the Company by Parent, and on the terms and subject to the conditions set forth in this
Agreement and in accordance with the DGCL, Merger Sub shall be merged with and into the Company (the
Merger
), with the Company surviving the Merger as a wholly owned Subsidiary of Parent, and each outstanding share of Company
Common Stock (other than Cancelled Shares and Dissenting Shares) shall be converted into the right to receive an amount in cash, without interest, equal to the Per Share Price (the
Merger Consideration
);
WHEREAS, the Board of Directors of the Company (the
Company Board of Directors
) has unanimously (a) determined that it
is in the best interests of the Company and its stockholders, and declared it advisable, to enter into this Agreement, (b) approved the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
hereby, including the Merger, and (c) resolved to recommend that the holders of shares of Company Common Stock adopt this Agreement;
WHEREAS, the Boards of Directors of each of Parent and Merger Sub have approved the execution, delivery and performance of this Agreement and
the consummation of the transactions contemplated hereby, including the Merger;
WHEREAS, Parent, as the sole stockholder of Merger Sub,
has approved the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby, including the Merger, and adopted this Agreement; and
WHEREAS, Parent, Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements specified herein.
NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained herein, and
intending to be legally bound hereby, Parent, Merger Sub and the Company agree as follows:
ARTICLE I.
THE MERGER
Section 1.1
The Merger
. At the Effective Time, upon the terms and subject to the conditions set forth in this Agreement and in
accordance with the applicable provisions of the Delaware General Corporation Law (the
DGCL
), including Section 251 of the DGCL, Merger Sub shall be merged with and into the Company, whereupon the separate corporate existence
of Merger Sub shall cease, and the Company shall continue its existence under Delaware law as the surviving company in the Merger (the
Surviving Company
) and a wholly owned subsidiary of Parent.
Section 1.2
Closing
. The closing of the Merger (the
Closing
) shall take place at 10:00 a.m. local time at the
offices of Wachtell, Lipton, Rosen & Katz, 51 West 52nd Street, New York, New York, 10019 on the third
A-1
Business Day following the day on which the last of the conditions set forth in
Article VI
to be satisfied or waived (other than those conditions that by their nature are to be satisfied
at the Closing, but subject to the satisfaction or waiver of those conditions) shall be satisfied or waived in accordance with this Agreement, or at such other place, date and time as the Company and Parent may agree in writing. The date on which
the Closing actually occurs is referred to as the
Closing Date
.
Section 1.3
Effective Time
. On the Closing
Date, the Company and Merger Sub shall file with the Secretary of State of the State of Delaware a certificate of merger (the
Certificate of Merger
), executed in accordance with, and containing such information as is required by,
the relevant provisions of the DGCL in order to effect the Merger. The Merger shall become effective at such time as the Certificate of Merger has been filed with the Secretary of State of the State of Delaware or at such time as is agreed between
the parties and specified in the Certificate of Merger in accordance with the relevant provisions of the DGCL (such time is hereinafter referred to as the
Effective Time
).
Section 1.4
Effects of the Merger
. The effects of the Merger shall be as provided in this Agreement and in the applicable
provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all of the property, rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Company,
and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Company, all as provided under the DGCL.
Section 1.5
Organizational Documents of the Surviving Company
.
(a) Subject to the requirements set forth in
Section 5.10
, at the Effective Time, the certificate of incorporation of Merger Sub,
as in effect immediately prior to the Effective Time, shall be the certificate of incorporation of the Surviving Company until thereafter amended in accordance with the provisions thereof and applicable Law, except that the name of the Surviving
Company shall be The Valspar Corporation.
(b) Subject to the requirements set forth in
Section 5.10
, at the
Effective Time, the bylaws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the bylaws of the Surviving Company until thereafter amended in accordance with the provisions thereof and applicable Law, except that the name
of the Surviving Company shall be The Valspar Corporation.
Section 1.6
Directors
. Subject to applicable Law, the
directors of Merger Sub immediately prior to the Effective Time shall be the initial directors of the Surviving Company and shall hold office until their respective successors are duly elected and qualified, or their earlier death, resignation or
removal.
Section 1.7
Officers
. Except as otherwise determined by Parent prior to the Effective Time, the officers of the
Company immediately prior to the Effective Time shall be the initial officers of the Surviving Company and shall hold office until their respective successors are duly elected and qualified, or their earlier death, resignation or removal.
ARTICLE II.
CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES
Section 2.1
Effect on Capital Stock
.
(a) At the Effective Time, by virtue of the Merger and without any action on the part of Parent, the Company, Merger Sub or the holder of any
shares of Company Common Stock or common stock of Merger Sub:
(i)
Common Stock of Merger Sub
. Each share of common
stock, par value $0.50 per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and become one validly issued, fully paid and nonassessable share of common stock, par value $0.50 per
A-2
share, of the Surviving Company. From and after the Effective Time, all certificates representing the common stock of Merger Sub shall be deemed for all purposes to represent the number of shares
of common stock of the Surviving Company into which they were converted in accordance with the immediately preceding sentence.
(ii)
Cancellation of Certain Stock
. Each share of Company Common Stock issued and outstanding immediately prior to the
Effective Time that is owned or held in treasury by the Company, each share of Company Common Stock issued and outstanding immediately prior to the Effective Time that is owned or held by any wholly owned Subsidiary of the Company, and each share of
Company Common Stock issued and outstanding immediately prior to the Effective Time that is owned by Parent or any of its wholly owned Subsidiaries (including Merger Sub), other than, in each case, shares of Company Common Stock held on behalf of
third parties, shall no longer be outstanding and shall automatically be cancelled and shall cease to exist (the
Cancelled Shares
), and no consideration shall be delivered in exchange therefor.
(iii)
Conversion of Company Common Stock
. Each share of Company Common Stock issued and outstanding immediately prior to
the Effective Time (other than Cancelled Shares and Dissenting Shares) shall be automatically converted into the right to receive the Merger Consideration.
All of the shares of Company Common Stock converted into the right to receive the Merger Consideration pursuant to this
Article II
shall no longer be
outstanding and shall automatically be cancelled and shall cease to exist as of the Effective Time, and uncertificated shares of Company Common Stock represented by book-entry form (
Book-Entry Shares
) and each certificate that,
immediately prior to the Effective Time, represented any such shares of Company Common Stock (each, a
Certificate
) shall thereafter represent only the right to receive the Merger Consideration into which the shares of Company
Common Stock represented by such Book-Entry Share or Certificate have been converted pursuant to this
Section 2.1
.
(b)
Shares of Dissenting Stockholders
. Notwithstanding anything in this Agreement to the contrary, if a Person (a
Dissenting Stockholder
) who has complied with all the provisions of the DGCL concerning the right of holders of
shares of Company Common Stock to require appraisal (the
Appraisal Provisions
) of their shares of Company Common Stock has demanded appraisal under the Appraisal Provisions with respect to any issued and outstanding shares of
Company Common Stock held by such Dissenting Stockholder (
Dissenting Shares
), to the extent the Appraisal Provisions are applicable, shall not be converted into the right to receive the Merger Consideration as described in
Section 2.1(a)(iii)
, but shall be converted into the right to receive such consideration as may be determined to be due to such Dissenting Stockholder pursuant to the procedures set forth in Section 262 of the DGCL. If such
Dissenting Stockholder withdraws its demand for appraisal or fails to perfect or otherwise loses its right of appraisal, in any case pursuant to the DGCL, each Dissenting Share shall thereupon be treated as though such share of Company Common Stock
had been converted into the right to receive the Merger Consideration pursuant to
Section 2.1(a)(iii)
. The Company shall give Parent prompt notice (but in any event within 48 hours of receipt thereof) of any demands for appraisal of
shares of Company Common Stock received by the Company, withdrawals of such demands and any other instruments served pursuant to Section 262 of the DGCL and shall give Parent the opportunity to participate in all negotiations and proceedings
with respect thereto. The Company shall not, without the prior written consent of Parent, make any payment with respect to, or settle or offer to settle, any such demands.
(c)
Certain Adjustments
. If, between the date of this Agreement and the Effective Time, the outstanding shares of Company Common Stock
shall have been changed into a different number of shares or a different class of shares by reason of any stock dividend, subdivision, reorganization, reclassification, recapitalization, stock split, reverse stock split, combination or exchange of
shares, or any similar event shall have occurred, then the Merger Consideration shall be equitably adjusted, without duplication, to proportionally reflect such change;
provided
that nothing in this
Section 2.1(c)
shall be
construed to permit the Company to take any action with respect to its securities that is prohibited by the terms of this Agreement.
A-3
Section 2.2
Exchange of Certificates
.
(a)
Appointment of Paying Agent
. Prior to the Closing, Parent shall appoint a bank or trust company reasonably acceptable to the
Company to act as payment agent (the
Paying Agent
) for the payment of the Merger Consideration and shall enter into a paying agent agreement reasonably acceptable to the Company relating to the Paying Agents responsibilities
under this Agreement.
(b)
Deposit of Merger Consideration
. Prior to the Effective Time, Parent shall deposit, or cause to be
deposited, with the Paying Agent, in trust for the benefit of the holders of Company Common Stock, cash sufficient to pay the aggregate Merger Consideration (such aggregate Merger Consideration, the
Payment Fund
).
(c)
Exchange Procedures
. As promptly as practicable (and no later than the third Business Day) after the Effective Time, Parent shall
cause the Paying Agent to mail to each holder of record of shares of Company Common Stock whose shares of Company Common Stock were converted pursuant to
Section 2.1(a)(iii)
into the right to receive the Merger Consideration (i) a
letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title shall pass, only upon delivery of the Certificates or transfer of the Book-Entry Shares to the Paying Agent and shall be in such form and have
such other provisions as Parent shall reasonably designate) (the
Letter of Transmittal
) and (ii) instructions for use in effecting the surrender of Certificates or Book-Entry Shares in exchange for the Merger Consideration.
(d)
Surrender of Certificates or Book-Entry Shares
. Upon surrender of Certificates or Book-Entry Shares to the Paying Agent
together with the Letter of Transmittal, duly completed and validly executed in accordance with the instructions thereto, and such other documents as may reasonably be required by the Paying Agent, the holder of such Certificates or Book-Entry
Shares shall be entitled to receive in exchange therefor the Merger Consideration into which the shares represented by such Certificates or Book-Entry Shares have been converted pursuant to this Agreement. In the event of a transfer of ownership of
shares of Company Common Stock that is not registered in the transfer or stock records of the Company, any cash to be paid upon due surrender of the Certificate or Book-Entry Share formerly representing such shares of Company Common Stock may be
paid to any such transferee if such Certificate or Book-Entry Share is presented to the Paying Agent, accompanied by all documents required to evidence and effect such transfer and to evidence that any applicable stock transfer or other similar
Taxes have been paid or are not applicable. No interest shall be paid or shall accrue on the Merger Consideration payable upon surrender of any Certificate or Book-Entry Share.
(e)
No Further Ownership Rights in Company Common Stock
. From and after the Effective Time, subject to applicable Law in the case of
Dissenting Shares, all holders of Certificates and Book-Entry Shares shall cease to have any rights as stockholders of the Company other than the right to receive the Merger Consideration into which the shares represented by such Certificates or
Book-Entry Shares have been converted pursuant to this Agreement upon the surrender of such Certificate or Book-Entry Share in accordance with
Section 2.2(d)
, without interest. At the Effective Time, the stock transfer books of the
Company shall be closed with respect to all shares of Company Common Stock outstanding immediately prior to the Effective Time, and there shall be no further registration of transfers on the stock transfer books of the Surviving Company of shares of
Company Common Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, any Certificates or Book-Entry Shares formerly representing shares of Company Common Stock are presented to the Surviving Company,
Parent or the Paying Agent for any reason, such Certificates or Book-Entry Shares shall be cancelled and exchanged as provided in this
Article II
, subject to applicable Law in the case of Dissenting Shares.
(f)
Investment of Payment Fund
. The Paying Agent shall invest any cash included in the Payment Fund as directed by Parent;
provided
that no such investment or loss thereon shall affect the amounts payable to holders of Certificates or Book-Entry Shares pursuant to this
Article II
, and following any losses from any such investment, Parent shall promptly
provide additional funds to the Paying Agent for the benefit of the holders of
A-4
shares of Company Common Stock at the Effective Time in the amount of such losses, which additional funds will be deemed to be part of the Payment Fund. Any interest or other income resulting
from such investments shall be paid to Parent, upon demand.
(g)
Termination of Payment Fund
. Any portion of the Payment Fund
(including any interest or other amounts received with respect thereto) that remains unclaimed by, or otherwise undistributed to, the holders of Certificates and Book-Entry Shares for six months after the Effective Time shall be delivered to Parent,
upon demand, and any holder of Certificates or Book-Entry Shares that has not theretofore complied with this
Article II
shall thereafter look only to Parent or the Surviving Company (subject to abandoned property, escheat or other similar
Laws), as general creditors thereof, for satisfaction of its claim for Merger Consideration that such holder has the right to receive pursuant to this
Article II
without any interest thereon.
(h)
No Liability
. Subject to applicable Law, none of Parent, the Company, Merger Sub or the Paying Agent shall be liable to any Person
in respect of any portion of the Payment Fund or the Merger Consideration delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. Subject to applicable Law, notwithstanding any other provision of this
Agreement, any portion of the Merger Consideration or the cash to be paid in accordance with this
Article II
that remains undistributed to the holders of Certificates and Book-Entry Shares as of immediately prior to the date on which the
Merger Consideration or such cash would otherwise escheat to or become the property of any Governmental Entity, shall, to the extent permitted by applicable Law, become the property of the Surviving Company, free and clear of all claims or interest
of any Person previously entitled thereto.
(i)
Withholding Rights
. Each of the Company, the Surviving Company, Parent, Merger Sub
and the Paying Agent (without duplication) shall be entitled to deduct and withhold from amounts otherwise payable pursuant to this Agreement, any amounts required to be deducted or withheld with respect to the making of such payment under
applicable Tax Law. To the extent that any amounts are so deducted, withheld and timely remitted to the appropriate Taxing Authority, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of
which such deduction or withholding was made.
(j)
Lost Certificates
. If any Certificate shall have been lost, stolen or destroyed,
upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by Parent or the Paying Agent, the posting by such Person of a bond in such amount as Parent or the Paying Agent
may determine is reasonably necessary as indemnity against any claim that may be made against it or the Surviving Company with respect to such Certificate, the Paying Agent (or, if subsequent to the termination of the Payment Fund and subject to
Section 2.2(g)
, Parent) shall deliver, in exchange for such lost, stolen or destroyed Certificate, the Merger Consideration in accordance with the terms of this Agreement.
Section 2.3
Treatment of Company Equity Awards; Stock Purchase Program.
(a) At the Effective Time, each option granted by the Company to purchase shares of Company Common Stock (a
Company Option
)
that is outstanding as of the Effective Time, whether vested or unvested, shall be cancelled by virtue of the Merger and without any action on the part of the holder thereof, in consideration for the right to receive, as promptly as practicable (but
no later than fifteen calendar days) following the Effective Time, a cash payment (without interest and less applicable withholding Taxes) with respect thereto equal to the product of (i) the number of shares of Company Common Stock subject to
such Company Option as of the Effective Time and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Company Common Stock subject to such Company Option as of the Effective Time. For the avoidance of doubt,
any Company Option with an exercise price equal to or in excess of the Merger Consideration shall be cancelled by virtue of the Merger without any action on the part of the holder thereof and without any payment to the holder thereof.
Notwithstanding the foregoing, at the Effective Time, each Company Option granted after the date of the Agreement, whether or not vested, that is outstanding and unexercised as of immediately prior to the Effective Time, shall be converted into an
option to acquire, on the same terms and
A-5
conditions as were applicable under such Company Option immediately prior to the Effective Time, including vesting (and any applicable accelerated vesting), a number of shares of Parent common
stock equal to the product (rounded down to the nearest whole number of shares) of the number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time multiplied by the Equity Award Exchange Ratio (as
defined below) at a price per share (rounded up to the nearest whole cent) of Parent common stock equal to the price per share under such Company Option immediately prior to the Effective Time divided by the Equity Award Exchange Ratio (each Company
Option, as so adjusted, an
Adjusted Option
).
Equity Award Exchange Ratio
shall mean the quotient (rounded to four decimal places) obtained by dividing the Merger Consideration by the volume weighted average
trading price of Parent common stock for the five consecutive trading days ending with, and including, the trading day immediately prior to the Closing Date.
(b) At the Effective Time, each time-vesting restricted stock unit award granted by the Company in respect of shares of Company Common Stock
(a
Company RSU Award
) and each performance-based restricted stock unit award granted by the Company in respect of shares of Company Common Stock (a
Company PSU Award
) that is outstanding as of the Effective Time
shall be cancelled by virtue of the Merger and without any action on the part of the holder thereof, in consideration for the right to receive, as promptly as practicable (but no later than fifteen calendar days) following the Effective Time, a cash
payment (without interest and less applicable withholding Taxes) with respect thereto equal to the product of (i) the number of shares of Company Common Stock subject to such Company RSU Award or Company PSU Award as of the Effective Time (with
respect to each Company PSU Award, such number of shares shall be determined, in accordance with the applicable award terms, by assuming the actual level of achievement of the applicable performance goals in respect of fiscal years during the
performance period that are completed prior to the Effective Time and the target level of achievement of the applicable performance goals in respect of all other fiscal years during the performance period) and (ii) the Merger Consideration;
provided
,
however
, that to the extent that any such Company RSU Award or Company PSU Award constitutes nonqualified deferred compensation subject to Section 409A of the Code, such cash payment shall be paid in accordance with the
applicable awards terms and at the earliest time permitted under the terms of such award that will not result in the application of a tax or penalty under Section 409A of the Code. Notwithstanding the foregoing, at the Effective Time,
each Company RSU Award granted after the date of this Agreement that is outstanding as of immediately prior to the Effective Time shall, automatically and without any required action on the part of the holder thereof, be converted into a Parent
restricted stock unit award with the same terms and conditions, including vesting (and any applicable accelerated vesting), as were applicable to such Company RSU Award immediately prior to the Effective Time, and relating to the number of shares of
Parent common stock (rounded up to the nearest whole number of shares) equal to the product of (a) the Equity Award Exchange Ratio, multiplied by (b) the number of shares of Company Common Stock subject to such Company RSU Award as of
immediately prior to the Effective Time (each Company RSU Award, as so adjusted, an
Adjusted RSU Award
).
(c) At the
Effective Time, each share of Company stock subject to vesting, repurchase or other lapse restrictions pursuant to an award granted by the Company (a
Company Restricted Share
) that is outstanding as of the Effective Time shall, by
virtue of the Merger and without any action on the part of the holder thereof, vest in full and become free of restrictions and shall be cancelled and converted automatically, in accordance with the procedures set forth in this Agreement, into the
right of the holder to receive the Merger Consideration (less applicable withholding Taxes).
(d) Prior to the Effective Time, the Company
shall take the actions necessary to effectuate the following: (i) cause the Company Stock Purchase Program provided through Computershare Shareowner Services (the
Stock Purchase Program
), to be terminated subject to, and
effective as of immediately prior to, the Effective Time and (ii) cause all accumulated employee payroll deductions held pursuant to the Stock Purchase Program as of the Effective Time to be refunded to employees as promptly as practicable
following the Effective Time.
A-6
(e) Prior to the Effective Time, the Company, the Company Board of Directors or the Compensation
Committee of the Company Board of Directors, as applicable, shall adopt any resolutions that are necessary to effectuate the provisions of this
Section 2.3
, and shall provide notices to holders of Company Options regarding the treatment
of Company Options pursuant to this
Section 2.3
. As of no later than the Effective Time, Parent shall file a registration statement with the SEC on Form S-8 (or other applicable form) with respect to the shares of Parent common stock
subject to the Adjusted Options and Adjusted RSU Awards, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such registration statement for so long as such Adjusted Options and Adjusted RSU Awards remain
outstanding.
Section 2.4
Further Assurances
. Subject to
Section 5.7(d)
, if at any time before or after the
Effective Time, Parent or the Company reasonably believes or is advised that any further instruments, deeds, assignments or assurances are reasonably necessary or desirable to consummate the Merger or to carry out the purposes and intent of this
Agreement at or after the Effective Time, then Parent, Merger Sub, the Company and the Surviving Company and their respective officers and directors shall execute and deliver all such proper instruments, deeds, assignments or assurances and do all
other things reasonably necessary or desirable to consummate the Merger and to carry out the purposes and intent of this Agreement.
ARTICLE III.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except (a) as disclosed in any SEC Document of the Company publicly filed with or publicly furnished to the SEC from and after
November 1, 2014 and prior to the date hereof (excluding any disclosures set forth in any risk factors, forward-looking statements or market risk sections or other forward-looking disclosures that are not
specific or are cautionary or predictive in nature) or (b) as disclosed in the disclosure schedule delivered by the Company to Parent concurrently with the execution of this Agreement (the
Company Disclosure Schedule
)
(
provided
that disclosure of any item in any section or subsection of the Company Disclosure Schedule shall be deemed disclosed with respect to any other section or subsection to the extent that the relevance of any disclosed event, item or
occurrence in such section or subsection to such other section or subsection is reasonably apparent), the Company represents and warrants to Parent as follows:
Section 3.1
Organization
.
(a) The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware. The Company
has all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted, except where the failure to have such power or authority has not had or would not reasonably be
expected to have, individually or in the aggregate, (i) a Material Adverse Effect or (ii) a material adverse effect on the Companys and its Subsidiaries ability to timely consummate the transactions contemplated hereby
(including the Merger). Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, each of the Companys Subsidiaries is a legal entity duly organized and validly existing and
in good standing under the Laws of its respective jurisdiction of organization and has all requisite corporate or similar power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted.
Each of the Company and its Subsidiaries is duly qualified or licensed, and has all necessary governmental approvals, to do business and is in good standing in each jurisdiction in which the property owned, leased or operated by it or the nature of
the business conducted by it makes such approvals, qualification or licensing necessary, except where the failure to be so duly approved, qualified or licensed and in good standing has not had or would not reasonably be expected to have,
individually or in the aggregate, (i) a Material Adverse Effect or (ii) a material adverse effect on the Companys and its Subsidiaries ability to timely consummate the transactions contemplated hereby (including the Merger).
A-7
(b) The Company has made available to Parent a true and complete copy of (i) the
Companys certificate of incorporation and bylaws (collectively, the
Company Organizational Documents
) and (ii) each Significant Subsidiarys certificate of incorporation, bylaws or similar organizational documents
(collectively, the
Significant Subsidiaries Organizational Documents
), in each case, as amended through the date hereof. The Company Organizational Documents and the Significant Subsidiaries Organizational Documents are in full
force and effect, and neither the Company nor any Significant Subsidiary is in material violation of any of their provisions. Section 3.1(b) of the Company Disclosure Schedule sets forth a list, true and complete in all respects, of all
Subsidiaries of the Company and any joint ventures, partnerships or similar arrangements in which the Company or its Subsidiaries has a limited liability, partnership or other equity interest (and the amount and percentage of any such interest).
Section 3.2
Capital Stock and Indebtedness
.
(a) The authorized capital stock of the Company consists of 120,000,000 shares of common stock, par value $0.50 per share (the
Company Common Stock
). As of March 18, 2016 (the
Specified Date
), (i) 79,156,963 shares of Company Common Stock were issued and outstanding (not including shares held in treasury), of which 169,848
shares were Company Restricted Shares, (ii) 39,285,661 shares of Company Common Stock were held in treasury, (iii) 4,618,230 shares of Company Common Stock were issuable upon the exercise of outstanding Company Options, which had a
weighted average exercise price of $40.08, (iv) 538,306 shares were subject to Company RSU Awards, (v) 366,736 shares were subject to Company PSU Awards (assuming achievement of the applicable performance goals at the maximum level), and
(vi) no other shares of capital stock or other voting securities of the Company were issued, reserved for issuance or outstanding. All outstanding shares of Company Common Stock are duly authorized, validly issued, fully paid and nonassessable
and free of preemptive rights. Except as set forth in this
Section 3.2(a)
or as expressly permitted by
Section 5.1(b)
, there are no outstanding subscriptions, options, warrants, calls, puts, convertible securities,
exchangeable securities or other similar rights, agreements or commitments to which the Company or any of its Subsidiaries is a party (1) obligating the Company or any of its Subsidiaries to (I) issue, transfer, exchange, sell or register
for sale any shares of capital stock or other equity interests of the Company or any Subsidiary of the Company or securities convertible into or exchangeable for such shares or equity interests, (II) grant, extend or enter into any such
subscription, option, warrant, call, put, convertible securities, exchangeable securities or other similar right, agreement or commitment relating to the capital stock or other equity interest of the Company or any Subsidiary of the Company, (III)
redeem or otherwise acquire any such shares of capital stock or other equity interests, (IV) provide a material amount of funds to, or make any material investment (in the form of a loan, capital contribution or otherwise) in, any Subsidiary or
(V) make any payment to any Person the value of which is derived from or calculated based on the value of Company Common Stock, or (2) granting any preemptive or antidilutive or similar rights with respect to any security issued by the
Company or its Subsidiaries. No Subsidiary of the Company owns any shares of capital stock of the Company. Neither the Company nor any of its Subsidiaries has outstanding any bonds, debentures, notes or other indebtedness, the holders of which have
the right to vote (or which are convertible or exchangeable into or exercisable for securities having the right to vote) with the stockholders of the Company on any matter. There are no voting trusts or other agreements or understandings to which
the Company or any of its Subsidiaries is a party with respect to the voting or registration of the capital stock or other equity interest of the Company or any of its Subsidiaries. Since the Specified Date through the date hereof, the Company has
not issued or repurchased any shares of its capital stock (other than in connection with the exercise, settlement or vesting of Company Equity Awards in accordance with their respective terms) or granted any Company Equity Awards.
(b) The Company or a Subsidiary of the Company owns, directly or indirectly, all of the issued and outstanding shares of capital stock or
other equity interests of each Subsidiary of the Company, and all of such shares of capital stock or other equity interests are duly authorized, validly issued, fully paid and nonassessable and free of preemptive rights in favor of any Person other
than the Company or a wholly owned Subsidiary of the Company. Except for equity interests in the Companys Subsidiaries, as of the date hereof, neither the Company nor any of its Subsidiaries owns, directly or indirectly, any equity interest in
any Person (or any security or other
A-8
right, agreement or commitment convertible or exercisable into, or exchangeable for, any equity interest in any Person) other than equity interests that are not material to the Company and
Subsidiaries, taken as a whole. As of the date hereof, neither the Company nor any of its Subsidiaries has any obligation to acquire any material equity interest, security, right, agreement or commitment or to provide funds to or make any investment
(in the form of a loan, capital contribution or otherwise) in, any Person.
Section 3.3
Corporate Authority Relative to this
Agreement; Consents and Approvals; No Violation
.
(a) The Company has the requisite corporate power and authority to enter into this
Agreement and, subject only to adoption of this Agreement by the holders of a majority of the outstanding shares of Company Common Stock entitled to vote on such matter at a stockholders meeting duly called and held for such purpose (the
Requisite Company Vote
), to consummate the transactions contemplated hereby, including the Merger. The execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated
hereby, including the Merger, have been duly and validly authorized by the Company Board of Directors and, except for the Requisite Company Vote and the filing of the Certificate of Merger with the Secretary of State of the State of Delaware, no
other corporate proceedings on the part of the Company or vote of the Companys stockholders are necessary to authorize the consummation of the transactions contemplated hereby, including the Merger. The Company Board of Directors has
unanimously (i) resolved to recommend that the holders of shares of Company Common Stock adopt this Agreement (the
Company Recommendation
), (ii) declared it advisable to enter into the Merger Agreement,
(iii) determined that this Agreement and the Merger and the other transactions contemplated by this Agreement are fair to and in the best interests of the Company and the Companys stockholders and (iv) approved this Agreement and the
Merger and the other transactions contemplated by this Agreement. This Agreement has been duly and validly executed and delivered by the Company and, assuming this Agreement constitutes the legal, valid and binding agreement of Parent and Merger
Sub, this Agreement constitutes the legal, valid and binding agreement of the Company and is enforceable against the Company in accordance with its terms, except as such enforcement may be subject to applicable bankruptcy, reorganization, fraudulent
conveyance, insolvency, moratorium or other similar Laws affecting creditors rights generally and the availability of equitable relief and any implied covenant of good faith and fair dealing (the
Enforceability Exceptions
).
(b) Other than in connection with or in compliance with (i) the filing of the Certificate of Merger with the Secretary of State of
the State of Delaware, (ii) the filing of a proxy statement relating to the Stockholders Meeting to be held in connection with this Agreement, the Merger and the other transactions contemplated hereunder (as it may be amended or supplemented,
the
Proxy Statement
) with the U.S. Securities and Exchange Commission (the
SEC
), (iii) the U.S. Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder (the
Exchange
Act
), (iv) the rules and regulations of the New York Stock Exchange and (v) the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the
HSR
Act
) and as set forth in Section 3.3(b) of the Company Disclosure Schedule (covering the applicable Laws or other legal restraints of foreign countries designed to govern competition or trade regulation or to prohibit, restrict or
regulate actions with the purpose or effect of monopolization or restraint of trade (collectively,
Antitrust Laws
and each such law individually an
Antitrust Law
)) (collectively, the
Transaction
Approvals
), no authorization, consent, order, license, permit or approval of, or registration, declaration, notice or filing with, any Governmental Entity is required to be made or obtained under applicable Law for the consummation by the
Company of the transactions contemplated by this Agreement, except for such authorizations, consents, orders, licenses, permits, approvals, registrations, declarations, notices and filings that are not required to be made or obtained prior to the
consummation of such transactions or that the failure to make or obtain would not reasonably be expected to have, individually or in the aggregate, (x) a Material Adverse Effect or (y) a material adverse effect on the Companys and
its Subsidiaries ability to timely consummate the transactions contemplated hereby (including the Merger).
(c) The execution and
delivery by the Company of this Agreement does not, and (assuming the Transaction Approvals are obtained) the consummation of the transactions contemplated hereby and compliance
A-9
with the provisions hereof will not, (i) result in any loss, or suspension, limitation or impairment of any right of the Company or any of its Subsidiaries to own or use any assets required
for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation, first offer, first refusal, modification or acceleration of,
or trigger the grant of any material rights or material change to the payment terms under, any obligation or to the loss of a benefit under any loan, guarantee of indebtedness or credit agreement, note, bond, mortgage, indenture, lease, agreement,
Contract, instrument, Permit, concession, franchise, right or license binding upon the Company or any of its Subsidiaries or by which or to which any of their respective properties, rights or assets are bound or subject, or result in the creation of
any liens, claims, mortgages, encumbrances, pledges, security interests, equities or charges of any kind (each, a
Lien
) other than Permitted Liens, in each case, upon any of the properties or assets of the Company or any of its
Subsidiaries, except for any of the foregoing as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (ii) conflict with or result in any violation of any provision of the Company Organizational
Documents or (iii) conflict with or violate any provision of the Significant Subsidiaries Organizational Documents or any applicable Laws, in each case except as would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, except in the case of
clauses (i)
,
(ii)
, and
(iii)
above as would not reasonably be expected to have, individually or in the aggregate, a material adverse effect on the Companys and its
Subsidiaries ability to timely consummate the transactions contemplated hereby (including the Merger).
Section 3.4
Reports
and Financial Statements
.
(a) The Company has timely filed or furnished all forms, documents and reports required to be filed or
furnished by it with the SEC since November 1, 2014 (all such forms, documents and reports filed or furnished by the Company since such date, the
Company SEC Documents
). As of their respective dates or, if amended, as of the
date of the last such amendment (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), the Company SEC Documents complied in all material respects with
the applicable requirements of the U.S. Securities Act of 1933, as amended (the
Securities Act
), the Exchange Act and the Sarbanes-Oxley Act of 2002 (the
Sarbanes-Oxley Act
), as the case may be, and the
applicable rules and regulations of the SEC promulgated thereunder, and none of the Company SEC Documents, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. None of the Companys Subsidiaries is, or at any time since November 1, 2014 has been, required to file any forms, reports or other documents
with the SEC.
(b) The consolidated financial statements (including all related notes and schedules) of the Company included in or
incorporated by reference into the Company SEC Documents (the
Company Financial Statements
) (i) fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries, as
at the respective dates thereof, and the consolidated results of their operations and their consolidated cash flows for the respective periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments that are
not material and to any other adjustments described therein, including the notes thereto), (ii) were prepared in conformity with U.S. generally accepted accounting principles (
GAAP
) (except, in the case of the unaudited
statements, as permitted by the SEC) applied on a consistent basis during the periods involved (except as may be indicated therein or in the notes thereto), and (iii) comply as to form in all material respects with the applicable accounting
requirements under the Securities Act, the Exchange Act and the applicable rules and regulations of the SEC. As of the date of this Agreement, Ernst & Young LLP has not resigned (or informed the Company that it intends to resign) or been
dismissed as independent public accountants of the Company as a result of or in connection with any disagreements with the Company on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure.
Section 3.5
Internal Controls and Procedures
. The Company has established and maintains disclosure controls and procedures and
internal control over financial reporting (as such terms are defined in paragraphs
A-10
(e) and (f), respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15 under the Exchange Act. The Companys disclosure controls and procedures are designed to
ensure that all information required to be disclosed by the Company in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC,
and that all such information is accumulated and communicated to the Companys management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections 302 and 906 of the
Sarbanes-Oxley Act. The Companys management has completed an assessment of the effectiveness of the Companys internal controls over financial reporting in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act for
the fiscal year ended October 30, 2015, and such assessment concluded that such controls were effective. Based on its most recent evaluation of internal controls over financial reporting prior to the date hereof, management of the Company has
disclosed to the Companys auditors and the audit committee of the Company Board of Directors (i) any significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting that are reasonably
likely to adversely affect in any material respect the Companys ability to report financial information and (ii) any fraud or allegations of fraud, whether or not material, that involves management or other employees who have a
significant role in the Companys internal control over financial reporting, and each such deficiency, weakness and fraud so disclosed to auditors, if any, has been disclosed to Parent prior to the date hereof. Each of the Company and its
Subsidiaries has substantially addressed any such deficiency, material weakness or fraud.
Section 3.6
No Undisclosed
Liabilities
. There are no Liabilities of the Company or any of its Subsidiaries of any nature whatsoever (whether accrued, absolute, determined, contingent or otherwise and whether due or to become due) except for (i) Liabilities that are
reflected or reserved against on the consolidated balance sheet of the Company and its Subsidiaries included in its Annual Report on Form 10-K for the annual period ended October 30, 2015 (including any notes thereto), (ii) Liabilities
arising in connection with the transactions contemplated hereby or in connection with obligations under existing Contracts or applicable Law (other than any Liability that has arisen due to a breach or violation of any such Contract or Law),
(iii) Liabilities incurred in the ordinary course of business since October 30, 2015, (iv) Liabilities that have been discharged or paid in full in the ordinary course of business and (v) Liabilities that have not had or would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. As of the date hereof, neither the Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any material, or to
the Companys knowledge, immaterial, off-balance sheet partnership, joint venture or any similar arrangement (including any Contract relating to any transaction or relationship between or among the Company and/or any of its Subsidiaries, on the
one hand, and any other Person, including any structured finance, special purpose or limited purpose Person, on the other hand), or any material, or to the Companys knowledge, immaterial, off-balance sheet arrangement (as defined
in Item 303(a) of Regulation S-K of the Securities Act).
Section 3.7
Compliance with Law; Permits
.
(a) Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the
Company and each of its Subsidiaries are, and since November 1, 2014 have been, in compliance with all applicable federal, state, local and foreign laws, statutes, ordinances, rules, regulations, judgments, orders, injunctions, decrees or
agency requirements of Governmental Entities (collectively,
Laws
and each, a
Law
). Since November 1, 2014, neither the Company nor any of its Subsidiaries has received any written notice or, to the
Companys knowledge, other communication from any Governmental Entity regarding any actual or alleged failure to comply with or violation of any Law in a material respect.
(b) Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the
Company and its Subsidiaries hold all franchises, grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals, clearances, permissions, qualifications and registrations and orders of all applicable
Governmental Entities (
Permits
), and all rights under all Company Material Contract with all Governmental Entities, and have filed all tariffs, reports, notices and other documents with all Governmental Entities necessary for the
Company and its Subsidiaries to own,
A-11
lease and operate their properties and assets and to carry on their businesses as they are now being conducted (collectively, the
Company Permits
), and have paid all fees and
assessments due and payable in connection therewith. Except as have not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) all Company Permits are valid and in full force and
effect, (ii) all Company Permits are, to the knowledge of the Company, not subject to any administrative or judicial proceeding that could result in any material modification, termination or revocation thereof, (iii) the Company and its
Subsidiaries are in compliance with the terms and requirements of all such Company Permits and, (iv) to the Companys knowledge, no suspension or cancellation of any such Company Permit is threatened or pending.
(c) None of the Company or its Subsidiaries, or to the Companys knowledge, any director, officer, employee, agent of the Company or any
of its Subsidiaries, in each case, acting on behalf of the Company or any of its Subsidiaries, has, directly or indirectly, (i) used any funds of the Company or any of its Subsidiaries for unlawful contributions, unlawful gifts, unlawful
entertainment or other unlawful expenses relating to political activity; (ii) made any unlawful payment to foreign or domestic governmental officials or employees or to foreign or domestic political parties or campaigns from funds of the
Company or any of its Subsidiaries; (iii) violated or is in violation of the Foreign Corrupt Practices Act of 1977, as amended (the
FCPA
), or is in violation of any similar Law or other applicable Bribery Legislation;
(iv) established or maintained any unlawful fund of monies or other assets of the Company or any of its Subsidiaries; (v) made, promised or authorized any fraudulent entry on the books or records of the Company or any of its Subsidiaries;
(vi) made any unlawful bribe, unlawful kickback or other unlawful payment to any Person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing business to obtain special
concessions for the Company or any of its Subsidiaries; or (vii) violated any provision of the USA PATRIOT Act applicable to the Company and its Subsidiaries; in each case other than as would be material to the Company and its Subsidiaries,
taken as a whole.
(d) None of the Company or its Subsidiaries, or to the Companys knowledge, any director, officer, employee or
agent of the Company or any of its Subsidiaries (i) is a Sanctioned Person, (ii) has in the past five years engaged in, has any plan or commitment to engage in, direct or indirect dealings with any Sanctioned Person or in any Sanctioned
Country on behalf of the Company or any of its Subsidiaries, except pursuant to a license from the United States, or (iii) has in the past five years violated, or engaged in any conduct sanctionable under, any Sanctions Law, nor to the
Companys knowledge, been the subject of an investigation or allegation of such a violation or sanctionable conduct, other than, in the case of
clauses (ii)
and
(iii)
, as would be material to the Company and its Subsidiaries,
taken as a whole.
(e) Notwithstanding anything contained in this
Section 3.7
, no representation or warranty shall be deemed
to be made in this
Section 3.7
in respect of the matters specifically covered in any other Section of this
Article III
, including the provisions of environmental, Tax, employee benefits or labor matters.
Section 3.8
Environmental Laws and Regulations
. Except as has not had or would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect: (a) there are no suits, actions, claims, proceedings, arbitrations, demands or, to the knowledge of the Company, investigations pending or, to the knowledge of the Company, threatened against the
Company or any of its Subsidiaries, alleging actual or potential non-compliance with or other Liability under any Environmental Law or arising from the Release of or exposure to any Hazardous Materials, (b) the Company and its Subsidiaries are
and have since October 26, 2013 been, and, to the Companys knowledge as of the date hereof, have between October 29, 2011 and October 26, 2013 been, in compliance with all Environmental Laws (which compliance includes the
possession by the Company and each of its Subsidiaries of all Company Permits required under applicable Environmental Laws to conduct their respective business and operations, and compliance with the terms and conditions thereof), (c) there has
been no Release at, on, in, under or migrating to or from any real property that the Company or any of its Subsidiaries operates, uses or occupies or has the right to operate, use or occupy pursuant to a lease, sublease or other agreement (such
property subject to a lease, sublease or other agreement, collectively, the
Company Leased Real Property
) or at, on, in, under or migrating to or from any real property owned by the Company and
A-12
its Subsidiaries (
Company Owned Real Property
) of Hazardous Materials by the Company or any of its Subsidiaries or, to the knowledge of the Company, as a result of any
operations or activities of the Company or any of its Subsidiaries or, to the knowledge of the Company, by any other Persons, in each case that would reasonably be expected to give rise to any Liability to the Company or its Subsidiaries,
(d) to the Companys knowledge, no Hazardous Materials are present at, on, in, under or migrating to or from any property currently or formerly owned, operated or leased by the Company or its Subsidiaries that would reasonably be expected
to result in Liabilities under applicable Environmental Laws, (e) none of the Company and its Subsidiaries is subject to any Order or any indemnity obligation or other Contract with any Person that would reasonably be expected to result in
Liabilities to the Company or any of its Subsidiaries under applicable Environmental Laws or concerning Hazardous Materials or Releases, (f) since October 26, 2013 through the date of this Agreement, and, to the Companys knowledge as
of the date hereof, between October 29, 2011 and October 26, 2013, neither the Company nor any of its Subsidiaries has received any written notice from any Governmental Entity alleging non-compliance by, or potential liability to, the
Company or any of its Subsidiaries with respect to any Environmental Law or Company Permit required by applicable Environmental Law in connection with the ownership or operation of their respective businesses and (g) no Liens (other than
Permitted Liens) pursuant to Environmental Laws are imposed on the property owned or operated by the Company or its Subsidiaries, and, to the Companys knowledge, no such Liens (other than Permitted Liens) have been threatened in writing; it
being understood that for purposes of
clause (g)
of this
Section 3.8
, the definition of Permitted Liens shall not include
clause (G)
set forth in that definition. Except as has not had or would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, neither the execution of this Agreement nor the consummation of the transactions contemplated hereby will require any investigation or remediation
activities or notice to or consent of any Governmental Entity or third party pursuant to any Environmental Law.
Section 3.9
Employee Benefit Plans
.
(a) Section 3.9(a) of the Company Disclosure Schedule sets forth a list of each material U.S. Company
Benefit Plan in effect as of the date hereof. With respect to each material U.S. Company Benefit Plan, to the extent applicable, correct and complete copies of the following have been made available to Parent by the Company: (i) all plan
documents (including all written amendments thereto) (which, for the avoidance of doubt, with respect to any material U.S. Company Benefit Plan for which a form agreement is used, shall consist of a copy of such form); (ii) all related trust
documents; (iii) all insurance contracts or other funding arrangements; (iv) the most recent annual report (Form 5500) filed with the Internal Revenue Service (the
IRS
); (v) the most recent determination, opinion or
advisory letter from the IRS for any U.S. Company Benefit Plan that is intended to qualify under Section 401(a) of the Code; (vi) the most recent summary plan description; and (vii) all material correspondence to or from the IRS, the
United States Department of Labor (
DOL
), the Pension Benefit Guaranty Corporation (
PBGC
) or any other Governmental Authority received in the last three years with respect to such material U.S. Company Benefit
Plan. No award agreement governing any Company Equity Award prohibits the treatment of such Company Equity Award in the manner set forth in
Section 2.3
.
(b) Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, with
respect to each U.S. Company Benefit Plan (including any related trusts), (i) such U.S. Company Benefit Plan has been established, operated and administered in accordance with its terms and the requirements of all applicable Laws, including
ERISA and the Code; and (ii) all contributions required to be made to any U.S. Company Benefit Plan (or related trusts) by applicable Law or by any plan document or other contractual undertaking, and all premiums due or payable with respect to
insurance policies funding any U.S. Company Benefit Plan, for any period in the prior three years through the date hereof, have been timely made or paid in full or, to the extent not required to be made or paid on or before the date hereof, have
been fully reflected on the books and records of the Company.
(c) Section 3.9(c) of the Company Disclosure Schedule identifies each
U.S. Company Benefit Plan that is intended to be qualified under Section 401(a) of the Code (each, a
Qualified Plan
). With respect to each Qualified Plan, (i) the IRS has issued a favorable determination, opinion or
advisory letter with respect to each
A-13
Qualified Plan and its related trust, and such letter has not been revoked (nor has revocation been threatened in writing), and (ii) to the knowledge of the Company, there are no existing
circumstances and no events have occurred that would reasonably be expected to adversely affect the qualified status of any Qualified Plan or the related trust.
(d) Each Company Benefit Plan that is subject to Title IV or Section 302 of ERISA or Section 412 of the Code is listed on
Section 3.9(d) of the Company Disclosure Schedule and: (i) each such Company Benefit Plan satisfies all minimum funding requirements under Sections 412, 430 and 431 of the Code and Sections 302, 303 and 304 of ERISA, whether or not waived;
(ii) no Lien in favor of any such Company Benefit Plan has arisen under Section 430(k) of the Code or Section 303(k) of ERISA; (iii) such Company Benefit Plan is not in at risk status within the meaning of
Section 430(i) of the Code or Section 303(i) of ERISA; (iv) the Company has delivered or made available to Parent a copy of the most recent actuarial valuation report for such Company Benefit Plan and such report is complete and
accurate in all material respects; (iv) the PBGC has not instituted proceedings to terminate such Company Benefit Plan; and (v) except as would not reasonably be expected to have, individually in the aggregate, a Material Adverse Effect,
there has not been any reportable event (as that term is defined in Section 4043 of ERISA) during the last six years as to which the 30-day advance notice requirement has not been waived.
(e) None of the Company, its Subsidiaries or any of their respective ERISA Affiliates has, in the past six years, maintained, established,
contributed to, been obligated to contribute to, or has any Liability (including withdrawal liability within the meaning of Title IV of ERISA) with respect to, any plan that is a multiemployer plan within the meaning of
Section 4001(a)(3) of ERISA (a
Multiemployer Plan
) or a plan that has two or more contributing sponsors at least two of whom are not under common control, within the meaning of Section 4063 of ERISA.
(f) Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, as of the
date hereof, (i) there are no pending or, to the knowledge of the Company, threatened claims (other than claims for benefits in the ordinary course), lawsuits or arbitrations which have been asserted or instituted, and, to the Companys
knowledge, no set of circumstances exists that would reasonably be expected to give rise to a claim or lawsuit, against the Company, the U.S. Company Benefit Plans, any fiduciaries thereof with respect to their duties to the U.S. Company Benefit
Plans and for whom the Company has an obligation to indemnify, or the assets of any of the trusts under any of the U.S. Company Benefit Plans; and (ii) and there are no audits or other proceedings by a Governmental Authority pending, or to the
knowledge of the Company, threatened with respect to any U.S. Company Benefit Plan.
(g) Except as has not had or would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, neither the Company, any U.S. Company Benefit Plan nor, to the knowledge of the Company, any trustee, administrator or other third-party fiduciary and/or
party-in-interest thereof, has engaged in any breach of fiduciary duty or any prohibited transaction (as such term is defined in Section 406 of ERISA or Section 4975 of the Code) which could subject the Company or any ERISA
Affiliate to any Liability, tax or penalty under ERISA or the Code.
(h) Except as required by Section 4980B of the Code, no U.S.
Company Benefit Plan provides for any post-employment or post-retirement medical or life insurance benefits for retired, former or current employees or beneficiaries or dependents thereof, and neither of the Company nor any of its Subsidiaries has
any obligation to provide such benefits.
(i) Except as has not, and would not reasonably be expected to, result in material liability to
the Company, each U.S. Company Benefit Plan that is a nonqualified deferred compensation plan subject to Section 409A of the Code has been maintained in documentary and operational compliance with Section 409A of the Code. The Company is
not party to, or otherwise obligated under, any contract, agreement, plan or arrangement that provides for the gross-up of Taxes imposed by Section 409A(a)(1)(B) of the Code.
A-14
(j) Except as has not had or would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, each Non-U.S. Company Benefit Plan (i) if intended to qualify for special tax treatment, meets all the requirements for such treatment, (ii) if required to be funded, book-reserved or secured by an
insurance policy, is funded, book-reserved, or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable accounting principles, (iii) has been maintained in compliance with all
applicable Laws and (iv) there is no pending, or to the knowledge of the Company, threatened litigation relating to any Non-U.S. Company Benefit Plan.
(k) The consummation of the transactions contemplated by this Agreement will not, either alone or in combination with another event
(i) entitle any current or former employee, director, or officer of the Company or any of its Subsidiaries to severance pay or any increase in severance pay, accrued pension benefit or any other payment under a U.S. Company Benefit Plan or,
except as would not reasonably be expected to result in a material Liability to the Company and its Subsidiaries, taken as a whole, any Non-U.S. Company Benefit Plan, (ii) accelerate the time of payment or vesting, or increase the amount of
compensation due to any such employee, director, or officer under a U.S. Company Benefit Plan or, except as would not reasonably be expected to result in a material Liability to the Company and its Subsidiaries, taken as a whole, any Non-U.S.
Company Benefit Plan, (iii) except as would not reasonably be expected to result in a material Liability to the Company, entitle any independent contractor (who is a natural person) to any severance pay, increase in severance pay or any other
payment under a U.S. Company Benefit Plan, or accelerate the time of payment or vesting, or increase the amount of compensation due to any independent contractor (who is a natural person), (iv) trigger any funding obligation under any U.S.
Company Benefit Plan or, except as would not reasonably be expected to result in a material Liability to the Company and its Subsidiaries, taken as a whole, any Non-U.S. Company Benefit Plan, or (v) result in any payment (whether in cash or
property or the vesting of property) to any disqualified individual (as such term is defined in Treasury Regulation Section 1.280G-1) that would, individually or in combination with any other such payment, constitute an excess
parachute payment (as defined in Section 280G(b)(1) of the Code). No Company Benefit Plan provides for the gross-up or reimbursement of Taxes under Section 4999 of the Code.
Section 3.10
Absence of Certain Changes or Events
.
(a) Since January 29, 2016, and through the date of this Agreement, (i) the businesses of the Company and its Subsidiaries have been
conducted in all material respects in the ordinary course of business and (ii) neither the Company nor any of its Subsidiaries has taken any action of the types described in
Sections 5.1(b)(G)
,
5.1(b)(H)
or
5.1(b)(M)
which would have been a breach of any such Section if taken after the date hereof.
(b) Since January 29, 2016, there has not been
any fact, change, effect, event, occurrence or development that has had or would reasonably be expected to have, individually or in the aggregate, (i) a Material Adverse Effect, or (ii) a material adverse effect on the Companys and
its Subsidiaries ability to timely consummate the transactions contemplated hereby (including the Merger).
Section 3.11
Investigations; Litigation
. Except as are not or would not reasonably be expected to be, material to the Company and its Subsidiaries, taken as a whole, (a) there is no suit, action, claim, proceeding, arbitration, or investigation
pending or, to the knowledge of the Company, threatened (i) against the Company or any of its Subsidiaries before (or, if threatened, that would be before) or by any Governmental Entity or (ii) to which any of the properties or assets of
the Company or any of its Subsidiaries are subject; and (b) there is no judgment, decree, injunction, rule or order of any Governmental Entity or arbitrator outstanding against or, to the knowledge of the Company, investigation by any
Governmental Entity involving, the Company or any of its Subsidiaries or any of their respective properties or assets.
Section 3.12
Company Information
. The information supplied or to be supplied by the Company for inclusion or incorporation by reference in the Proxy Statement will not, at the time any such document is filed
A-15
with the SEC, amended or supplemented, or first published, sent or provided to holders of shares of Company Common Stock, or at the time of the Stockholders Meeting, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, except that no representation or
warranty is made by the Company with respect to statements made therein based on information supplied by Parent or Merger Sub for inclusion or incorporation by reference therein.
Section 3.13
Tax Matters
. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect:
(a) (i) The Company and each of its Subsidiaries have timely filed (taking into account any valid extension of time within which
to file) all Tax Returns required to be filed by any of them and all such Tax Returns are true, complete and accurate, and (ii) the Company and each of its Subsidiaries have timely paid all Taxes that are required to be paid by any of them or
that the Company or any of its Subsidiaries are obligated to withhold and pay over to an applicable Taxing Authority (including, in connection with amounts paid or owing to any employee, independent contractor, creditor, customer, stockholder or
other third party), except, in each case of
clauses (i)
and
(ii)
, with respect to matters for which adequate reserves have been established, in accordance with GAAP, by the Company.
(b) There is no deficiency for any amount of Taxes which has been proposed, asserted or assessed, in each case, in writing, by any Taxing
Authority against the Company or any of its Subsidiaries that has not been paid or for which adequate reserves have not been established, in accordance with GAAP, by the Company. There are no audits, suits, proceedings, examinations, investigations
or other administrative or judicial proceedings ongoing, pending or, to the knowledge of the Company, threatened in writing in respect of Taxes or Tax matters of the Company or any of its Subsidiaries, in each case, other than in respect of matters
for which adequate reserves have been established, in accordance with GAAP, by the Company.
(c) There are no Liens for Taxes on any of
the assets of the Company or any of its Subsidiaries other than Permitted Liens (within the meaning of
clause (A)
of such term).
(d) Neither the Company nor any Subsidiary of the Company has been a controlled corporation or a distributing
corporation (in each case, within the meaning of Section 355(a)(1)(A) of the Code) in any distribution that was purported or intended to be governed by Section 355 of the Code and for which the applicable statute of limitations has
not expired.
(e) Neither the Company nor any of its Subsidiaries (i) is a party to any agreement or arrangement relating to the
apportionment, sharing or allocation of any Taxes (other than (x) an agreement or arrangement solely among the Company and/or its Subsidiaries or (y) pursuant to leases, credit agreements, employment agreements, purchase agreements or
supply or other commercial agreements or other contracts, agreements or arrangements not primarily relating to Taxes) or (ii) has any Liability for Taxes of any Person (other than the Company or any of its Subsidiaries) under Treasury
Regulation Section 1.1502-6 (or any similar provision of state, local or foreign Tax Law) or as transferee or successor.
(f) None of
the Company or any of its Subsidiaries has participated in any reportable transaction within the meaning of Section 6707A(c)(1) of the Code or Treasury Regulation Section 1.6011-4(b) (or any transaction requiring disclosure to
a Taxing Authority under any similar provision of state, local or foreign Tax Law).
(g) Neither the Company nor any of its Subsidiaries
would reasonably be expected to be required to include any item of income in, or exclude any item of deduction from, taxable income for any period (or any portion thereof) ending after the Closing Date, as a result of any: (i) change in method
of accounting pursuant to Section 481(a) of the Code or any similar provision of applicable Tax Law made on or prior to the Closing;
A-16
(ii) installment sale made on or prior to the Closing; (iii) closing agreement described in Section 7121 of the Code or any similar provision of applicable Tax Law executed on or
prior to the Closing; (iv) intercompany transaction described in Treasury Regulations Section 1.1502-13 or excess loss account described in Treasury Regulations Section 1.1502-19 (in each case, or any similar provision of applicable
state, local or foreign Tax Law) entered into or existing, respectively, prior to the Closing; or (v) indebtedness discharged in connection with any election under Section 108(i) of the Code.
(h) Other than in the ordinary course of business, neither the Company nor any of its Subsidiaries has obtained any ruling from or entered
into any settlement or written agreement with any Taxing Authority with respect to income or value added Taxes that would be binding on Parent for any Tax period (or portion thereof) ending after the Closing Date.
(i) Neither the Company nor any Subsidiary is a party to any advance pricing agreement or any similar material agreement with any Taxing
Authority.
(j) Since October 30, 2015, the Company and its Subsidiaries have not incurred, individually or in the aggregate, any
material liability for Taxes outside the ordinary course of business (unless required by applicable Law).
(k) Neither the Company nor any
Subsidiary has participated in an international boycott within the meaning of Section 999 of the Code.
(l) Notwithstanding anything
herein to the contrary, the representations and warranties contained in this
Section 3.13
and, to the extent expressly referring to Code sections,
Section 3.9
are the sole and exclusive representations of the Company with
respect to Taxes and Tax matters of the Company and each of its Subsidiaries.
Section 3.14
Employment and Labor Matters
.
(a) Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement, labor union contract, or trade union
agreement (each, a
Collective Bargaining Agreement
) covering employees in the United States or Canada. To the knowledge of the Company, as of the date hereof, there are no material activities or proceedings of any labor or trade
union to organize any employees of the Company or any of its Subsidiaries. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, as of the date hereof, (i) there is no strike, lockout,
slowdown, or work stoppage against the Company or any of its Subsidiaries pending or, to the Companys knowledge, threatened; (ii) there is no pending charge or complaint against the Company or any of its Subsidiaries by the National Labor
Relations Board or any comparable Governmental Entity; (iii) none of the Company and its Subsidiaries are a party, or to the knowledge of the Company otherwise bound by, any consent decree with, or citation by, any Governmental Entity relating
to employees or employment practices; (iv) the Company and its Subsidiaries have complied with all Laws regarding employment and employment practices (including anti-discrimination), terms and conditions of employment and wages and hours
(including classification of employees and equitable pay practices) and other Laws in respect of any reduction in force (including notice, information and consultation requirements), and no claims relating to non-compliance with the foregoing are
pending or, to the Companys knowledge, threatened; and (v) to the knowledge of the Company, there are no outstanding assessments, penalties, fines, Liens, charges, surcharges, or other amounts required to be paid that are due or owing by
the Company pursuant to any workplace safety and insurance/workers compensation Laws.
(b) Neither the Company nor any of its
Subsidiaries has incurred or expects to incur any material liability or obligation under the Worker Adjustment and Retraining Notification Act and the regulations promulgated thereunder or any similar state or local Law in the United States, which
material liability or obligation remains unsatisfied.
A-17
Section 3.15
Intellectual Property
.
(a) The Patents, pending Patent applications, registered Marks, pending applications for registration of Marks and registered Copyrights owned
by the Company or any of its Subsidiaries are referred to collectively as the
Company Registered Intellectual Property
. No registrations or applications for Company Registered Intellectual Property have expired or been cancelled
or abandoned except in accordance with the expiration of the term of such rights, other than for the non-payment of maintenance and similar costs prior to the expiration of the term of such rights, except as has not had or would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect.
(b) Except as has not had or would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, (i) all of the Company Registered Intellectual Property, with the exception of pending applications and domain names, are valid and enforceable; and (ii) to the
Companys knowledge, no third Person is challenging the validity or enforceability of the Company Registered Intellectual Property.
(c) The Company and its Subsidiaries solely own all right, title, and interest, free and clear of all Liens (except for Permitted Liens) to,
or otherwise have a valid and enforceable right, or any necessary license, to use all Intellectual Property necessary for or used in the conduct of the business of the Company and its Subsidiaries as currently conducted, except as has not had or
would not reasonably be expected to have, individually or in the aggregate a Material Adverse Effect.
(d) Except as has not had or would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) the conduct of the business of the Company and its Subsidiaries does not infringe, violate or constitute misappropriation of any Intellectual
Property of any third Person; (ii) to the Companys knowledge, no third Person is infringing, violating, or misappropriating any Intellectual Property owned by the Company or its Subsidiaries; and (iii) as of the date hereof, there is
no pending claim or asserted claim in writing, or, to the knowledge of the Company, any threatened claim (including any cease and desist letters and invitations to license) asserting that the Company or any Subsidiary has infringed,
violated or misappropriated, or is infringing, violating or misappropriating any Intellectual Property rights of any third Person.
(e)
Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) the Company and its Subsidiaries have implemented (x) commercially reasonable measures to protect the
confidentiality, integrity and security of the Companys and its Subsidiaries Trade Secrets and material IT Assets (and the information and transactions stored or contained therein or transmitted thereby); and (y) commercially
reasonable data backup, data storage, system redundancy and disaster avoidance and recovery procedures, as well as a commercially reasonable business continuity plan; and (ii) the IT Assets used by the Company and its Subsidiaries perform the
functions necessary to carry on the conduct of their respective businesses.
(f) Except as has not had or would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect, (i) the Company and its Subsidiaries have taken commercially reasonable measures to protect the confidentiality of the Trade Secrets of the Company and its Subsidiaries and
third party confidential information provided to the Company or any Subsidiary that the Company or such Subsidiary is obligated to maintain in confidence; (ii) the Company and its Subsidiaries comply in all material respects with their internal
policies and procedures and with the Payment Card Industry Data Security Standard and any other legally binding credit card company and other legal requirements, to the extent applicable, relating to privacy, data protection, and the collection,
retention, protection and use of Sensitive Data and personal information collected, used, or held for use by (or on behalf of) the Company and its Subsidiaries; (iii) there are no claims pending or, to the knowledge of the Company, threatened
against the Company or its Subsidiaries alleging a violation of any third Persons privacy or personal information or data rights; and (iv) since October 26, 2013, to the Companys knowledge, there has been no unauthorized
access, unauthorized acquisition or disclosure, or any loss or theft, of Sensitive Data of the Company, its Subsidiaries or its customers while such Sensitive Data is in the possession or control of the Company, its Subsidiaries or third-party
vendors.
A-18
Section 3.16
Opinion of Financial Advisor
. The Company Board of Directors has
received the opinion of each of Goldman, Sachs & Co. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, dated the date of this Agreement, to the effect that, as of the date of each such opinion and subject to the assumptions,
limitations, qualifications and other matters considered in the preparation thereof as set forth in each such opinion, the Merger Consideration (whether or not a Triggering Event occurs) to be received by the holders of shares of the Company Common
Stock in the Merger pursuant to this Agreement is fair, from a financial point of view, to such holders.
Section 3.17
Material
Contracts
.
(a) As of the date of this Agreement, neither the Company nor any of its Subsidiaries is a party to or bound by:
(i) any material contract (as such term is defined in Item 601(b)(10) of Regulation S-K promulgated by the
SEC) (other than any Company Benefit Plan);
(ii) any Contract with any of its directors or officers (other than any
Company Benefit Plan);
(iii) any Contract that (A) imposes any material restriction on the right or ability of the
Company or any of its Subsidiaries to compete with any other Person or solicit any client or customer or (B) following the Closing will materially restrict the ability of Parent or its Subsidiaries to so compete or solicit;
(iv) any material Contract with a customer that obligates the Company or its Subsidiaries (or following the Closing, Parent or
its Subsidiaries) to conduct business with any third party on a preferential or exclusive basis or that contains most favored nation or similar covenants;
(v) any Contract relating to Indebtedness (other than intercompany Indebtedness owed by the Company or any wholly owned
Subsidiary to any other wholly owned Subsidiary, or by any wholly owned Subsidiary to the Company) of the Company or any of its Subsidiaries having an outstanding principal amount in excess of $50,000,000.00, other than the Credit Agreement and the
Company Notes and related indentures;
(vi) any Contract that grants any right of first refusal, right of first offer or
similar right with respect to any material assets, rights or properties of the Company or its Subsidiaries;
(vii) any
Contract that provides for the acquisition or disposition, directly or indirectly, of any assets (other than acquisitions or dispositions of sale in the ordinary course of business) or business (whether by merger, sale of stock, sale of assets or
otherwise) or capital stock or other equity interests of any Person, and with any outstanding obligations as of the date of this Agreement, in each case with a value in excess of $10,000,000.00;
(viii) any joint venture, partnership or limited liability company agreement or other similar Contract relating to the
formation, creation, operation, management or control of any material joint venture, partnership or limited liability company, other than any such Contract solely between the Company and its wholly owned Subsidiaries or among the Companys
wholly owned Subsidiaries;
(ix) any Contract with an affiliate or other Person that would be required to be disclosed
under Item 404(a) of Regulation S-K promulgated under the Exchange Act;
(x) any Contract (A) with any customer
that is one of the Top Customers or (B) with any supplier that is one of the Top Suppliers;
(xi) any Contract
pursuant to which the Company or any of its Subsidiaries has purchased, licensed or sold during the twelve months prior to the date hereof, goods or services that involved payment by or to the Company and its Subsidiaries in excess of $40,000,000.00
during such period or that provides for payments in excess of such amount over the remaining term of such agreement (in each case, whether under a single agreement or a series of related agreements);
A-19
(xii) any Contract pursuant to which (A) the Company or any of its
Subsidiaries grants to any third party any license, release, covenant not to sue or similar right with respect to any material Intellectual Property owned by the Company or any of its Subsidiaries, or (B) the Company or any of its Subsidiaries
receives a license, release, covenant not to sue or similar right with respect to any material Intellectual Property owned by a third party (other than generally commercially available software in object code form); and
(xiii) any material Contract or any other Contract that contains most favored nation or similar covenant with
respect to pricing terms or requires on-going reporting obligations of the Company and/or its Subsidiaries, in each case to which the Company or any of its Subsidiaries is a party and any counterparty is a Governmental Entity (or the counterparty
has represented in writing to the Company or any of its Subsidiaries that it is a prime contractor or subcontractor to a Governmental Entity).
All contracts of the types referred to in
clauses (i)
through
(xiii)
above are referred to herein as
Company
Material Contracts
.
(b) Neither the Company nor any Subsidiary of the Company is in breach of or default in any respect under
the terms of any Company Material Contract and, to the knowledge of the Company, as of the date hereof, no other party to any Company Material Contract is in breach of or default in any respect under the terms of any Company Material Contract, and
no event has occurred or not occurred through the Companys or any of its Subsidiaries action or inaction or, to the Companys knowledge, prior to the date hereof through the action or inaction of any third party, that with notice or
the lapse of time or both would constitute a breach of or default or result in the termination of or a right of termination or cancelation thereunder, accelerate the performance or obligations required thereby, or result in the loss of any benefit
under the terms of any Company Material Contract, in each case except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Each Company Material Contract (i) is a valid and
binding obligation of the Company or the Subsidiary of the Company that is party thereto and, to the knowledge of the Company, of each other party thereto, and (ii) is in full force and effect, subject to the Enforceability Exceptions, in each
case except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. There are no disputes pending or, to the Companys knowledge, threatened with respect to any Company Material
Contract, and neither the Company nor any of its Subsidiaries has received any written notice of the intention of any other party to a Company Material Contract to terminate for default, convenience or otherwise any Company Material Contract, nor to
the Companys knowledge, is any such party threatening to do so, in each case except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
Section 3.18
Finders or Brokers
. Except for Goldman, Sachs & Co. and Merrill Lynch, Pierce, Fenner & Smith
Incorporated, neither the Company nor any of its Subsidiaries has employed any investment banker, broker or finder in connection with the transactions contemplated by this Agreement who is or would be entitled to any fee or any commission in
connection with or upon consummation of the Merger.
Section 3.19
State Takeover Statutes
. Assuming the accuracy of the
Parents representations and warranties set forth in
Section 4.10
, no state fair price, moratorium, control share acquisition, supermajority, affiliate transactions or
business combination statute or regulation or other anti-takeover or similar Law (including Section 203 of the DGCL) is applicable to this Agreement, the Merger or any of the other transactions contemplated by this Agreement. The
Company Board of Directors has taken all actions necessary to render all potentially applicable Takeover Statutes and anti-takeover provisions of the Company Organizational Documents inapplicable to this Agreement, the Merger and the other
transactions contemplated by this Agreement.
Section 3.20
Insurance
. Except as has not had or would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, (a) all insurance policies and surety bonds carried by or covering the Company and its Subsidiaries (collectively, the
Insurance Policies
),
together with adequately capitalized
self-insured
arrangements, provide coverage in such amounts and with respect to such risks and losses as is
A-20
customary for the industries in which the Company and its Subsidiaries operate and that the management of the Company has in good faith determined to be adequate for the respective businesses and
operations of the Companies and its Subsidiaries; (b) the Insurance Policies are in full force and effect, and, as of the date of this Agreement, no notice of cancellation has been received by the Company or any of its Subsidiaries with respect
to any Insurance Policy which has not been cured by the payment of premiums that are due; (c) all premiums, audits, adjustments or collateralization requirements on the Insurance Policies have been paid, and the Company and its Subsidiaries
have complied with the terms and provisions of the Insurance Policies; and (d) the insurance coverage provided by the Insurance Policies (including as to deductibles and self-insured retentions) is substantially consistent with the
Companys past practices. To the knowledge of the Company, as of the date hereof, there is no reason that the Company or any of its Subsidiaries will not be able to (a) renew its existing Insurance Policies as and when such policies expire
or (b) obtain comparable coverage from insurers as may be necessary to continue its business without a significant increase in cost.
Section 3.21
Warranties/Product Liability
. Except as has not had or would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect, (a) except as specifically reflected, reserved against in accordance with GAAP or otherwise disclosed on the consolidated balance sheet of the Company included in the Companys Annual Report on
Form 10-K for the fiscal year ended October 30, 2015, or incurred since October 30, 2015 in the ordinary course of business, (i) neither the Company nor any of its Subsidiaries has received any written notice of any material suit,
action, claim, proceeding or investigation by or before any Governmental Entity relating to any product that is or has been developed, manufactured, marketed, sold or distributed by the Company or any of its Subsidiaries (each, a
Company
Product
), including the packaging and advertising related thereto, or any services provided by the Company or any of its Subsidiaries, nor is there any suit, action, claim, proceeding or investigation involving a Company Product pending
or, to the knowledge of the Company, threatened by any Person, (ii) there has not been, nor is there under consideration by the Company or any of its Subsidiaries, any recall or post-sale warning of a material nature concerning any Company
Product, (iii) there are no pending or, to the knowledge of the Company, threatened claims with respect to any such warranty, and (iv) there are no pending or, to the knowledge of the Company, threatened product liability claims with
respect to any Company Product; and (b) since November 1, 2014, there have not been and there are no material defects or deficiencies in such Company Products. None of the Company, any of its Subsidiaries, or, to the knowledge of the
Company, its predecessors or Affiliates, has manufactured, sold, distributed, marketed or installed any asbestos or lead-containing products, where the asbestos or lead quantities or qualities in such products would have been in breach in any
material respect of the standards permitted by the applicable Law in force during such period Neither the Company nor any of its Subsidiaries has in the last five years received in connection with any product containing asbestos or lead
manufactured, sold or distributed by the Company or any of its Subsidiaries notice of any (A) claim or allegation of personal injury, death, or property or economic damages, (B) product recall, (C) claim for punitive or exemplary
damages, (D) claim for contribution or indemnification or (E) claim for injunctive relief, in each case, related to asbestos or lead containing products.
Section 3.22
Customers and Suppliers
.
(a) Section 3.22(a) of the Company Disclosure Schedule sets forth the Top Customers of the Company and its Subsidiaries as of the date
hereof. As of the date of this Agreement, none of the Top Customers has cancelled or otherwise terminated, or, to the knowledge of the Company, threatened in writing to cancel or otherwise terminate its relationship with the Company or any of its
Subsidiaries. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice from any such Top Customer, nor does the Company have knowledge, that such Top Customer intends to cancel or otherwise
materially and adversely modify its relationship (including by seeking to renegotiate contractual terms) with the Company or any of its Subsidiaries.
(b) Section 3.22(b) of the Company Disclosure Schedule sets forth the Top Suppliers of the Company and its Subsidiaries as of the date
hereof. As of the date of this Agreement, none of the Top Suppliers has cancelled or otherwise terminated, or, to the knowledge of the Company, threatened in writing to cancel or
A-21
otherwise terminate its relationship with the Company or any of its Subsidiaries. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice
from any such Top Supplier, nor does the Company have knowledge, that any such Top Supplier intends to cancel or otherwise materially and adversely modify its relationship (including by seeking to renegotiate contractual terms) with the Company or
any of its Subsidiaries.
Section 3.23
No Other Representations
. Except for the representations and warranties contained in
Article IV
, the Company agrees and acknowledges that none of Parent, Merger Sub or any Person on behalf of Parent or Merger Sub makes any other express or implied representation or warranty with respect to Parent, Merger Sub or any of their
respective Subsidiaries or with respect to any other information provided or made available to the Company in connection with the transactions contemplated by this Agreement, including information conveyed at management presentations, in virtual
data rooms or in due diligence sessions and, without limiting the foregoing, including any estimates, projections, predictions or other forward-looking information.
ARTICLE IV.
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
Except as disclosed in the disclosure schedule delivered by Parent to the Company concurrently with the execution of this Agreement (the
Parent Disclosure Schedule
) (
provided
that disclosure of any item in any section or subsection of the Parent Disclosure Schedule shall be deemed disclosed with respect to any other section or subsection to the extent that
the relevance of any disclosed event, item or occurrence in such section or subsection to such other section or subsection is reasonably apparent), Parent and Merger Sub jointly and severally represent and warrant to the Company as follows:
Section 4.1
Organization
. Parent is a corporation duly incorporated, validly existing and in good standing under the laws of the
State of Ohio. Merger Sub is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware. Each of Parent and Merger Sub has all requisite corporate power and authority to own, lease and operate its
properties and assets and to carry on its business as presently conducted, except where the failure to have such power or authority would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Each of
Parent and Merger Sub is duly qualified or licensed, and has all necessary governmental approvals, to do business and (where such concept is recognized) is in good standing in each jurisdiction in which the property owned, leased or operated by it
or the nature of the business conducted by it makes such approvals, qualification or licensing necessary, except where the failure to be so duly approved, qualified or licensed and in good standing would not reasonably be expected to have,
individually or in the aggregate, a Parent Material Adverse Effect.
Section 4.2
Corporate Authority Relative to this Agreement;
Consents and Approvals; No Violation
.
(a) Each of Parent and Merger Sub has all necessary corporate power and authority to enter into
this Agreement and to consummate the transactions contemplated hereby, including the Merger and the Financing. The execution, delivery and performance by Parent and Merger Sub of this Agreement and the consummation by each of them of the
transactions contemplated hereby, including the Merger and the Financing, have been duly and validly authorized by all necessary corporate action on the part of Parent and Merger Sub, and no other corporate action or proceedings on the part of
either Parent or Merger Sub, or other vote of Parents or Merger Subs stockholders, is necessary to authorize the execution and delivery by Parent and Merger Sub of this Agreement and the consummation of the transactions contemplated
hereby, including the Merger and the Financing. The Board of Directors of each of Parent and Merger Sub has unanimously (i) determined that this Agreement and the Merger are fair to and in the best interests of Parents or Merger
Subs (as the case may be) stockholders and (ii) approved this Agreement and the Merger. This Agreement has been duly and validly executed and delivered by Parent and Merger Sub and, assuming this Agreement constitutes the legal, valid and
A-22
binding agreement of the Company, this Agreement constitutes the legal, valid and binding agreement of Parent and Merger Sub and is enforceable against Parent and Merger Sub in accordance with
its terms, except as such enforcement may be subject to the Enforceability Exceptions.
(b) Other than in connection with or in compliance
with the Transaction Approvals, no authorization, consent, order, license, permit or approval of, or registration, declaration, notice or filing with, any Governmental Entity is required to be made or obtained, under applicable Law, for the
consummation by Parent or Merger Sub of the transactions contemplated by this Agreement, including the Financing, except for such authorizations, consents, orders, licenses, permits, approvals, registrations, declarations, notices and filings that
are not required to be made or obtained prior to the consummation of such transactions or that the failure to make or obtain would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
(c) The execution and delivery by Parent and Merger Sub of this Agreement does not, and (assuming the Transaction Approvals are obtained) the
consummation of the transactions contemplated hereby, including the Financing, and compliance with the provisions hereof will not, (i) result in any loss, or suspension, limitation or impairment of any right of Parent or Merger Sub to own or
use any assets required for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation, first offer, first refusal,
modification or acceleration of, or trigger the grant of any material rights or material change to the payment terms under, any obligation or to the loss of a benefit under any loan, guarantee of indebtedness or credit agreement, note, bond,
mortgage, indenture, lease, agreement, Contract, instrument, Permit, concession, franchise, right or license binding upon Parent or Merger Sub or by which or to which any of their respective properties, rights or assets are bound or subject or
result in the creation of any Liens other than Permitted Liens, in each case, upon any of the properties or assets of the Parent or Merger Sub, except for any of the foregoing as would not reasonably be expected, individually or in the aggregate, to
have a Parent Material Adverse Effect, (ii) conflict with or result in any violation of any provision of the charter or bylaws or other equivalent organizational document, of Parent or Merger Sub or (iii) conflict with or violate any
provision of the organizational documents of any Significant Subsidiary of Parent (other than Merger Sub, to the extent it would be a Significant Subsidiary) or any applicable Laws, in each case except as would not reasonably be expected to have,
individually or in the aggregate, a Parent Material Adverse Effect.
Section 4.3
Absence of Certain Changes or Events
. Since
December 31, 2015, there has not been any fact, change, effect, event, occurrence or development that has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
Section 4.4
Reports and Financial Statements
.
(a) Parent has timely filed or furnished all forms, documents and reports required to be filed or furnished by it with the SEC since
December 31, 2015 (all such forms, documents and reports filed or furnished by Parent since such date, the
Parent SEC Documents
). As of their respective dates or, if amended, as of the date of the last such amendment (and, in
the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), the Parent SEC Documents complied in all material respects with the applicable requirements of the
Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and the applicable rules and regulations of the SEC promulgated thereunder, and none of the Parent SEC Documents, contained any untrue statement of a material fact or
omitted to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. None of Parents Subsidiaries is, or at any time since
December 31, 2014 has been, required to file any forms, reports or other documents with the SEC.
(b) The consolidated financial
statements (including all related notes and schedules) of Parent included in or incorporated by reference into the Parent SEC Documents (the
Parent Financial Statements
) (i) fairly present in all material respects the
consolidated financial position of the Parent and its consolidated Subsidiaries, as at the respective dates thereof, and the consolidated results of their operations and their consolidated cash
A-23
flows for the respective periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments that are not material and to any other adjustments described
therein, including the notes thereto), (ii) were prepared in conformity with GAAP (except, in the case of the unaudited statements, as permitted by the SEC) applied on a consistent basis during the periods involved (except as may be indicated
therein or in the notes thereto), and (iii) comply as to form in all material respects with the applicable accounting requirements under the Securities Act, the Exchange Act and the applicable rules and regulations of the SEC. As of the date of
this Agreement, Ernst & Young LLP has not resigned (or informed Parent that it intends to resign) or been dismissed as independent public accountants of Parent as a result of or in connection with any disagreements with Parent on a matter
of accounting principles or practices, financial statement disclosure or auditing scope or procedure.
Section 4.5
Compliance with
Law
. Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, Parent and each of its Subsidiaries are, and since December 31, 2014 have been, in compliance with all Laws. Except
as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, since December 31, 2014, neither Parent nor any of its Subsidiaries has received any written notice or, to Parents knowledge,
other communication from any Governmental Entity regarding any actual or alleged failure to comply with or violation of any Law in a material respect.
Section 4.6
Parent and Merger Sub Information
. The information supplied or to be supplied by Parent and Merger Sub for inclusion
or incorporation by reference in the Proxy Statement will not, at the time any such document is filed with the SEC, amended or supplemented, or first published, sent or provided to holders of shares of Company Common Stock, or at the time of the
Stockholders Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not
misleading, except that no representation or warranty is made by Parent or Merger Sub with respect to statements made therein based on information supplied by the Company for inclusion or incorporation by reference therein.
Section 4.7
Finders or Brokers
. Except for Citigroup Global Markets Inc., neither Parent nor any of Parents Subsidiaries has
employed any investment banker, broker or finder in connection with the transactions contemplated by this Agreement who would be entitled to any fee or any commission in connection with or upon consummation of the Merger.
Section 4.8
Financing
.
(a) Parent has delivered to the Company a true, complete and correct copy of the fully executed debt commitment letter, together with any
related fee letters (in the case of the fee letters, redacted in a customary manner), dated as of the date of this Agreement, by and between Citigroup Global Markets Inc. and Parent providing for debt financing as described therein (together,
including all exhibits, schedules and annexes, the
Commitment Letter
), pursuant to which, upon the terms and subject to the conditions set forth therein, Citigroup Global Markets Inc. has agreed to lend the amounts set forth
therein, for the purpose of, among other things, paying the Merger Amounts.
(b) As of the date of this Agreement, the Commitment Letter
is in full force and effect and constitutes the valid, binding and enforceable obligation of Parent and, to the knowledge of Parent, the other parties thereto, enforceable in accordance with its terms, in each case, subject to the Enforceability
Exceptions. There are no conditions precedent related to the funding of the full amount of the Financing contemplated by the Commitment Letter, other than the conditions precedent set forth the Commitment Letter (such conditions precedent, the
Financing Conditions
).
(c) As of the date of this Agreement, the Commitment Letter has not been amended or modified in
any manner, and the respective commitments contained therein have not been terminated, reduced, withdrawn or rescinded in any respect by Parent or, to the knowledge of Parent, any other party thereto, and no such
A-24
termination, reduction, withdrawal or rescission is contemplated by Parent or, to the knowledge of Parent, any other party thereto, other than mandatory reductions expressly contemplated thereby.
(d) As of the date of this Agreement, assuming the accuracy of the representations and warranties of the Company made to Parent such that
the condition set forth in
Section 6.2(a)
is satisfied, assuming the conditions set forth in
Section 6.1
are satisfied, and assuming the Companys compliance with its obligations under this Agreement such that the
condition set forth in
Section 6.2(b)
is satisfied, Parent has no reason to believe that (i) any of the Financing Conditions will not be satisfied on or prior to the Closing Date or (ii) the Financing contemplated by the
Commitment Letter will not be available to Parent on the Closing Date.
(e) As of the date of this Agreement, Parent is not in default or
breach under the terms and conditions of the Commitment Letter.
(f) As of the date of this Agreement, there are no side letters,
understandings or other agreements or arrangements relating to funding of the full amount of the Financing to which Parent or any of its Affiliates is a party that would be reasonably likely to affect the Financing contemplated by the Commitment
Letter in any respect, other than those set forth in the Commitment Letter.
(g) Parent or an Affiliate thereof on its behalf has fully
paid any and all commitment or other fees and amounts required by the Commitment Letter to be paid on or prior to the date of this Agreement.
(h) In each case, regardless of whether the Adjusted Per Share Price or the Baseline Per Share Price is the Per Share Price and regardless of
any actions taken or committed to be taken by Parent or its Subsidiaries pursuant to
Section 5.7
, Parent will have at and as of the Closing Date sufficient available funds to consummate the Merger and to make all payments required to be
made in connection therewith, including payment of the Merger Consideration, any payments made in respect of equity compensation obligations to be paid in connection with the transactions contemplated hereby, the payment of any debt required to be
repaid, redeemed, retired, cancelled, terminated or otherwise satisfied or discharged in connection with the Merger (including all Indebtedness of the Company and its Subsidiaries required to be repaid, redeemed, retired, cancelled, terminated or
otherwise satisfied or discharged in connection with the Merger and the other transactions contemplated hereby) and all premiums and fees required to be paid in connection therewith and all other amounts to be paid pursuant to this Agreement and
associated costs and expenses of the Merger (such amounts, collectively, the
Merger Amounts
). As of the date of this Agreement, Parent has no reason to believe that the representation contained in the immediately preceding
sentence will not be true at and as of the Closing Date. In no event shall the receipt or availability of any funds or financing (including the Financing contemplated by the Commitment Letter) by or to Parent or any of its Affiliates or any other
financing transaction be a condition to any of the obligations of Parent or Merger Sub hereunder.
Section 4.9
Merger Sub
.
Merger Sub is a wholly owned subsidiary of Parent. As at the date of this Agreement, the authorized capital stock of Merger Sub consists of 100 shares of common stock, par value of $0.50 per share, all of which are validly issued and outstanding.
All of the issued and outstanding capital stock of Merger Sub is, and at the Effective Time will be, owned by Parent or a direct or indirect wholly owned Subsidiary of Parent. There is no outstanding option, warrant, right or any other agreement
pursuant to which any Person other than Parent may acquire any equity security of Merger Sub. Since its date of incorporation, Merger Sub has not and prior to the Effective Time will not have carried on any business or conducted any operations other
than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto and has and prior to the Effective Time will have no assets, liabilities or obligations of any nature other than those incident to its
formation and pursuant to this Agreement and the Merger and the other transactions contemplated by this Agreement.
Section 4.10
Ownership of Company Common Stock
. Neither Parent nor any of its Subsidiaries is, or has been at any time during the period commencing three years prior to the date hereof through the date hereof, an interested stockholder of the
Company, as such term is defined in Section 203 of the DGCL.
A-25
Section 4.11
No Vote of Parent Stockholders
. No vote of the stockholders of Parent or
the holders of any other securities of Parent (equity or otherwise) is required by Law, the organizational documents of Parent or the applicable rules of any exchange on which securities of Parent are traded in order for Parent to consummate the
transactions contemplated by this Agreement, including the Merger and the Financing.
Section 4.12
No Other Representations
.
Except for the representations and warranties contained in
Article III
, each of Parent and Merger Sub agrees and acknowledges that neither the Company nor any Person on behalf of the Company makes any other express or implied representation
or warranty with respect to the Company or any of its Subsidiaries or with respect to any other information provided or made available to Parent or Merger Sub in connection with the transactions contemplated by this Agreement, including information
conveyed at management presentations, in virtual data rooms or in due diligence sessions and, without limiting the foregoing, including any estimates, projections, predictions or other forward-looking information.
ARTICLE V.
COVENANTS AND AGREEMENTS
Section 5.1
Conduct of Business
.
(a) During the period from the date hereof until the earlier of the termination of this Agreement in accordance with its terms and the
Effective Time, except (i) as required by applicable Law, (ii) with the prior written consent of Parent (which shall not be unreasonably withheld, conditioned or delayed), (iii) as required by this Agreement or (iv) as set forth
in Section 5.1(a) of the Company Disclosure Schedule, the Company shall and shall cause each of its Subsidiaries to, (x) conduct its business in all material respects in the ordinary course consistent with past practice and
(y) subject to compliance with the other restrictions in this
Section 5.1
, use commercially reasonable efforts to maintain and preserve intact, in all material respects, its business organization, assets, key employees, present
lines of business, rights, franchises, permits and business relationships with customers (generally) and suppliers.
(b) During the period
from the date hereof until the earlier of the termination of this Agreement in accordance with its terms and the Effective Time, except (i) as required by applicable Law, (ii) with the prior written consent of Parent (which shall not be
unreasonably withheld, conditioned or delayed), (iii) as required by this Agreement, or (iv) as set forth in Section 5.1(b) of the Company Disclosure Schedule, the Company shall not, and shall not permit any of its Subsidiaries to:
(A) amend the Company Organizational Documents or otherwise take any action to exempt any Person from any provision of the
Company Organizational Documents or the Significant Subsidiaries Organizational Documents;
(B) split, including a reverse
stock split, combine, exchange, reclassify or take any similar action with respect to any of its capital stock, voting securities or other equity interests;
(C) make, declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase or
otherwise acquire, any shares of its capital stock, or any other securities or obligations convertible (whether currently convertible or convertible only after the passage of time or the occurrence of certain events) into or exchangeable for any
shares of its capital stock (except (1) dividends paid by any of the Subsidiaries of the Company to the Company or any of their wholly owned Subsidiaries, respectively, (2) the acceptance of shares of Company Common Stock as payment for
the exercise price of Company Options, or (3) the acceptance of shares of Company Common Stock, or withholding of shares of Company Common Stock otherwise deliverable, to satisfy withholding Taxes incurred in connection with the exercise,
vesting and/or settlement of Company Equity Awards;
provided
that the Company may make, declare and pay quarterly cash dividends (and,
A-26
with respect to the Company Equity Awards, as and if applicable, dividends or dividend equivalents) in an amount per share not in excess of $0.33 per quarter for dividends declared in the fiscal
year ending October 28, 2016, and not in excess of $0.37 per quarter for dividends declared in the fiscal year ending October 27, 2017 and not in excess of $0.42 per quarter thereafter, and with record dates consistent with the record
dates customarily used by the Company for the payment of quarterly cash dividends, including with respect to the quarter in which the Effective Time occurs unless the Effective Time precedes the record date for such quarter;
(D) grant any Company Equity Awards or other equity-based awards or interests, or grant any individual, corporation or other
entity any right to acquire any shares of its capital stock;
(E) (1) issue, sell or otherwise permit to become outstanding
any additional shares of its capital stock or securities convertible or exchangeable into, or exercisable for, any shares of its capital stock or any options, warrants, or other rights of any kind to acquire any shares of its capital stock, except
pursuant to the due exercise, vesting and/or settlement of Company Equity Awards outstanding as of the date hereof in accordance with their terms or (2) enter into any agreement, understanding or arrangement with respect to the sale or voting
of its capital stock or equity interests;
(F) adopt a plan of complete or partial liquidation, dissolution, merger,
consolidation, restructuring, recapitalization or other reorganization, other than the Merger;
(G) incur, assume, endorse,
guarantee or otherwise become liable for or modify in any material respects the terms of any Indebtedness for borrowed money or issue or sell any debt securities or any rights to acquire any debt securities, except for (1) any Indebtedness for
borrowed money among the Company and/or its wholly owned Subsidiaries or among wholly owned Subsidiaries of the Company, (2) guarantees by the Company of Indebtedness for borrowed money of Subsidiaries of the Company or guarantees by
Subsidiaries of the Company of Indebtedness for borrowed money of the Company or any of its Subsidiaries, which Indebtedness is incurred in compliance with this
clause (G)
or is outstanding on the date hereof, (3) Indebtedness for
commercial paper, (4) Indebtedness incurred from time to time pursuant to agreements entered into by the Company or any Subsidiary of the Company in effect prior to the execution of this Agreement, and (5) additional Indebtedness for
borrowed money incurred by the Company or any of its Subsidiaries not to exceed $100,000,000.00 in aggregate principal amount outstanding;
(H) except as otherwise permitted or required by this Agreement or for transactions between or among the Company and/or its
wholly owned Subsidiaries, prepay, redeem, repurchase, defease, cancel or otherwise terminate any Indebtedness for borrowed money of the Company or any Subsidiary other than (1) Indebtedness under the Companys revolving credit facilities,
receivables facilities, commercial paper arrangements and any other working capital facilities and (2) any prepayment, redemption, repurchase, defeasance, cancellation or other termination of Indebtedness made within 90 days of the same
becoming due;
(I) (1) other than in accordance with Contracts or agreements in effect on the date hereof, sell, transfer,
mortgage, encumber or otherwise dispose of any of its properties or assets having a value in excess of $10,000,000.00 individually or $50,000,000.00 in the aggregate to any Person (other than to the Company or a wholly owned Subsidiary of the
Company and other than (w) sales of inventory, (x) sales of obsolete or worthless equipment, or (y) commodity, purchase, sale or hedging agreements that can be terminated upon 90 days or less notice without penalty, and power
contracts in each case in the ordinary course of business consistent with past practice, or (2) other than in accordance with Contracts or agreements in effect on the date hereof, cancel, release or assign any material Indebtedness for borrowed
money of any such Person owed to it or any claims held by it against any such Person other than Indebtedness by the Company or any wholly owned Subsidiary to any other wholly owned Subsidiary, or by any wholly owned Subsidiary to the Company;
(J) acquire any assets (other than acquisitions of assets in the ordinary course of business consistent with past practice) or
any other Person or business of any other Person (whether by merger
A-27
or consolidation, acquisition of stock or assets or by formation of a joint venture or otherwise) or make any investment in any Person, in each case other than a wholly owned Subsidiary of the
Company (or any assets thereof), either by purchase of stock or securities, contributions to capital, property transfers or purchase of property or assets of any Person other than a wholly owned Subsidiary of the Company, if such acquisition or
investment (x) is in excess of $20,000,000.00 individually or $100,000,000.00 in the aggregate;
(K) make any capital
expenditures (i) in excess of $125,000,000.00 in any fiscal year or (ii) that materially deviate from the Companys categories of capital expenditures (Growth, Maintenance/HSE and Productivity);
(L) except as required by any Collective Bargaining Agreement in effect as of the date hereof or the terms of any Company
Benefit Plan existing as of the date hereof, (1) establish, adopt, amend or terminate any material Collective Bargaining Agreement or Company Benefit Plan or create or enter into any plan, agreement, program, policy, trust, fund or other
arrangement that would be a Company Benefit Plan if it were in existence as of the date of this Agreement, except for adoptions, amendments or terminations in the ordinary course of business that do not materially increase the cost of such
Collective Bargaining Agreement or Company Benefit Plan to the Company and its Subsidiaries, taken as a whole, (2) grant any new awards under any Company Benefit Plan, (3) amend or modify any outstanding award under any Company Benefit
Plan, (4) enter into any third-party Contract with respect to a Company Benefit Plan (including Contracts for the provision of services to such Company Benefit Plan, including benefits administration) having a term of greater than one year that
is not terminable on 90 calendar days notice or less, (5) increase in any manner the compensation (including bonus, incentive, severance, change-in-control and retention compensation) or benefits (including pension, welfare, fringe or
other benefits) of any current or former directors, officers, employees or consultants (who are natural persons) of the Company or its Subsidiaries, (6) pay or award, or commit to pay or award, any bonuses or incentive compensation, other than
pursuant to the currently existing terms of any Company Benefit Plan, (7) accelerate any rights or benefits under, or, other than in the ordinary course of business consistent with past practice, make any material determinations or
interpretations with respect to, any Company Benefit Plan, (8) accelerate the time of funding or payment of, or increase the amount required to fund, any Company Benefit Plan, or fund any rabbi trust or similar arrangement associated with or
intended to satisfy liabilities under any Company Benefit Plan, (9) enter into any collective bargaining agreement or other agreement with a labor union, works council or similar organization, other than in connection with the expiration of any
Collective Bargaining Agreement that is scheduled to expire during the 18-month period beginning on the date of this Agreement, or (10) forgive any loans, or issue any loans (other than routine travel advances issued in the ordinary course of
business) to any of its or its Subsidiaries directors, officers, contractors or employees;
(M) implement or adopt
any change in its financial accounting principles or its methods, other than as may be required by GAAP or applicable Law;
(N) except as otherwise provided in
Section 5.14
, settle or compromise any litigation, claim, suit, action or
proceeding (other than any litigation, claim, suit, action or proceeding in respect of Taxes or Tax matters or in which the Company or one of its Subsidiaries is the plaintiff), except for (1) settlements or compromises that (x) involve
monetary remedies with a value not in excess of, with respect to any individual litigation, claim, suit, action or proceeding, $2,000,000.00 (net of any insurance and indemnity, contribution and similar obligations for the benefit of the Company or
any of its Subsidiaries in respect thereof) or, in the aggregate with respect to all litigation, claims, suits, actions and proceedings, $10,000,000.00 (net of any insurance and indemnity, contribution and similar obligations for the benefit of the
Company or any of its Subsidiaries in respect thereof) and (y) do not impose any material restriction on the business of the Company or the business of its Subsidiaries, (2) settlements of any (x) workers compensation or
(y) U.S. Equal Employment Opportunity Commission charges or ordinary course of business consistent with past practice U.S. Department of Labor matters or (3) the commencement of any litigation, claim, suit, action or proceeding in the
ordinary course of business;
A-28
(O) (1) make, change or revoke any material Tax election, other than in the
ordinary course of business, (2) enter into any closing agreement within the meaning of Section 7121 of the Code (or any similar provision of state, local or foreign Tax Law) with respect to a material amount of Taxes for an amount
materially in excess of the amount reserved therefor, in accordance with GAAP, by the Company, (3) settle or compromise any material Tax litigation, claim, suit action or proceeding for an amount materially in excess of the amount reserved
therefor, in accordance with GAAP, by the Company, or consent to any extension or waiver of the statute of limitations for any U.S. federal income Tax Return, (4) obtain any material Tax ruling that would be binding on Parent for any Tax period
(or portion thereof) beginning after the Closing Date, or (5) file any material amended Tax Return;
(P) agree to
take, or make any commitment to take, any of the foregoing actions that are prohibited pursuant to this
Section 5.1(b)
; or
(Q) (1) except in the ordinary course of business consistent with past practice, enter into any Contract which would be
considered, or materially amend any Contract in effect as of the date hereof that is considered, a Company Material Contract under
Section 3.17(a)(iii)
or
(xii)
or (2) enter into any Contract which would be considered,
or materially amend any Contract in effect as of the date hereof that is considered, a Company Material Contract under
Section 3.17(a)(iv)
or
(vi)
.
(c) During the period from the date hereof until the earlier of the termination of this Agreement in accordance with its terms and the
Effective Time, (i) Parent shall not, and shall not permit any of its Subsidiaries to, knowingly take any action that would prevent, materially delay or materially impede the consummation of the Financing, and (ii) neither Parent nor the
Company shall, and shall not permit any of their respective Subsidiaries to, acquire or agree to acquire by merging or consolidating with, or by purchasing a material portion of the assets of or equity in, any Person (a
Specified
Acquisition
) or enter into any new line of business, if the entering into of a definitive agreement relating to or the consummation of such a Specified Acquisition or the entering into of such new line of business, as applicable, would
reasonably be expected to (A) prevent, materially delay or materially impede the obtaining of, or adversely affect in any material respect the ability of Parent or the Company to procure, any authorizations, consents, orders, declarations or
approvals of any Governmental Entity or the expiration or termination of any applicable waiting period necessary to consummate the transactions contemplated hereby, (B) materially increase the risk of any Governmental Entity entering an order,
ruling, judgment or injunction prohibiting the consummation of the transactions contemplated hereby or (C) result in Parent or the Company being required pursuant to
Section 5.7
to take, or cause to be taken, or commit to take, or
commit to cause to be taken, any action constituting a Triggering Divestiture.
(d) Prior to making any written communications (or oral
communications in the nature of a webcast, wide-participant conference call or town hall-style meeting), in any case intended for broad-based and general distribution to the employees of the Company or any of its Subsidiaries that relate
to compensation and benefit matters and the transactions contemplated by this Agreement, the Company shall provide Parent with a copy of the intended communication, and Parent shall have a reasonable period of time to review and comment on the
communication;
provided
that the Company may make any such communications without prior review and comment from Parent if its content is consistent with information contained in any previously issued press release, public announcement or
public filing, or any other communication previously made in accordance with this
Section 5.1(d)
;
provided
,
further
, that this
Section 5.1(d)
shall not apply to any communication with respect to any Company
Takeover Proposal or from and after a Company Adverse Recommendation Change.
(e) From and after the date of this Agreement, the Company
will notify Parent reasonably promptly of any notice or other communication received by the Company or any of its Subsidiaries from the PBGC regarding any defined benefit pension plan of the Company or any of its Subsidiaries and will take the
actions described in Section 5.1 of the Company Disclosure Schedule.
A-29
Section 5.2
Access
.
(a) For purposes of furthering the transactions contemplated hereby, the Company shall afford Parent and its controlled Affiliates, and its
and their employees, accountants, consultants, legal counsel, financial advisors, financing sources and agents and other representatives, reasonable access during normal business hours upon reasonable advance notice to the Company, throughout the
period from the date hereof until the earlier of the termination of this Agreement in accordance with its terms and the Effective Time, to its and its Subsidiaries personnel, properties, contracts, commitments, Tax Returns, books and records
and such other information concerning its business, properties and personnel as Parent may reasonably request. All access pursuant to this
Section 5.2(a)
shall be (A) conducted in such a manner as not to interfere unreasonably with
the normal operations of the Company or any of its Subsidiaries and (B) coordinated through the General Counsel of the Company or a designee thereof.
(b) Notwithstanding anything to the contrary contained in this
Section 5.2
, no party to this Agreement nor any of its Subsidiaries
shall be required to provide any access, or make available any document, correspondence or information, if doing so would, in such partys and its outside legal counsels reasonable judgment, (i) jeopardize the attorney-client
privilege of such party or any of its Subsidiaries or (ii) conflict with any (A) Law applicable to such party or any of its Subsidiaries or the assets, or operation of the business, of such party or any of its Subsidiaries or
(B) Contract to which such party or any of its Subsidiaries is a party or by which any of their assets or properties are bound;
provided
,
however
, that in such instances such party shall inform the other party of the general
nature of the information being withheld and, upon the other partys request, reasonably cooperate with the other party to provide such information, in whole or in part, in a manner that would not result in any of the outcomes described in the
foregoing
clauses (i)
and
(ii)
.
(c) The parties hereto hereby agree that all information provided to them or their
respective officers, directors, employees or representatives in connection with this Agreement and the consummation of the transactions contemplated hereby shall be governed in accordance with the confidentiality agreement, dated as of
January 18, 2016, between the Company and Parent (the
Confidentiality Agreement
), which shall continue in full force and effect in accordance with its terms.
Section 5.3
No Solicitation
.
(a) Except as permitted by this
Section 5.3
, the Company shall, and shall cause each of its Subsidiaries and its and their
respective officers, directors, employees and agents, and shall direct each of its financial advisors, investment bankers, attorneys, accountants and other representatives (collectively,
Representatives
) to not, directly or
indirectly, (A) solicit, initiate, or knowingly encourage or facilitate any inquiries regarding, or the making of any proposal or offer, including any proposal or offer to its stockholders, that constitutes, or could reasonably be expected to
lead to, a Company Takeover Proposal, (B) engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any other Person any information in connection with or for the purpose of encouraging or
facilitating, any inquiry, proposal or offer that constitutes, or could reasonably be expected to lead to, a Company Takeover Proposal (other than, solely in response to an unsolicited Company Takeover Proposal, to ascertain facts from the Person
making such Company Takeover Proposal for the sole purpose of the Company Board of Directors informing itself about such Company Takeover Proposal and the Person that made it and to refer the inquiring Person to this
Section 5.3
and to
limit its conversation or other communication exclusively to such referral and such ascertaining of facts), or (C) approve, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent or similar document,
agreement, commitment, or agreement in principle with respect to a Company Takeover Proposal. Without limiting the foregoing, it is understood that any violation of the foregoing restrictions by the Companys Subsidiaries or Representatives
acting by or on behalf of the Company shall be deemed to be a breach of this
Section 5.3
by the Company.
(b) The Company
shall immediately cease and cause to be terminated any discussions or negotiations with any Persons (other than Parent and Merger Sub) that may be ongoing with respect to a Company Takeover
A-30
Proposal. The Company shall (i) use reasonable best efforts to enforce to the fullest extent, and (ii) not release any third party from, or waive, amend or modify any provision of, or
grant permission under, (x) any standstill provision in any agreement to which the Company is a party or (y) any confidentiality provision in any agreement to which the Company is a party;
provided
that if the Company Board of
Directors determines in good faith, after consultation with its outside legal counsel that the failure to take such action would be inconsistent with the directors fiduciary duties under applicable Law, the Company may waive any such
standstill provision solely to the extent necessary to permit a third party to make a Company Takeover Proposal to the Company Board of Directors.
(c) Notwithstanding anything to the contrary contained in
Section 5.3(a)
or
(b)
, if at any time after the date of this
Agreement and prior to the time, but not after, the Requisite Company Vote is obtained, the Company receives a
bona fide
written Company Takeover Proposal from any Person that did not result from a breach of this
Section 5.3
, and
if the Company Board of Directors determines in good faith, after consultation with its independent financial advisors and outside legal counsel, that such Company Takeover Proposal constitutes or could reasonably be expected to lead to a Company
Superior Proposal, then the Company and its Representatives may (i) furnish, pursuant to an Acceptable Confidentiality Agreement, information (including non-public information) with respect to the Company and its Subsidiaries to the Person that
has made such Company Takeover Proposal and its Representatives;
provided
that the Company shall substantially concurrently with the delivery to such Person provide to Parent any non-public information concerning the Company or any of its
Subsidiaries that is provided or made available to such Person or its Representatives unless such non-public information has been previously provided to Parent and (ii) engage in or otherwise participate in discussions or negotiations with the
Person making such Company Takeover Proposal and its Representatives regarding such Company Takeover Proposal. The Company shall promptly (and in any event within 24 hours) notify Parent in writing if the Company takes any of the actions in
clauses (i)
and
(ii)
above.
(d) The Company shall promptly (and in no event later than 48 hours after receipt)
notify Parent in writing in the event that the Company or any of its Representatives receives a Company Takeover Proposal or any offer, proposal, inquiry or request for information or discussions relating to the Company or its Subsidiaries that
would be reasonably likely to lead to or that contemplates a Company Takeover Proposal, including the identity of the Person making the Company Takeover Proposal or offer, proposal, inquiry or request and the material terms and conditions thereof.
The Company shall keep Parent reasonably informed, on a reasonably current basis (but in no event more often than once every 48 hours), as to the status of (including any material developments related thereto) such Company Takeover Proposal, offer,
proposal, inquiry or request, it being understood that the Company shall also provide Parent with copies of any draft agreements to the extent that any such draft is or would reasonably be expected to be material to the ability of Parent to exercise
its rights to propose revisions to this Agreement pursuant to the proviso in
Section 5.3(f)
. The Company will not enter into any agreement with any Person subsequent to the date of this Agreement that prohibits the Company from providing
any information to Parent in accordance with, or otherwise complying with, this
Section 5.3
.
(e) Except as expressly
permitted by this
Section 5.3
, neither the Company Board of Directors nor any committee thereof, nor group of directors, formally or informally, acting intentionally and publicly, either directly or indirectly, in a manner materially
inconsistent with the Company Recommendation, shall (i) (A) change, qualify, withhold, withdraw or modify, or authorize or resolve to or publicly propose or announce its intention to change, qualify, withhold, withdraw or modify, in each
case in any manner adverse to Parent, the Company Recommendation, (B) approve or recommend to the stockholders of the Company, or resolve to or publicly propose or announce its intention to approve or recommend to the stockholders of the
Company, a Company Takeover Proposal (any action described in this
clause (i)
being referred to as a
Company Adverse Recommendation Change
), or (ii) authorize, cause or permit the Company or any of its
Subsidiaries to enter into any letter of intent, memorandum of understanding, agreement (including an acquisition agreement, merger agreement, joint venture agreement or other agreement), commitment or agreement in principle with respect to, or that
is intended or could reasonably be expected to lead to, any Company Takeover Proposal (other than an Acceptable Confidentiality Agreement entered into in accordance with
Section 5.3(c)
) (a
Company Acquisition
Agreement
) or resolve, publicly propose or agree to do any of the foregoing. Notwithstanding anything to the contrary set forth in this
A-31
Agreement, at any time after the date of this Agreement and prior to the time, but not after, the Requisite Company Vote is obtained, the Company Board of Directors may make a Company Adverse
Recommendation Change if (1) such action is taken in response to an Intervening Event and (2) prior to taking such action, the Company Board of Directors has determined in good faith, after consultation with outside legal counsel, that the
failure to take such action would be inconsistent with the Company Board of Directors fiduciary duties under applicable Law;
provided
,
however
, that prior to making such Company Adverse Recommendation Change, (x) the Company
has given Parent at least four Business Days prior written notice of its intention to take such action, and specifying, in reasonable detail, the reasons therefor, and (y) upon the end of such notice period, the Company Board of Directors shall
have considered in good faith any revisions to the terms of this Agreement proposed in writing by Parent, and shall have determined, after consultation with independent financial advisors and outside legal counsel, that the failure to make a Company
Adverse Recommendation Change would continue to be inconsistent with the Company Board of Directors fiduciary duties under applicable Law.
(f) Notwithstanding the foregoing, at any time after the date of this Agreement and prior to the time, but not after, the Requisite Company
Vote is obtained, if the Company Board of Directors has determined in good faith, after consultation with independent financial advisors and outside legal counsel, that a written Company Takeover Proposal made after the date hereof that did not
result from a breach of this
Section 5.3
constitutes a Company Superior Proposal, then the Company Board of Directors may, subject to compliance with this
Section 5.3(f)
, (x) make a Company Adverse Recommendation Change
or (y) cause the Company to terminate this Agreement in accordance with
Section 7.1(f)
in order to enter into a definitive agreement relating to such Company Superior Proposal subject to paying the Company Termination Fee, which
shall be paid prior to or concurrently with such termination in accordance with
Section 7.3
;
provided
,
however
, that prior to so making a Company Adverse Recommendation Change or terminating this Agreement, (A) the
Company has given Parent at least four Business Days prior written notice of its intention to take such action, including the material terms and conditions of, and the identity of the Person making, any such Company Superior Proposal and has
contemporaneously provided to Parent a copy of the Company Superior Proposal and a copy of any proposed Company Acquisition Agreements, (B) at the end of such notice period, the Company Board of Directors shall have considered in good faith any
revisions to the terms of this Agreement proposed in writing by Parent, and shall have determined, after consultation with its independent financial advisors and outside legal counsel, that the Company Superior Proposal would nevertheless continue
to constitute a Company Superior Proposal if the revisions proposed by Parent were to be given effect, and (C) in the event of any change to any of the financial terms (including the form, amount and timing of payment of consideration) or any
other material terms and conditions of such Company Superior Proposal, the Company shall, in each case, have delivered to Parent an additional notice consistent with that described in
clause (A)
above of this proviso and a new notice
period under
clause (A)
of this proviso shall commence (
provided
that the notice period thereunder shall only be two Business Days) during which time the Company shall be required to comply with the requirements of this
Section 5.3(f)
anew with respect to such additional notice, including
clauses (A)
through
(C)
above of this proviso.
(g) Nothing contained in this
Section 5.3
shall prohibit the Company or the Company Board of Directors from taking and disclosing
to the stockholders of the Company a position contemplated by Rule 14e-2(a) or Rule 14d-9 promulgated under the Exchange Act;
provided
that (i) if such disclosure does not reaffirm the Company Recommendation or state that the Company
Recommendation remains unchanged, such disclosure shall be deemed to be a Company Adverse Recommendation Change and (ii) the Company Board of Directors may not effect a Company Adverse Recommendation Change unless permitted to do so by this
Section 5.3
;
provided
,
further
, that notwithstanding anything herein to the contrary, any stop, look and listen disclosure in and of itself shall not be considered a Company Adverse Recommendation Change.
Nothing contained in this
Section 5.3
shall be deemed to limit the proviso set forth in
Section 5.9
.
Section 5.4
Proxy Filing; Information Supplied
. The Company will prepare and file with the SEC, as promptly as reasonably
practicable after the date of this Agreement, and in any event within 20 Business Days (subject to Parents compliance in all material respects with this
Section 5.4
), a Proxy Statement in preliminary form relating to the
Stockholders Meeting. The Company shall use reasonable best efforts to provide to Parent a
A-32
draft of the Proxy Statement as promptly as reasonably practicable after the date of this Agreement, and in any event within 17 Business Days after the date of this Agreement. Subject to
Section 5.3(e)
, the Company Board of Directors shall include the Company Recommendation in the Proxy Statement. Parent shall cooperate with the Company in the preparation of the Proxy Statement and furnish all information concerning
Parent and Merger Sub that is required in connection with the preparation of the Proxy Statement. The Company agrees, as to it and its Subsidiaries, that at the date of mailing to stockholders of the Company and at the time of the Stockholders
Meeting the Proxy Statement will comply as to form in all material respects with the applicable provisions of the Exchange Act and the rules and regulations thereunder. If at any time prior to the Stockholders Meeting (or any adjournment or
postponement thereof) any information relating to Parent or the Company, or any of their respective Affiliates, officers or directors, is discovered by Parent or the Company that should be set forth in an amendment or supplement to the Proxy
Statement, so that the Proxy Statement would not include a misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the
party that discovers such information shall promptly notify the other parties hereto and an appropriate amendment or supplement describing such information shall be promptly filed by the Company with the SEC and, to the extent required by applicable
Law, disseminated to the stockholders of the Company. The Company will promptly, and in any event, within 48 hours, notify Parent of the receipt of all comments of the SEC with respect to the Proxy Statement and of any request by the SEC for any
amendment or supplement thereto or for additional information and will promptly provide to Parent copies of all written correspondence between the Company and/or any of its Representatives and the SEC with respect to the Proxy Statement. Subject to
Section 5.7
and applicable attorney-client privilege, the Company and Parent will each use its reasonable best efforts to promptly provide responses to the SEC with respect to all comments received on the Proxy Statement by the SEC and
the Company will cause the definitive Proxy Statement to be mailed (i) if the SEC provides comments to the preliminary Proxy Statement, as promptly as reasonably practicable (and in any event within five Business Days) after the date the SEC
staff advises that it has no further comments thereon or (ii) if, within 10 calendar days after the filing of the preliminary Proxy Statement, the SEC staff has not indicated that it expects to have comments to the preliminary Proxy Statement,
as promptly as reasonably practicable (and in any event within five Business Days) after such 10th calendar day.
Section 5.5
Stockholders Meeting
. Subject to
Section 5.3
, the Company will take, in accordance with applicable Law and its certificate of incorporation and bylaws, all action necessary to convene a meeting of holders of Company Common Stock
(the
Stockholders Meeting
) as promptly as reasonably practicable after the date of mailing of the Proxy Statement (and in any event no more than 25 Business Days) to consider and vote upon the adoption of this Agreement. Without
limiting the generality of the foregoing, but subject to
Section 5.3
, the Companys obligations pursuant to the first sentence of this
Section 5.5
will not be affected by the commencement, public proposal, public
disclosure or communication to the Company of any Company Takeover Proposal or the Company Board of Directors making a Company Adverse Recommendation Change. Subject to
Section 5.3(f)
, unless the Company shall have made a Company Adverse
Recommendation Change, the Company Board of Directors will use its reasonable best efforts to solicit the Requisite Company Vote at the Stockholders Meeting. Prior to the mailing of the Proxy Statement, the Company will engage a proxy solicitor that
is reasonably satisfactory to Parent. The Company shall keep Parent reasonably informed regarding its solicitation efforts and proxy tallies following the mailing of the Proxy Statement, including by allowing Parent and its Representatives to
participate in any substantive meeting or discussion with such proxy solicitor, in each case, to the extent practicable;
provided
,
however
, that the foregoing right for Parent and its Representatives to participate in meetings or
discussions shall not apply from and after a Company Adverse Recommendation Change. Notwithstanding anything in this Agreement to the contrary, the Company may only postpone or adjourn the Stockholders Meeting (i) to solicit additional proxies
for the purpose of obtaining the Requisite Company Vote, (ii) for the absence of a quorum, (iii) to allow reasonable additional time for the filing and/or mailing of any supplemental or amended disclosure that the Company has determined
after consultation with outside legal counsel is necessary under applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by the Companys stockholders prior to the Stockholders Meeting, or (iv) with
the written consent of Parent, which may be withheld in its sole discretion.
A-33
Section 5.6
Employee Matters
.
(a) Effective as of the Effective Time and during the one-year period immediately following the Effective Time (the
Continuation
Period
), Parent shall provide, or shall cause the Surviving Company to provide, to each employee of the Company or its Subsidiaries who continues to be employed by Parent or the Surviving Company or any of their respective Subsidiaries
following the Effective Time (collectively, the
Company Employees
), (i) an annual base salary or wage rate, target and maximum short-term annual incentive compensation opportunities and target equity-based incentive
compensation opportunities that, in each case, are no less than those provided to such Company Employee immediately prior to the Effective Time and (ii) employee benefits that are substantially similar in the aggregate to the employee benefits
provided to such Company Employee immediately prior to the Effective Time;
provided
that, notwithstanding the foregoing, (A) during the Continuation Period, the non-discretionary matching contribution opportunity in effect for each
Company Employee under any 401(k) plan maintained by Parent or any of its Subsidiaries (including the Surviving Company and its Subsidiaries) (a
Parent 401(k) Plan
) in which such Company Employee participates shall be no less
favorable than that in effect for such Company Employee immediately prior to the Effective Time under the applicable 401(k) plan maintained by the Company or any of its Subsidiaries (a
Company 401(k) Plan
), (B) a profit
sharing contribution shall be made to the applicable Parent 401(k) Plan for each Company Employee participant in respect of (x) calendar year 2016, if the Effective Time occurs in such calendar year, and (y) calendar year 2017, in each
case based on a percentage of eligible compensation equal to 8%, and (C) any amounts calculated in accordance with
clause (B)
that cannot be contributed to the applicable Parent 401(k) Plan due to applicable limitations under the
Code shall instead be paid to the applicable Company Employee in a manner consistent with the Companys past practice regarding such excess amounts. Notwithstanding anything contained herein to the contrary, during the one-year period
immediately following the Effective Time, Parent shall continue to maintain or cause to be maintained, without amendment, the severance plan adopted by the Company prior to the Effective Time in accordance with Section 5.6 of the Company
Disclosure Schedule (the
Company Severance Plan
), and shall provide, or cause to be provided in accordance with the terms of the Company Severance Plan, to each Company Employee who experiences a severance-qualifying termination
under the Company Severance Plan, the severance benefits specified in the Company Severance Plan;
provided
,
however
, that if any such Company Employee is entitled to severance benefits under an individual severance, employment or
similar agreement, such Company Employee shall receive the severance benefits provided under the terms of such agreement and not the severance benefits set forth in the Company Severance Plan.
(b) Following the Closing Date, Parent shall, or shall cause the Surviving Company to, cause any employee benefit plans sponsored or
maintained by Parent or the Surviving Company or their Subsidiaries in which the Company Employees are eligible to participate following the Closing Date (collectively, the
Post-Closing Plans
) to recognize the service of each
Company Employee with the Company and its Subsidiaries (and any predecessor thereto) prior to the Closing Date for purposes of eligibility, vesting and level of benefits under such Post-Closing Plans;
provided
that such recognition of service
shall not (i) apply for purposes of any Post-Closing Plan that is a defined benefit retirement plan or any Post-Closing Plan that provides retiree welfare benefits, (ii) operate to duplicate any benefits of a Company Employee with respect
to the same period of service or (iii) apply for purposes of any plan, program or arrangement (x) under which similarly situated employees of Parent and its Subsidiaries do not receive credit for prior service or (y) that is
grandfathered or frozen, either with respect to level of benefits or participation. With respect to any Post-Closing Plan that provides medical, dental or vision insurance benefits, for the plan year in which such Company Employee is first eligible
to participate during the Continuation Period, Parent shall use reasonable best efforts to (A) cause any preexisting condition limitations or eligibility waiting periods under such plan to be waived with respect to such Company Employee to the
extent such limitation would have been waived or satisfied under the Company Benefit Plan in which such Company Employee participated immediately prior to the Effective Time and (B) credit each Company Employee for any co-payments or
deductibles incurred by such Company Employee in such plan year for purposes of any applicable deductible and annual out-of-pocket expense requirements under any such Post-Closing Plan. Such credited expenses shall also count toward any annual or
lifetime limits, treatment or visit limits or similar limitations that apply under the terms of the applicable plan.
A-34
(c) Notwithstanding anything contained herein to the contrary, with respect to any Company
Employees who are covered by a Collective Bargaining Agreement or who are based outside of the United States, Parents obligations under this
Section 5.6
shall be in addition to, and not in contravention of, any obligations under
the applicable Collective Bargaining Agreement or under the Laws of the foreign countries and political subdivisions thereof in which such Company Employees are based.
(d) Parent hereby acknowledges that a change in control of the Company or other event with similar import, within the meaning of
the Company Benefit Plans that contain such terms, will occur upon the Effective Time.
(e) No later than 30 Business Days following the
date hereof, the Company shall make available to Parent (i) a copy of each material Non-U.S. Company Benefit Plan, and the most recent summary plan description and actuarial valuation report relating to such material Non-U.S. Company Benefit
Plan, to the extent applicable, and (ii) a list and copies of all Collective Bargaining Agreements covering employees outside of the United States.
(f) Nothing in this Agreement shall confer upon any Company Employee or other service provider any right to continue in the employ or service
of Parent, the Surviving Company or any Affiliate of Parent, or shall interfere with or restrict in any way the rights of Parent, the Surviving Company or any of their Affiliates, which rights are hereby expressly reserved, to discharge or terminate
the services of any Company Employee or other service provider at any time for any reason whatsoever, with or without cause. In no event shall the terms of this Agreement be deemed to (i) establish, amend, or modify any Company Benefit Plan or
any employee benefit plan as defined in Section 3(3) of ERISA, or any other benefit plan, program, agreement or arrangement maintained or sponsored by Parent, Surviving Company, the Company or any of their Subsidiaries (including,
after the Closing Date, Company and its Subsidiaries) or Affiliates or (ii) alter or limit the ability of Parent, the Surviving Company or any of their Subsidiaries (including, after the Closing Date, Company and its Subsidiaries) or Affiliates
to amend, modify or terminate any Company Benefit Plan or any other compensation or benefit or employment plan, program, agreement or arrangement after the Closing Date. Notwithstanding any provision in this Agreement to the contrary, nothing in
this
Section 5.6
shall create any third-party beneficiary rights in any Company Employee or current or former service provider of the Company or its Affiliates (or any beneficiaries or dependents thereof).
Section 5.7
Regulatory Approvals; Efforts
.
(a) Subject to the terms and conditions of this Agreement (including
Section 5.7(d)
), prior to the Closing, Parent, Merger Sub and
the Company shall use their respective reasonable best efforts to take, or cause to be taken, all reasonable actions, and to do, or cause to be done, all reasonable things necessary, proper or advisable under any applicable Laws to consummate and
make effective the Merger as promptly as practicable, including (i) the preparation and filing of all forms, registrations and notifications required (whether by Law or in order to satisfy the condition set forth in
Section 6.1(c)
)
to be filed to consummate the Merger, (ii) using reasonable best efforts to satisfy the conditions to consummating the Merger, (iii) using reasonable best efforts to obtain (and to cooperate with each other in obtaining) any consent,
authorization, expiration or termination of a waiting period, permit, Order or approval of, waiver or any exemption by, any Governmental Entity (which actions shall include furnishing all information and documentary material required under the HSR
Act) required to be obtained or made (whether by Law or in order to satisfy the condition set forth in
Section 6.1(c)
) by Parent, Merger Sub, the Company or any of their respective Subsidiaries in connection with the Merger or the taking
of any action contemplated by this Agreement, (iv) defending any lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Merger, (v) using reasonable best efforts to
obtain (and to cooperate with each other in obtaining) any consent, approval of, waiver or any exemption by, any non-governmental third party, in each case, to the extent necessary, proper or advisable to consummate the Merger, and (vi) the
execution and delivery of any reasonable additional instruments necessary to consummate the Merger and to fully carry out the purposes of this Agreement.
A-35
(b) Parent and the Company shall each keep the other apprised of the status of matters relating
to the completion of the Merger and work cooperatively in connection with obtaining all required (whether by Law or in order to satisfy the condition set forth in
Section 6.1(c)
) consents, authorizations, Orders or approvals of, or any
exemptions by, any Governmental Entity undertaken pursuant to the provisions of this
Section 5.7
. In that regard, prior to the Closing, each party to this Agreement shall promptly (i) consult with the other parties to this Agreement
with respect to and provide any necessary information and assistance as the other parties may reasonably request with respect to (and, in the case of correspondence, provide the other parties (or their counsel) with copies of) all notices,
submissions or filings made by or on behalf of such party with any Governmental Entity or any other information supplied by or on behalf of such party to, or correspondence with, a Governmental Entity in connection with this Agreement and the
Merger, and (ii) inform the other parties to this Agreement, and if in writing, furnish the other parties with copies of (or, in the case of oral communications, advise the other parties orally of) any Substantive Communication from or to any
Governmental Entity regarding the Merger, and permit the other parties to review and discuss in advance, and consider in good faith the views of the other parties in connection with, any proposed communication or submission with any such
Governmental Entity;
provided
,
however
, that Parent shall have the principal responsibility for devising and implementing the strategy for obtaining any necessary antitrust consents or approvals and shall lead and direct all
submissions to, meetings and communications with any Governmental Entity or other party in connection with antitrust matters, including litigation matters with respect to any Antitrust Law;
provided
,
however
, that no party shall
participate in any meeting or Substantive Communication with any Governmental Entity in connection with this Agreement and the Merger unless it consults with the other party in advance and, to the extent not prohibited by such Governmental Entity,
gives the other party the opportunity to attend and participate therein or thereat. Notwithstanding the foregoing and subject to the Confidentiality Agreement and the Joint Defense Agreement between Parent, the Company and their respective counsel
dated February 3, 2016, Parent and the Company may, as each deems advisable and necessary, reasonably designate any competitively sensitive material provided to the other under this
Section 5.7(b)
as Outside Counsel Only
Material. Such materials and the information contained therein shall be given only to the outside counsel of the recipient and will not be disclosed by such outside counsel to employees, officers or directors of the recipient unless express
permission is obtained in advance from the source of the materials (Parent or the Company, as the case may be) or its legal counsel. Notwithstanding anything to the contrary contained in this
Section 5.7
, materials provided pursuant to
this
Section 5.7
may be redacted (i) to remove references concerning the valuation of the Company and the Merger, (ii) as necessary to comply with contractual arrangements and (iii) as necessary to address reasonable
privilege concerns.
(c) The Company and Parent shall use reasonable best efforts to make or file with the appropriate Governmental Entity
all filings, forms, registrations and notifications required (whether by Law or in order to satisfy the condition set forth in
Section 6.1(c)
) to be filed to consummate the Merger under any applicable Antitrust Law, and subsequent to
such filings and subject to the terms and conditions of
Section 5.7(b)
, the Company and Parent will, respond to inquiries from Governmental Entities, or provide any supplemental information that may be requested by Governmental Entities,
in connection with filings made with such Governmental Entities. The Company and Parent shall file their notification and report forms under the HSR Act ten Business Days after the date of this Agreement or when advisable. Subject to
Section 5.7(b)
and the last sentence of this
Section 5.7(c)
, in the event that the parties receive a request for information or documentary material pursuant to any Antitrust Law, including the HSR Act (any such request
pursuant to the HSR Act, a
Second Request
), the parties will use their respective reasonable best efforts to submit an appropriate response to, and to certify compliance with, any such request for information or documentary
material, and counsel for both parties will closely cooperate during the entirety of any review process pursuant to any Antitrust Law. Notwithstanding the foregoing, Parent may, if Parent in good faith believes it to be necessary or advisable to do
so in order to permit the satisfaction of the conditions set forth in
Section 6.1(b)
and
Section 6.1(c)
or in order to avoid a Triggering Divestiture, elect not to certify compliance with any such Second Request until the
date that is seven months after the date hereof, but in no event shall Parent delay certification of compliance with any such Second Request beyond such date that is seven months after the date hereof. Notwithstanding anything herein to the
contrary, neither Parent nor the Company, without the other partys prior written consent, shall (i) enter into
A-36
any timing, settlement or similar agreement, or otherwise agree or commit to any arrangement, that would have the effect of extending, suspending, lengthening or otherwise tolling, beyond the
date that is eleven months after the date hereof, the expiration or termination of the waiting period applicable to the Merger under the HSR Act or, (ii) enter into any timing or similar agreement, or otherwise agree or commit to any
arrangement, that would bind or commit the parties not to complete the Merger (or that would otherwise prevent or prohibit the parties from completing the Merger) prior to any date that is after the date that is eleven months from the date hereof.
(d) Notwithstanding anything to the contrary set forth in this Agreement, Parent and the Company shall, in order to permit the
satisfaction of the conditions set forth in
Section 6.1(b)
and
Section 6.1(c)
as promptly as practicable (subject to the last sentence of this
Section 5.7(d)
), (i) propose, negotiate, commit to, effect and
agree to, by consent decree, hold separate order or otherwise, the sale, divestiture, license, holding separate, and other disposition of and restriction on the businesses, assets, properties, product lines, and equity interests of, or changes to
the conduct of business of, the Company, Parent and their respective Subsidiaries (including the Surviving Company and its Subsidiaries) and take such action or actions that would in the aggregate have a similar effect, (ii) create, terminate,
or divest relationships, ventures, contractual rights or obligations of the Company, Parent and their respective Subsidiaries (including the Surviving Company and its Subsidiaries), and (iii) otherwise take or commit to take any action that
would limit Parents freedom of action with respect to, or its ability to retain or hold, directly or indirectly, any businesses, assets, equity interests, product lines or properties of the Company, Parent and their respective Subsidiaries
(including the Surviving Company and its Subsidiaries);
provided
that any such sales, divestitures, licenses, holdings, dispositions, restrictions, changes or similar effects are conditioned upon and become effective only from and after the
Effective Time;
provided
,
further
,
however
, that nothing contained in this Agreement shall require Parent or the Company to take, or cause to be taken, or commit to take, or commit to cause to be taken, any divestiture, license,
hold separate, sale or other disposition, of or with respect to (A) assets, businesses or product lines of the Company, Parent or any of their respective Subsidiaries (including the Surviving Company and its Subsidiaries) representing, in the
aggregate, in excess of $1,500,000,000.00 of Net Sales or (B) Parents Sherwin-Williams, Krylon or Ronseal trademark or trade name or any businesses or product lines using any such trademarks or trade
names, in each case, in any jurisdiction other than Australia. If requested by Parent, the Company shall agree to any action contemplated by this
Section 5.7
;
provided
that any such agreement or action is conditioned on the
consummation of the Merger. Without limiting the foregoing, in no event shall the Company (and the Company shall not permit any of its Subsidiaries to) propose, negotiate, effect or agree to any such actions without the prior written consent of
Parent. Parent shall use its reasonable best efforts to permit the satisfaction of the conditions set forth in
Section 6.1(b)
and
Section 6.1(c)
without taking, or causing to be taken, or committing to take, or committing to
cause to be taken, any action that would constitute a Triggering Divestiture, unless and until the Company has requested that Parent offer a Triggering Divestiture or Parent reasonably determines, after communications between Parent and a
Governmental Entity to which the Company was a participant and after further consultation with the Company, that undertaking a Triggering Divestiture is necessary in order to permit the satisfaction of the conditions set forth in
Section 6.1(b)
and
Section 6.1(c)
by the End Date. Notwithstanding anything herein to the contrary, prior to the earlier of (x) the date that is nine months after the date hereof and (y) the commencement by a
Governmental Entity of litigation to prohibit the Merger or any other transaction contemplated by this Agreement as violative of any Antitrust Law, Parent shall not offer or propose, or cause to be offered or proposed, that it take, or cause to be
taken, or commit to take, or commit to cause to be taken, any action constituting a Triggering Divestiture.
(e) In furtherance and not in
limitation of the covenants of the parties contained in this
Section 5.7
, if any administrative or judicial action or proceeding, including any proceeding by a private party, is instituted (or threatened to be instituted) challenging the
Merger or any other transaction contemplated by this Agreement as violative of any Antitrust Law, each of the Company and Parent shall use reasonable best efforts to contest and resist any such action or proceeding and to have vacated, lifted,
reversed or overturned any decree, judgment, injunction or other order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the Merger.
A-37
(f) The parties agree and acknowledge that, notwithstanding anything herein to the contrary, no
filing, notice, approval or clearance pursuant to any Antitrust Law, other than those set forth in
Section 6.1(c)
, is a condition to any partys obligation to effect the Merger and consummate the transactions contemplated by this
Agreement.
Section 5.8
Takeover Statutes
. The Company and its Subsidiaries shall not take any action that would cause the
transactions contemplated by this Agreement, including the Merger, to be subject to requirements imposed by any takeover statute. If any moratorium, control share acquisition, fair price,
supermajority, affiliate transactions or business combination statute or regulation or other similar state anti-takeover Laws (including Section 203 of the DGCL) and regulations (each, a
Takeover
Statute
) may become, or may purport to be, applicable to this Agreement, the Merger or any other transactions contemplated by this Agreement, each of the Company and Parent shall grant such approvals and take such actions as are reasonably
necessary so that the transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to eliminate or minimize the effects of such statute or regulation on the transactions
contemplated hereby.
Section 5.9
Public Announcements
. The Company and Parent agree that the initial press release to be
issued with respect to the execution and delivery of this Agreement shall be in a form agreed to by the parties and that the parties shall consult with each other before issuing any press release or making any public announcement with respect to
this Agreement and the transactions contemplated hereby and shall not issue any such press release or make any such public announcement without the prior consent of the other party (which shall not be unreasonably withheld, delayed or conditioned);
provided
,
however
, that a party may, without the prior consent of the other party (but after prior consultation, to the extent practicable in the circumstances) issue such press release or make such public statement to the extent
required by applicable Law or the applicable rules of any stock exchange;
provided
,
further
, that in the case of press releases or public announcements by the Company or Parent with respect to any Company Takeover Proposal or from and
after a Company Adverse Recommendation Change, neither the Company nor Parent shall not be required to consult with the other but shall give such other party a copy of any such press release or public announcement prior to the issuance thereof.
Section 5.10
Indemnification and Insurance
.
(a) Parent and Merger Sub agree that all rights to exculpation and indemnification for acts or omissions occurring at or prior to the
Effective Time, whether asserted or claimed prior to, at or after the Effective Time (including any matters arising in connection with the transactions contemplated by this Agreement), now existing in favor of the current or former directors,
officers or employees, as the case may be, of the Company or any of its Subsidiaries (the
Indemnified Parties
) as provided in the Company Organizational Documents and the certificate of incorporation, bylaws, limited partnership
agreement, limited liability company agreement or comparable constituent or organizational documents for each Subsidiary of the Company or in any agreement set forth on
Section 5.10(a)
of the Company Disclosure Schedule (an
Indemnity Agreement
), each as in effect on the date of this Agreement, shall survive the Merger and shall continue in full force and effect in accordance with their terms. For a period of not less than six years after the
Effective Time, Parent shall cause the Surviving Company to indemnify, defend and hold harmless, and advance expenses to, the Indemnified Parties with respect to all acts or omissions by them in their capacities as such at any time prior to the
Effective Time, to the fullest extent provided by: (i) the Company Organizational Documents or the certificate of incorporation, bylaws, limited partnership agreement, limited liability company agreement or comparable constituent or
organizational documents for each Subsidiary of the Company as in effect on the date of this Agreement; (ii) any Indemnity Agreement between any such Indemnified Party on the one hand and the Company or any of its Subsidiaries on the other
hand, as in effect on the date of this Agreement; and (iii) applicable Law.
(b) Without limiting the provisions of
Section 5.10(a)
, from and after the Effective Time, Parent shall and shall cause the Surviving Company to, in each case, to the fullest extent permitted by applicable Law: (i) indemnify, defend and hold harmless each Indemnified
Party from and against any costs or expenses
A-38
(including reasonable attorneys fees), judgments, fines, losses, claims, damages, penalties, liabilities and amounts paid in settlement (including, in each case, any interest or assessments
thereon) in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, to the extent such claim, action, suit, proceeding or investigation arises out of or pertains to any action
or omission or alleged action or omission in such Indemnified Partys capacity as a director, officer or employee of the Company or any of its Subsidiaries prior to the Effective Time; and (ii) pay the expenses of any Indemnified Party
incurred in connection with any such claim, action, suit, proceeding or investigation, in each case, to the extent that such Persons are indemnified or have the right to advancement of expenses as of the date of this Agreement by the Company or any
of its Subsidiaries pursuant to the Company Organizational Documents, the certificate of incorporation, bylaws, limited partnership agreement, limited liability company agreement or comparable constituent or organizational documents for each
Subsidiary of the Company, any Indemnity Agreement or applicable Law. Notwithstanding the foregoing, the Indemnified Parties as a group may retain only one law firm to represent them (and local counsel in each necessary jurisdiction) with respect to
each such matter unless there is, under applicable standards of professional conduct, a conflict on any significant issue between the positions of any two or more Indemnified Parties.
(c) For a period of six years after the Closing and at all times subject to applicable Law, Parent shall not (and shall not cause or permit
the Surviving Company or any its Subsidiaries or any of Parents other Subsidiaries or Affiliates to) amend or modify in any way adverse to the Indemnified Parties, or to the beneficiaries thereof, the exculpation and indemnification provisions
set forth in the organizational documents of the Surviving Company or its Subsidiaries to make them less favorable to the Indemnified Parties or the beneficiaries thereof than the provisions which are currently provided by the Company and its
Subsidiaries. In addition, Parent will obtain, or cause the Surviving Company to obtain, for a period of not less than six years after the Effective Time, the Indemnified Parties who are insured under the Companys directors and
officers insurance and indemnification policy with an insurance and indemnification policy that provides coverage for events occurring at or prior to the Effective Time (the
D&O Insurance
) that is no less favorable than
the existing policy of the Company;
provided
that Parent and the Surviving Company shall not be required to pay an annual premium for the D&O Insurance in excess of 300% of the annual premium paid as of the date hereof by the Company for
such insurance;
provided
,
further
, that if the annual premiums of such insurance coverage at any time exceed such amount, Parent or the Surviving Company shall obtain a policy which, in its good faith determination, provides the
greatest coverage available for a cost not exceeding such amount. Notwithstanding anything in this Agreement to the contrary, the Company may, and at Parents request shall, purchase a tail directors and officers
insurance and indemnification policy;
provided
that payment for insurance coverage provided by such tail directors and officers insurance policy shall not exceed 300% of the annual premium paid as of the date hereof by
the Company. Any such tail directors and officers insurance policy will satisfy Parents obligations under this
Section 5.10(c)
to obtain D&O Insurance.
(d) The Indemnified Parties to whom this
Section 5.10
applies shall be third-party beneficiaries of this
Section 5.10
.
The provisions of this
Section 5.10
are intended to be for the benefit of each Indemnified Party and his or her successors, heirs and representatives.
(e) This
Section 5.10
shall survive the consummation of the Merger and shall be binding, jointly and severally, on all successors
and assigns of Parent, the Surviving Company and its Subsidiaries, and shall be enforceable by the Indemnified Parties and their successors, heirs or representatives. In the event that Parent, the Surviving Company or any of their respective
successors or assigns consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or transfers or conveys all or a majority of its properties and assets to any
Person, then, and in each such case, proper provision shall be made so that such other Person or the successors and assigns of Parent or the Surviving Company, as the case may be, shall succeed to its obligations set forth in this
Section 5.10
.
Section 5.11
Section 16 Matters
. Prior to the Effective Time, the Company shall take all such
steps as may be required to cause any dispositions of Company Common Stock (including derivative securities with respect to
A-39
Company Common Stock) resulting from the transactions contemplated by this Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the Exchange Act with
respect to the Company, to be exempt under Rule 16b-3 promulgated under the Exchange Act.
Section 5.12
Financing and Financing
Cooperation
.
(a) Parent shall use its reasonable best efforts to take, or cause to be taken, all actions and do, or cause to
be done, all things necessary, advisable or proper, in each case, regardless of whether the Adjusted Per Share Price or the Baseline Per Share Price is the Per Share Price, to obtain the Financing contemplated by the Commitment Letter on or prior to
the Closing Date on the terms and conditions described in the Commitment Letter, including using reasonable best efforts to: (i) maintain in effect the Commitment Letter and any Definitive Debt Financing Agreements and comply with its
obligations thereunder; (ii) satisfy or if applicable use reasonable best efforts to cause to be satisfied (or, if deemed advisable by Parent, seek a waiver of) on a timely basis all conditions to the funding of the Financing (including the
Financing Conditions) set forth in the Commitment Letter and the Definitive Debt Financing Agreements; and (iii) negotiate and enter into definitive debt financing agreements on the terms and subject to the conditions contemplated by the
Commitment Letter (including, if necessary, any flex provisions) (the
Definitive Debt Financing Agreements
). Upon the reasonable request of the Company, Parent shall provide the Company information in reasonable detail
about the status of its efforts to arrange the Financing contemplated by the Commitment Letter and any other financing and shall give the Company prompt notice of any fact, change, event or circumstance that is reasonably likely to have,
individually or in the aggregate, a material adverse impact on the Financing necessary to pay the Merger Amount contemplated by the Commitment Letter.
(b) Prior to the Closing, Parent shall not, and shall not permit Merger Sub to, agree to or permit any termination, amendment, replacement or
other modification of the Commitment Letter or Definitive Debt Financing Agreements if such termination, amendment, replacement or modification (i) reduces the aggregate amount of the Financing or (ii) imposes new or additional conditions
or other terms or otherwise modifies any of the conditions to the receipt of the Financing or other terms in a manner that would reasonably be expected to (x) delay or prevent the Closing or (y) make the timely funding of the Financing or
satisfaction of the conditions to obtaining the Financing materially less likely to occur, other than, in each case, (A) a waiver of any closing conditions by lender(s) or their agent or (B) to add lenders, lead arrangers, bookrunners,
syndication agents or similar entities who had not executed the Commitment Letter as of the date hereof or to reassign titles to such parties who had executed the Commitment Letter as of the date hereof. Upon any such amendment, replacement or
modification, the term Commitment Letter and Definitive Debt Financing Agreement shall mean the Commitment Letter or Definitive Debt Financing Agreement, as applicable, as so amended, replaced or modified. Parent shall
promptly deliver to the Company copies of any such amendment, replacement or other modification of the Commitment Letter.
(c)
Notwithstanding anything contained in clause (b) above to the contrary, in addition to the rights of Parent set forth in clause (b) above, Parent shall have the right to substitute the proceeds of consummated equity offerings or debt
offerings or incurrences of debt for all or any portion of the Financing contemplated by the Commitment Letter by reducing commitments under the Commitment Letter;
provided
that (i) to the extent any such equity or debt has a scheduled
special or mandatory redemption right, such right is not exercisable prior to the earliest of the consummation of the Merger on the Closing Date, the termination of this Agreement and the End Date and (ii) the conditions to the use of such
proceeds to pay the Merger Amounts shall be no more restrictive than the conditions set forth in the Commitment Letter.
(d) If all or any
portion of the Financing necessary for Parent to pay the Merger Amount becomes unavailable, then Parent shall use its reasonable best efforts to arrange and obtain, as promptly as practicable, from the same and/or alternative financing sources,
alternative financing in an amount sufficient to consummate the transactions contemplated by this Agreement and pay the Merger Amounts. In the event any alternative financing is obtained in accordance with this
Section 5.12(d)
(
Alternative Financing
), references in this
A-40
Agreement to the Financing shall also be deemed to refer to such Alternative Financing, and if one or more commitment letters or definitive financing agreements are entered into or proposed to be
entered into in connection with such Alternative Financing, references in this Agreement to the Commitment Letters and the Definitive Debt Financing Agreements shall also be deemed to refer to such commitment letters and definitive financing
agreements relating to such Alternative Financing, and all obligations of Parent pursuant to this
Section 5.12
shall be applicable thereto to the same extent as Parents obligations with respect to the Financing.
(e) The Company shall, and shall cause its Subsidiaries to, and shall use its reasonable best efforts to cause its and their respective
officers, directors, employee, attorneys, accountants and other Representatives to, use reasonable best efforts to provide all customary cooperation reasonably requested by Parent that is necessary in connection with arranging, obtaining and
syndicating the Financing and any other financing or refinancing transactions undertaken by Parent or its Subsidiaries in connection with the Merger, in each case, to the extent such cooperation is customarily provided for financings of the type
contemplated by the Commitment Letter, including using reasonable best efforts to (A) make one or more members of senior management of the Company available, for a reasonable number of meetings or telephone calls, at reasonable times and
locations mutually agreed, and upon reasonable notice, to participate in the preparation of customary offering and syndication documents and materials, including registration statements, prospectuses and prospectus supplements, private placement or
offering memoranda, bank information memoranda, bank syndication material and packages, lender and investor presentations, rating agency materials and presentations, and similar documents and materials, in connection with the marketing efforts of
Parent, Merger Sub and the Financing Sources related to the Financing (all such documents and materials, collectively, the
Offering Documents
), (B) furnish to Parent all Company Information as may be reasonably requested by
Parent to assist in the preparation of the Offering Documents or in connection with the syndication and marketing of the Financing, (C) provide information that is reasonably available or readily obtainable regarding the Company and its
Subsidiaries reasonably necessary to assist Parent in preparing pro forma financial statements required by SEC Regulation S-X for registered offerings of securities in connection with the Financing, (D) make one or more members of senior
management of the Company available for a reasonable number of meetings or telephone calls, at reasonable times and locations mutually agreed, and upon reasonable notice, in due diligence sessions, drafting sessions, management presentations, rating
agency presentations, lender meetings (including one-on-one meetings) and one or more road shows related to the Financing, (E) assist Parent in obtaining any corporate credit and family ratings and, if applicable, facility ratings from any
ratings agency relating to the Financing, (F) request the Companys independent auditors to cooperate with Parents independent auditors, participate in accounting due diligence sessions and provide accountants comfort letters
and consents, (G) assist in the preparation of Definitive Debt Financing Agreements and related definitive documents, including guarantees (if required) and other certificates and documents as may be requested by Parent, (H) provide
authorization letters to the Financing Sources authorizing the distribution of information provided by the Company to prospective lenders containing a representation to the Financing Sources that the information provided by the Company for inclusion
in the public side versions of such documents, if any, does not include material non-public information about the Company or its Subsidiaries or their respective securities and (I) provide at least five Business Days prior to the anticipated
Closing all documentation and other information about the Company or any of its Subsidiaries or Affiliates required by applicable know your customer and anti-money laundering rules and regulations, including the USA PATRIOT Act, to the
extent reasonably requested at least ten Business Days prior to the anticipated Closing.
(f) Parent will be permitted to commence and
conduct offers to purchase or exchange, and conduct consent solicitations with respect to, any or all of the outstanding series of senior notes of the Company (the
Company Notes
), on such terms and conditions, including pricing
terms and amendments to the terms and provisions of the applicable indenture, that are specified, from time to time, by Parent (each, a
Debt Offer
and collectively, the
Debt Offers
) and which are permitted by
the terms of such Company Notes, the applicable indentures and applicable Law, including SEC rules and regulations;
provided
that any such Debt Offer shall be consummated substantially simultaneously with or after the Closing using funds
provided by Parent. Parent shall consult with the Company regarding the material terms and conditions of any Debt Offer, including the timing and commencement of any Debt Offer and any tender deadlines. Parent shall not be permitted to commence any
A-41
Debt Offer until Parent shall have provided the Company with the necessary offer to purchase, consent solicitation statement, letter of transmittal or press release, if any, in connection with
the Debt Offer (collectively, the
Debt Offer Documents
) a reasonable period of time in advance of commencing the applicable Debt Offer to allow the Company and its counsel to review and comment on such Debt Offer Documents. In
addition, Parent shall not be permitted to commence any Debt Offer until the date that is 60 days prior to the first date on which the Company and Parent reasonably expect the Closing may occur. The closing of the Debt Offers shall be expressly
conditioned on the occurrence of the Closing. Subject to
Section 5.12(g)
, the Company shall, and shall cause its Subsidiaries to, and shall use its reasonable best efforts to cause its and their respective officers, directors, employee,
attorneys, accountants and other Representatives to, use reasonable best efforts to provide all reasonable cooperation reasonably requested by Parent in connection with any Debt Offer (including, to the extent required by the policies or procedures
of the Depository Trust Company (
DTC
) in connection with any consent solicitation that is part of any Debt Offer, the Company conducting any such consent solicitation);
provided
that neither the Company nor counsel for the
Company shall be required to furnish any legal opinions or negative assurance letters in connection with the Debt Offers (other than, in connection with any consent solicitation conducted by the Company, the Company using reasonable best efforts to
deliver and to cause counsel for the Company to deliver, customary legal opinions, to the extent such opinions would not conflict with applicable Law and would be accurate in light of the facts and circumstances at the time delivered). The dealer
manager, solicitation agent, information agent, depositary or other agent retained in connection with the Debt Offers will be selected by Parent after consultation with the Company and their fees and out-of-pocket expenses will be paid directly by
Parent. Notwithstanding anything to the contrary set forth in this Agreement, the condition set forth in
Section 6.2(b)
, as it applies to the Companys obligations under this
Section 5.12(f)
, shall be deemed satisfied.
(g) No obligations of the Company or any of its Subsidiaries or any of its or their respective officers, directors, employees, attorneys,
accountants or other Representatives under any certificate, document or instrument delivered pursuant to this
Section 5.12
, including in respect of any Debt Offer (other than any authorization letters delivered pursuant to
Section 5.12(e)(G),
any Form W-9 delivered pursuant to
Section 5.12(e)(I)
, and any certificate, document or instrument reasonably required by DTC or any dealer manager, solicitation agent, information agent, depositary or
other agent retained in connection with any consent solicitation that is part of any Debt Offer) shall be required to be effective until the Effective Time. In addition, notwithstanding anything in this
Section 5.12
or in
Section 5.13
to the contrary, in fulfilling its obligations pursuant to this
Section 5.12
, including in respect of any Debt Offer, or
Section 5.13
, (i) none of the Company, its Subsidiaries or its or their
respective officers, directors, employees and agents or other Representatives shall be required to (w) pay any commitment or other fee, provide any security or incur any Liability or obligation in connection with the Financing or any other
financing or refinancing transactions undertaken by Parent or its Subsidiaries in connection with the Merger prior to the Effective Time, except such expenses for which Parent is obligated to reimburse the Company or, if reasonably requested by the
Company, for which funds that are actually necessary to pay such expenses are provided in advance by Parent to the Company, (x) take or permit the taking of any action that would reasonably be expected to conflict with, result in any violation
or breach of, or default (with or without lapse of time, or both) under, the Company Organizational Documents or the organizational documents of any Subsidiary of the Company, or any applicable Law or material contracts of the Company or any of its
Subsidiaries, (y) pass resolutions or consents or approve or authorize the execution of the Financing or the definitive financing arrangements or any Debt Offer or any Debt Offer Documents (other than to the extent required by
Section 5.12(f)
and by the reasonable requirements of any dealer manager, solicitation agent, information agent, depositary or other agent retained in connection with the Debt Offers in connection with any consent solicitations that are
part of the Debt Offers), or (z) provide any cooperation that, in the opinion of the Company, would unreasonably interfere with the ongoing operations of the Company and its Subsidiaries, and (ii) Parent shall reimburse the Company for all
reasonable and documented out-of-pocket costs incurred by the Company or any of its Subsidiaries in connection with fulfilling its obligations pursuant to this
Section 5.12
or
Section 5.13
(including reasonable
attorneys fees, but excluding, for the avoidance of doubt, the costs of the preparation of any annual or quarterly financial statements). Parent shall indemnify and hold harmless the Company and its Subsidiaries (and their respective
Representatives) from and against any and all losses,
A-42
damages, claims, costs or expenses actually suffered or incurred by them in connection with (1) the Financing and any other financing or refinancing transactions undertaken by Parent or its
Subsidiaries in connection with the Merger (other than to the extent resulting from information provided to Parent in writing by the Company or its Subsidiaries), except in the event such loss or damage arises out of or results from the gross
negligence, willful misconduct or bad faith by the Company or its Subsidiaries in fulfilling their obligations pursuant to this
Section 5.12
or
Section 5.13
and (2) any Debt Offers. Subject to Parents
indemnification obligations under this
Section 5.12
, the Company hereby consents to the use of all of its and its Subsidiaries corporate logos in connection with the initial syndication or marketing of such Financing;
provided
that such logos are used solely in a manner that is not intended to or reasonably likely to harm or disparage the Company or its Subsidiaries or the reputation or goodwill of the Company or any of its Subsidiaries. Notwithstanding
anything in this Agreement to the contrary, in no event shall the receipt or availability of any funds or financing (including the Financing contemplated by the Commitment Letter) by or to Parent or any of its Affiliates or any other financing
transaction, or the commencement or consummation of a Debt Offer with respect to any series of Company Notes, be a condition to any of Parents or Merger Subs obligations hereunder.
Section 5.13
Treatment of Certain Indebtedness
. The Company shall, and shall cause its Subsidiaries to, use reasonable best
efforts to deliver all notices and to take all other reasonable actions to cause (a) the repayment in full on the Closing Date (or in the case of any letters of credit, cash collateralization, to the extent that Parent shall not have entered
into an alternative arrangement with the issuing bank) of all amounts and other obligations then outstanding under and (b) the termination (to the extent provided therein and pursuant to the terms thereof) on the Closing Date of (such
repayments and terminations, the
Existing Credit Facility Termination
) that certain Amended and Restated Credit Agreement, dated as of December 16, 2013, among the Company, Wells Fargo Bank, National Association, as
administrative agent, and the Subsidiaries of the Company, lenders and other financial institutions party thereto (the
Credit Agreement
), including using reasonable best efforts to obtain a payoff letter in customary form from the
agent under the Credit Agreement and, if applicable, Lien release, documentation. Parent shall provide all funds required to effect the Existing Credit Facility Termination. In no event shall the receipt of any such payoff letter or the consummation
of the Existing Credit Facility Termination, or of any other financing termination or the release of any Lien, be a condition to any of the obligations of Parent or Merger Sub hereunder.
Section 5.14
Transaction Litigation
. Each party shall promptly (and in any event, within one Business Day) notify the other
parties hereto in writing of any stockholder litigation or other litigation or proceedings brought or threatened in writing against it and/or its directors or executive officers or Representatives relating to this Agreement, the Merger and/or the
other transactions contemplated by this Agreement and shall keep the other parties hereto sufficiently informed on a reasonably current basis with respect to the status thereof (including by promptly furnishing to the other parties hereto and their
Representatives such information relating to such litigation or proceedings as may be reasonably requested). Each party shall, subject to the preservation of privilege and confidential information, give the other parties hereto the opportunity to
participate in (but not control) its defense or settlement of any stockholder litigation or other litigation or proceeding against it and/or its directors or executive officers or Representatives relating to this Agreement, the Merger and/or the
other transactions contemplated by this Agreement and shall give due consideration to such other parties advice with respect to such litigation or proceeding. No party shall cease to defend, consent to the entry of any judgment, settle or
offer to settle or take any other material action with respect to such litigation or proceeding commenced without the prior written consent of the other parties hereto (which shall not be unreasonably withheld, conditioned or delayed).
Section 5.15
Additional Agreements
. In case at any time after the Effective Time any further action is necessary or desirable to
carry out the purposes of this Agreement or to vest the Surviving Company with full title to all properties, assets, rights, approvals, immunities and franchises of either of the parties to the Merger, the officers of the Surviving Company shall be
authorized to, in the name and on behalf of the Company, execute and deliver such deeds, bills of sale, assignment or assurances and take all such other action as may be necessary in connection therewith.
A-43
Section 5.16
Obligations of Merger Sub
. Parent shall cause Merger Sub and the
Surviving Company to perform their respective obligations under this Agreement and to consummate the transactions contemplated hereby upon the terms and subject to the conditions set forth in this Agreement.
Section 5.17
Stock Exchange Delisting; Deregistration
. Prior to the Effective Time, the Company and, following the Effective Time,
Parent and the Surviving Company, shall use reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, necessary, proper or advisable on its part under applicable Law and rules and policies of the New
York Stock Exchange to cause the delisting of the Company and of the shares of Company Common Stock from the New York Stock Exchange as promptly as practicable after the Effective Time and the deregistration of the shares of Company Common Stock
under the Exchange Act as promptly as practicable after such delisting.
ARTICLE VI.
CONDITIONS TO THE MERGER
Section 6.1
Conditions to Each Partys Obligation to Effect the Merger
. The respective obligations of each party to effect
the Merger shall be subject to the fulfillment (or waiver by the Company and Parent, to the extent permissible under applicable Law and provided that such waiver shall only be effective as to the conditions of the waiving party) at or prior to the
Effective Time of the following conditions:
(a) the Requisite Company Vote shall have been obtained;
(b) no injunction by any court or other tribunal of competent jurisdiction shall have been entered and shall continue to be in effect and no
Law shall have been adopted that remains in effect or be effective, in each case that prevents, enjoins, prohibits or makes illegal the consummation of the Merger; and
(c) (i) all waiting periods applicable to the Merger under the HSR Act shall have expired or been terminated, and (ii) all other filings,
notices, approvals and clearances identified in
Section 6.1(c)
of the Company Disclosure Schedule have been obtained or filed or shall have occurred.
Section 6.2
Conditions to Obligations of Parent and Merger Sub
. The obligations of Parent and Merger Sub to effect the Merger are
also subject to the satisfaction or waiver (in writing) by Parent at or prior to the Effective Time of the following additional conditions:
(a) (i) The representations and warranties of the Company set forth in
Article III
that are qualified by a Material Adverse
Effect qualification (including the entirety of
Sections 3.1(a)
(other than the first sentence),
3.3(b)
,
3.3(c)
and
3.10(b)
) shall be true and correct in all respects as so qualified at and as of the Closing Date as
though made at and as of the Closing Date, (ii) other than
Section 3.1(a)
(first sentence only) and
Sections 3.2(a)
,
3.3(c)(ii)
,
3.10(b)
,
3.18
and
3.19
, the representations and warranties of the
Company set forth in
Article III
that are not qualified by a Material Adverse Effect qualification shall be true and correct both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as
of the Closing Date, except where such failures to be so true and correct would not, individually or in the aggregate, have a Material Adverse Effect, (iii) the representations and warranties of the Company set forth in
Section 3.2(a)
shall be true and correct both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date, except for any
de minimis
inaccuracies, (iv) the
representations and warranties of the Company set forth in
Section 3.1(a)
(first sentence only) and
Sections 3.3(c)(ii)
,
3.18
and
3.19
shall be true and correct in all material respects both at and as of the date of
this Agreement and at and as of the Closing Date as though made at and as of the Closing Date and (v) the representations and warranties of the Company set forth in
Section 3.10(b)
shall be true and correct in all respects both at
and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date;
provided
,
however
, that representations and warranties that
A-44
are made as of a particular date or period shall be true and correct (in the manner set forth in
clauses (i)
,
(ii)
,
(iii)
,
(iv)
and
(v)
, as applicable)
only as of such date or period. Parent shall have received at the Closing a certificate signed on behalf of the Company by the Chief Executive Officer or Chief Financial Officer of the Company to the effect that the conditions set forth in this
Section 6.2(a)
have been satisfied.
(b) The Company shall have performed and complied in all material respects with all
covenants required by this Agreement to be performed or complied with by it prior to the Closing Date. Parent shall have received at the Closing a certificate signed on behalf of the Company by the Chief Executive Officer or Chief Financial Officer
of the Company to the effect that the conditions set forth in this
Section 6.2(b)
have been satisfied.
Section 6.3
Conditions to Obligation of the Company
. The obligation of the Company to effect the Merger is also subject to the satisfaction or waiver (in writing) by the Company at or prior to the Effective Time of the following additional conditions:
(a) (i) The representations and warranties of Parent and Merger Sub set forth in
Article IV
that are qualified by a Parent
Material Adverse Effect qualification shall be true and correct in all respects as so qualified both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date, (ii) the
representations and warranties of Parent and Merger Sub set forth in
Article IV
(other than
Section 4.1
(first two sentences only) and
Sections 4.2(a)
,
4.2(c)(ii)
,
4.3
and
4.7
) that are not qualified by
a Parent Material Adverse Effect qualification shall be true and correct both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date, except for such failures to be true and
correct as would not, in the aggregate, reasonably be expected to have a Parent Material Adverse Effect, (iii) the representations and warranties of Parent and Merger Sub set forth
Section 4.1
(first two sentences only) and
Sections 4.2(a)
,
4.2(c)(ii)
and
4.7
shall be true and correct in all material respects both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date and (iv) the
representations and warranties of Parent and Merger Sub set forth in
Section 4.3
shall be true and correct in all respects both at and as of the date of this Agreement and at and as of the Closing Date as though made at the Closing Date;
provided
,
however
, that representations and warranties that are made as of a particular date or period shall be true and correct (in the manner set forth in
clauses (i)
,
(ii)
,
(iii)
and
(iv)
, as
applicable) only as of such date or period. The Company shall have received at the Closing a certificate signed on behalf of Parent by a senior executive officer of Parent to the effect that the conditions set forth in this
Section 6.3(a)
have been satisfied.
(b) Each of Parent and Merger Sub shall have performed and complied in all material
respects with all covenants required by this Agreement to be performed or complied with by it prior to the Closing Date. The Company shall have received at the Closing a certificate signed on behalf of Parent by a senior executive officer of Parent
to the effect that the conditions set forth in this
Section 6.3(b)
have been satisfied.
ARTICLE VII.
TERMINATION
Section 7.1
Termination or Abandonment
. Notwithstanding anything in this Agreement to the contrary, this Agreement may be
terminated and abandoned at any time prior to the Effective Time:
(a) by the mutual written consent of the Company and Parent;
(b) by the Company or Parent, if the Closing shall not have occurred on or prior to 5:00 p.m. Eastern Time, on March 21, 2017 (the
Original End Date
);
provided
,
however
, that if as of the Original End Date or the First Extended End Date (as defined below) any of the conditions set forth in
Section 6.1(b)
(solely to the extent
A-45
such condition has not been satisfied due to an order or injunction arising under any Antitrust Law) or
Section 6.1(c)
shall not have been satisfied or waived (to the extent
permitted), either Parent or the Company may, in its respective sole discretion: (1) at any time not more than 30 days prior to the Original End Date, elect to extend the Original End Date for a period of three months (the Original End Date as
so extended, the
First Extended End Date
), and (2) thereafter either Parent or the Company, may in its respective sole discretion at any time not more than 30 days prior to the First Extended End Date, elect to extend for
another period of up to three months (the First Extended End Date, as so further extended, the
Second Extended End Date
and, each of the First Extended End Date and the Second Extended End Date, the
Extended End
Date
, and the Original End Date, or, if extended, the Extended End Date then in effect, the
End Date
), it being agreed that there shall be no more than two such extensions pursuant to this
Section 7.1
in the
aggregate for all parties pursuant to this proviso and that in no event shall the End Date occur after 5:00 p.m. Eastern Time on September 21, 2017. Notwithstanding the foregoing, the right to terminate this Agreement pursuant to this
Section 7.1(b)
shall not be available to a party if the failure of the Closing to occur by such date shall be due to the intentional material breach by such party of any representation, warranty, covenant or other agreement of such party
set forth in this Agreement;
(c) by either the Company or Parent, if an order by a Governmental Entity of competent jurisdiction shall
have been issued permanently restraining, enjoining or otherwise prohibiting the consummation of the Merger and such order shall have become final and nonappealable;
provided
that the right to terminate this Agreement pursuant to this
Section 7.1(c)
shall not be available to a party if such order resulted due to the intentional material breach by such party of any representation, warranty, covenant or other agreement of such party set forth in this Agreement;
(d) by the Company, if Parent or Merger Sub shall have breached or there is any inaccuracy in any of its representations or warranties, or
shall have breached or failed to perform any of its covenants or other agreements contained in this Agreement, which breach, inaccuracy or failure to perform (i) would result in a failure of a condition set forth in
Section 6.3(a)
or
Section 6.3(b)
and (ii) is either not curable or is not cured by the earlier of (A) the End Date and (B) the date that is 30 days following written notice from the Company to Parent describing such breach or failure in
reasonable detail;
(e) by Parent, if the Company shall have breached or there is any inaccuracy in any of its representations or
warranties, or shall have breached or failed to perform any of its covenants or other agreements contained in this Agreement (other than those governed by
Section 5.3
,
Section 5.4
or the first sentence of
Section 5.5
), which breach, inaccuracy or failure to perform (i) would result in a failure of a condition set forth in
Section 6.2(a)
or
Section 6.2(b)
and (ii) is either not curable or is not cured by
the earlier of (A) the End Date and (B) the date that is 30 days following written notice from the Company to Parent describing such breach or failure in reasonable detail;
(f) at any time prior to the time the Requisite Company Vote is obtained, by the Company, in accordance with
Section 5.3(f)
;
(g) by Parent, if: (i) the Company Board of Directors shall have effected a Company
Adverse Recommendation Change; or (ii) the Company shall have breached (except for any
de minimis
breach) any of its obligations under
Section 5.3
or
Section 5.4
or the first sentence of
Section 5.5
; or
(h) by either the Company or Parent, if the Requisite Company Vote has not been obtained at the Stockholders Meeting or at any
adjournment or postponement of the Stockholders Meeting taken in accordance with this Agreement.
Section 7.2
Effect of
Termination
. In the event of termination of this Agreement pursuant to
Section 7.1
, this Agreement shall terminate (except that the Confidentiality Agreement and the provisions of
Section 5.12(e)
(final sentence), this
Section 7.2
,
Section 7.3
and
Article VIII
shall survive any termination), and there shall be
A-46
no other Liability on the part of the Company, on the one hand, or Parent or Merger Sub, on the other hand, to the other except as provided in
Section 5.12(e)
(final sentence) and
Section 7.3
;
provided
,
however
, that nothing herein shall relieve (a) any party from any Liability for any failure to consummate the transactions contemplated by this Agreement, including the Merger, if required to
pursuant to this Agreement (it being understood that the failure of Parent or Merger Sub to receive the proceeds of the Financing or of any alternative financing shall not relieve Parent or Merger Sub from any such liability or of their obligations
to consummate any of the transactions contemplated hereby, including the Merger), or (b) any party hereto from Liability for a Willful Breach of its covenants or agreements set forth in this Agreement prior to such termination, in which case
the aggrieved party shall be entitled to all rights and remedies available at Law or in equity.
Section 7.3
Termination Fee
.
(a) If: (i) this Agreement is terminated by the Company pursuant to
Section 7.1(f)
, (ii) this Agreement is
terminated by Parent pursuant to
Section 7.1(g)
or (iii) (A) after the date of this Agreement, a Company Takeover Proposal (substituting fifty percent (50%) for the twenty percent (20%) threshold set forth in the
definition of
Company Takeover Proposal
) (a
Qualifying Transaction
) shall have been publicly made and not withdrawn, (B) thereafter this Agreement is terminated by Parent or the Company pursuant to
Section 7.1(b)
(if the Company is in material breach of its obligations pursuant to
Section 5.7
),
Section 7.1(e)
or
Section 7.1(h)
and (C) at any time on or prior to the twelve-month anniversary
of such termination, the Company or any of its Subsidiaries enters into a definitive agreement with respect to any Qualifying Transaction or completes a Qualifying Transaction; then in any of such event in
clause (i)
,
(ii)
or
(iii)
above, the Company shall pay to Parent the Company Termination Fee in immediately available funds, in the case of
clause (i)
, in accordance with
Section 5.3(f)
, in the case of
clause (ii)
, within two
Business Days after such termination, and in the case of
clause (iii)
, upon the earlier of the announcement of its entering into a definitive agreement related to, consummation of any Qualifying Transaction.
(b) Notwithstanding anything to the contrary in this Agreement, if the Company Termination Fee shall become due and payable in accordance with
this
Section 7.3
, from and after such termination and payment of the Company Termination Fee in full pursuant to and in accordance with this
Section 7.3
, the Company shall have no further Liability of any kind for any reason
in connection with this Agreement or the termination contemplated hereby other than for any Liability arising from a Willful Breach of this Agreement as set forth in
Section 7.2
and this
Section 7.3
. Each of the parties
hereto acknowledges that the Company Termination Fee is not intended to be a penalty but rather is liquidated damages in a reasonable amount that will compensate Parent in the circumstances in which such Company Termination Fee is due and payable,
for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the transactions contemplated hereby, which amount would otherwise be
impossible to calculate with precision. In no event shall Parent be entitled to payment of the Company Termination Fee on more than one occasion.
(c) Each of the Company, Parent and Merger Sub acknowledges that the agreements contained in this
Section 7.3
are an integral part
of the transactions contemplated hereby, and that, without these agreements, the Company, Parent and Merger Sub would not enter into this Agreement. Accordingly, if the Company fails to pay in a timely manner the Company Termination Fee, then the
Company shall pay to Parent interest on such amount from and including the date payment of such amount was due to but excluding the date of actual payment at the prime rate set forth in
The Wall Street Journal
in effect on the date such
payment was required to be made plus 2% per annum.
A-47
ARTICLE VIII.
MISCELLANEOUS
Section 8.1
No Survival
. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument
delivered pursuant to this Agreement shall survive the Merger, except for covenants and agreements that contemplate performance after the Effective Time or otherwise expressly by their terms survive the Effective Time.
Section 8.2
Expenses; Transfer Taxes
.
(a) Except as otherwise provided in this Agreement (including in
Section 5.12(a)
, and
Section 7.3
), whether or not the
Merger is consummated, all costs and expenses incurred in connection with the Merger, this Agreement and the transactions contemplated hereby shall be paid by the party incurring or required to incur such expenses.
(b) Except as otherwise provided in
Section 2.2(d)
, all transfer, documentary, sales, use, stamp, registration and other such
similar non-income Taxes imposed with respect to the transfer of Company Common Stock pursuant to the Merger shall be borne by Parent or Merger Sub and expressly shall not be a liability of holders of Company Common Stock.
Section 8.3
Counterparts; Effectiveness
. This Agreement may be executed in counterparts, each of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of the parties and delivered (by telecopy, electronic delivery or otherwise) to
the other parties. Signatures to this Agreement transmitted by facsimile transmission, by electronic mail in portable document format (.pdf) form, or by any other electronic means intended to preserve the original graphic and
pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing the original signature.
Section 8.4
Governing Law
. This Agreement, and all claims or causes of action (whether at Law, in contract or in tort or
otherwise) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance hereof, shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any
choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.
Section 8.5
Jurisdiction; Specific Enforcement
.
(a) The parties rights in this
Section 8.5
are an integral part of the transactions contemplated by this Agreement and each
party hereby waives any objections to any remedy referred to in this
Section 8.5
. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed, or were threatened to
be not performed, in accordance with their specific terms or were otherwise breached, and that money damages would not be an adequate remedy, even if available. It is accordingly agreed that, in addition to any other remedy that may be available to
it, including monetary damages, each of the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement exclusively in
the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of
Delaware) (in addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative, except, in each case, as may be limited by
Section 7.3
). In the event any party seeks any remedy
referred to in this
Section 8.5
, such party shall not be required to prove damages or obtain, furnish, provide or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in
A-48
this
Section 8.5
and each party waives any objection to the imposition of such relief or any right it may have to require the obtaining, furnishing, providing or posting of any such
bond or similar instrument. In addition, each of the parties hereto irrevocably agrees that any legal action or proceeding with respect to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any
judgment in respect of this Agreement and the rights and obligations arising hereunder brought by the other party hereto or its successors or assigns, shall be brought and determined exclusively in the Delaware Court of Chancery and any state
appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware). Each of the parties hereto hereby
irrevocably submits with regard to any such action or proceeding for itself and in respect of its property, generally and unconditionally, to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any action relating to
this Agreement or any of the transactions contemplated by this Agreement in any court other than the aforesaid courts. Each of the parties hereto hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or
otherwise, in any action or proceeding with respect to this Agreement, (i) any claim that it is not personally subject to the jurisdiction of the above named courts, (ii) any claim that it or its property is exempt or immune from
jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (iii) to the
fullest extent permitted by applicable Law, any claim that (x) the suit, action or proceeding in such court is brought in an inconvenient forum, (y) the venue of such suit, action or proceeding is improper or (z) this Agreement, or
the subject matter hereof, may not be enforced in or by such courts. To the fullest extent permitted by applicable Law, each of the parties hereto hereby consents to the service of process in accordance with
Section 8.7
;
provided
,
however
, that nothing herein shall affect the right of any party to serve legal process in any other manner permitted by Law.
(b)
Notwithstanding the provisions of
Section 8.5(a)
and without limiting the provisions of
Section 8.15
, the Company (i) agrees that it will not, and will not permit its Affiliates to, bring or support any action, cause of
action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity and whether in contract or in tort or otherwise, against the Financing Sources in any way related to this Agreement or any of the transactions
contemplated by this Agreement (including any dispute arising out of or relating to the Financing or the performance thereof) in any forum other than the United States District Court for the Southern District of New York or the Supreme Court of the
State of New York, New York County, located in the Borough of Manhattan or, in either case, any appellate court thereof, (ii) agrees that any such action will be governed by the laws of the State of New York (except as otherwise set forth in
the Commitment Letter), (iii) agrees to waive and hereby waives, irrevocably and unconditionally, any right to a trial by jury in any such action and (iv) agrees to waive and hereby waives, to the fullest extent permitted by law, any
objection which such party may now or hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of, any such action in any such court.
Section 8.6
WAIVER OF JURY TRIAL
. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (INCLUDING ANY DISPUTE ARISING OUT OF OR RELATING TO THE FINANCING OR THE COMMITMENT LETTER OR THE PERFORMANCE OF SERVICES THEREUNDER OR RELATED
THERETO).
A-49
Section 8.7
Notices
. All notices and other communications hereunder shall be in
writing and shall be deemed given (a) upon personal delivery to the party to be notified; (b) when received when sent by email or facsimile by the party to be notified;
provided
,
however
, that notice given by email or
facsimile shall not be effective unless either (i) a duplicate copy of such email or fax notice is promptly given by one of the other methods described in this
Section 8.7
or (ii) the receiving party delivers a written
confirmation of receipt for such notice either by email or fax or any other method described in this
Section 8.7
; or (c) when delivered by a courier (with confirmation of delivery); in each case to the party to be notified at the
following address:
To Parent or Merger Sub:
The Sherwin-Williams Company
101
W. Prospect Ave.
Cleveland, Ohio 44115
|
Facsimile:
|
(216) 566-2947
|
|
Attention:
|
Sean P. Hennessy, Senior Vice President - Finance and Chief Financial Officer
|
|
|
Catherine M. Kilbane, Senior Vice President, General Counsel and Secretary
|
|
Email:
|
sphennessy@sherwin.com
|
|
|
cathy.kilbane@sherwin.com
|
with a copy (which shall not constitute notice) to:
Jones Day
222 East 41st Street
New York, New York 10017
|
Facsimile:
|
(212) 755-7306
|
|
Attention:
|
Robert A. Profusek, Esq.
|
|
Email:
|
raprofusek@jonesday.com
|
To the Company:
The Valspar Corporation
P.O. Box
1461
Minneapolis, Minnesota 55415
|
Facsimile:
|
(612) 486-7979
|
|
Attention:
|
Rolf Engh, Executive Vice President, General Counsel and Secretary
|
with a copy (which shall not constitute notice) to:
Wachtell, Lipton, Rosen & Katz
51 West 52nd Street
New York,
New York 10019
|
Facsimile:
|
(212) 403-2000
|
|
Attention:
|
Andrew R. Brownstein, Esq.
|
|
Email:
|
ARBrownstein@wlrk.com
|
or to such other address as any party shall specify by written notice so given, and such
notice shall be deemed to have been delivered as of the date so telecommunicated or personally delivered. Any party to this Agreement may notify any other party of any changes to the address or any of the other details specified in this
Section 8.7
;
provided
,
however
, that such notification shall only be effective on the date specified in such notice or five Business Days after the notice is given, whichever is later. Rejection or other refusal to accept
or the inability to deliver because of changed address of which no notice was given shall be deemed to be receipt of the notice as of the date of such rejection, refusal or inability to deliver.
A-50
Section 8.8
Assignment; Binding Effect
. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned or delegated by any of the parties hereto without the prior written consent of the other parties;
provided
,
however
, that each of Merger Sub and Parent may assign any of their rights
hereunder to a wholly owned direct or indirect Subsidiary of Parent without the prior written consent of the Company, but no such assignment shall relieve Parent or Merger Sub of any of its obligations hereunder. Subject to the first sentence of
this
Section 8.8
, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns. Any purported assignment not permitted under this
Section 8.8
shall be
null and void.
Section 8.9
Severability
. Any term or provision of this Agreement that is invalid or unenforceable in any
jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement in any other jurisdiction. If any
provision of this Agreement is so broad as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable.
Section 8.10
Entire Agreement
. This Agreement together with the exhibits hereto, schedules hereto and the Confidentiality
Agreement and the Joint Defense Agreement constitute the entire agreement, and supersede all other prior agreements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter hereof and
thereof, and this Agreement is not intended to grant standing to any Person other than the parties hereto.
Section 8.11
Amendments; Waivers
. At any time prior to the Effective Time, (i) any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by the Company,
Parent and Merger Sub and (ii)
Section 8.5
, this
Section 8.11
,
Section 8.13(b)
and
Section 8.15
may not be amended, supplemented, waived or otherwise modified in a manner adverse to the Financing
Sources without the prior written consent of the Financing Sources. Notwithstanding the foregoing, no failure or delay by any party hereto in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise of any other right hereunder.
Section 8.12
Headings
. Headings of the Articles
and Sections of this Agreement are for convenience of the parties only and shall be given no substantive or interpretive effect whatsoever. The table of contents to this Agreement is for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement.
Section 8.13
No Third-Party Beneficiaries
. Each of Parent, Merger Sub and the
Company agrees that (a) its representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other parties hereto, in accordance with and subject to the terms of this Agreement, and (b) this
Agreement is not intended to, and does not, confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, except for
Section 8.5
,
Section 8.11
, this
Section 8.13(b)
and
Section 8.15
which will inure to the benefit of the Financing Sources and their respective successors, legal representatives and permitted assigns,
all of whom are expressly intended to be third-party beneficiaries thereof and with respect to their rights thereunder. Notwithstanding the foregoing, each Company Indemnified Party shall be an express third-party beneficiary of and shall be
entitled to rely upon
Section 5.10
and this
Section 8.13
; and following the Effective Time each former stockholder of the Company shall be an express third-party beneficiary of and shall be entitled to obtain the Merger
Consideration to which it is entitled pursuant to the provisions hereof.
Section 8.14
Interpretation
. When a reference is
made in this Agreement to an Article or Section, such reference shall be to an Article or Section of this Agreement unless otherwise indicated. Whenever the words include, includes or including are used in this
Agreement, they shall be deemed to be followed by the words without limitation. The words hereof, herein and hereunder and words of similar import when used in this Agreement shall refer to this
Agreement as a whole and not to any particular provision of this Agreement, unless the
A-51
context otherwise requires. The word extent and the phrase to the extent when used in this Agreement shall mean the degree to which a subject or other thing extends, and
such word or phrase shall not mean simply if. All terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant thereto unless otherwise defined therein. The
definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such terms. References in this Agreement to specific laws or to
specific provisions of laws shall include all rules and regulations promulgated thereunder. Each of the parties has participated in the drafting and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this
Agreement must be construed as if it is drafted by all the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of authorship of any of the provisions of this Agreement.
Section 8.15
Liability of Financing Sources
. Notwithstanding anything to the contrary contained herein, the Company agrees that it
will not have any rights or claims against any Financing Source (in their capacity as such) or any of their respective officers, directors, employees, agents, advisors and representatives in connection with this Agreement, the Financing or the
transactions contemplated hereby or thereby, whether at law or in equity, in Contract, tort or otherwise.
Section 8.16
Definitions
.
(a)
General Definitions
. References in this Agreement to
Subsidiaries
of any party means
any corporation, partnership, association, trust or other form of legal entity of which (i) 50% or more of the voting power of the outstanding voting securities are directly or indirectly owned by such party or (ii) such party or any
Subsidiary of such party is a general partner. References in this Agreement (except as specifically otherwise defined) to
Affiliates
means, as to any Person, any other Person which, directly or indirectly, controls, or is
controlled by, or is under common control with, such Person. As used in this definition,
control
(including, with its correlative meanings,
controlled by
and
under common control with
) means
the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by contract or otherwise. As used
in this Agreement,
knowledge
means (i) with respect to Parent and its Subsidiaries, the actual knowledge of the individuals listed in Section 8.16(a) of the Parent Disclosure Schedule and (ii) with respect to the
Company and its Subsidiaries, the actual knowledge of the individuals listed on Section 8.16(a) of the Company Disclosure Schedule.
(b)
Certain Specified Definitions
. As used in this Agreement:
(i)
Adjusted Per Share Price
means $105.00 per share in cash.
(ii)
Acceptable Confidentiality Agreement
means any confidentiality agreement that contains confidentiality
provisions that are, in the aggregate, no less favorable to the Company than those contained in the Confidentiality Agreement.
(iii)
Baseline Per Share Price
means $113.00 per share in cash.
(iv)
Bribery Legislation
means all and any of the following: the FCPA; the Organization For Economic
Co-operation and Development Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and related implementing legislation; the relevant common law or legislation in England and Wales relating to bribery
and/or corruption, including, the Public Bodies Corrupt Practices Act 1889; the Prevention of Corruption Act 1906 as supplemented by the Prevention of Corruption Act 1916 and the Anti-Terrorism, Crime and Security Act 2001; the Bribery Act 2010; the
Proceeds of Crime Act 2002; and any applicable anti-bribery or anti-corruption related provisions in criminal and anti-competition laws and/or anti-bribery, anti-corruption and/or anti-money laundering laws of any jurisdiction in which the Company
or any of its Subsidiaries operates.
(v)
Business Day
means any day other than a Saturday, Sunday or
any other day on which commercial banks in New York, New York are authorized or required by Law to remain closed.
A-52
(vi)
Business Plan
means the Companys 2016 business
plan, a copy of which was made available to Parent prior to the date hereof.
(vii)
Code
means the
Internal Revenue Code of 1986, as amended.
(viii)
Company Benefit Plan
means each compensatory or
employee benefit plan, program, agreement or arrangement, including pension, retirement, profit-sharing, deferred compensation, stock option, change in control, retention, equity or equity-based compensation, stock purchase, employee stock
ownership, severance pay, vacation, bonus or other incentive plans, medical, retiree medical, vision, dental or other health plans, life insurance plans, and each other material employee benefit plan or fringe benefit plan, including any
employee benefit plan as that term is defined in Section 3(3) of ERISA, in each case, whether oral or written, funded or unfunded, or insured or self-insured, (A) that is maintained by the Company or any Subsidiary for the
benefit of any current or former employee, officer or director of the Company or any Subsidiary, or (B) to which the Company or any Subsidiary contributes or is obligated to contribute or would reasonably be expected to have any Liability,
other than a Multiemployer Plan and other than any plan or program maintained by a Governmental Entity to which the Company or any of its affiliates contribute pursuant to applicable Laws.
(ix)
Company Equity Awards
means the Company Options, Company RSU Awards, Company PSU Awards and Company
Restricted Shares.
(x)
Company Information
means: (i)(A) audited consolidated balance sheets and
related statements of income, comprehensive income, stockholders equity and cash flows of the Company for the three most recently completed fiscal years ended at least 60 days prior to the Closing Date prepared in accordance with GAAP and
(B) unaudited interim consolidated balance sheets and related statements of income, comprehensive income, stockholders equity and cash flows of the Company for each subsequent fiscal quarter ended at least 40 days prior to the Closing
Date (but excluding any fourth quarter of any fiscal year) prepared in accordance with GAAP and reviewed by the auditors of the Company as provided in Statement on Auditing Standards No. 100, in each case of the type and form required by SEC
Regulation S-X for registered offerings of securities under the Securities Act; and (ii) in each case to the extent reasonably available or readily obtainable by the Company, audit reports and draft comfort letters (including negative
assurance comfort), in each case, to the extent the auditors are prepared to deliver such audit reports and draft comfort letters and solely upon completion of customary procedures, and any information reasonably necessary for the preparation
of the pro forma financial statements by Parent for use in a registered offering of securities under the Securities Act, provided that such other information is reasonably requested in writing by Parent and is of the type and only to the extent
required by Regulation S-X and Regulation S-K of the SEC and other accounting rules and regulations of the SEC for registered offerings of securities under the Securities Act or that is customarily included in an offering memorandum for the private
placement of high yield securities pursuant to Rule 144A promulgated under the Securities Act; and will use reasonable best efforts to provide such financial information (x) such that when taken as a whole it does not or will not contain any
untrue statement of a material fact or omit to state any material fact necessary in order to make such information, in light of the circumstances under which they were made, not misleading, and (y) if applicable, as to which the Companys
auditors have not withdrawn any audit opinion with respect to any financial statements contained therein.
(xi)
Company Superior Proposal
means a Company Takeover Proposal, substituting fifty percent (50%) for twenty percent (20%), that the Company Board of Directors determines in good faith, after consultation with
the Companys independent financial advisors and outside legal counsel, taking into account the timing, likelihood of consummation, legal, financial, regulatory and other aspects of the Company Takeover Proposal, including the financing terms
thereof, and such other factors as the Company Board of Directors considers to be appropriate, to be more favorable to the Company and its stockholders than the transactions contemplated by this Agreement.
A-53
(xii)
Company Takeover Proposal
means any
bona fide
proposal or offer made by any Person or group of related Persons (other than Parent and its Subsidiaries), and whether involving a transaction or series of related transactions, for (i) a merger, reorganization, share exchange, consolidation,
business combination, recapitalization, dissolution, liquidation or similar transaction involving the Company, (ii) the acquisition by any Person or group of related Persons (other than Parent and its Subsidiaries) of more than twenty percent
(20%) of the assets of the Company and its Subsidiaries, on a consolidated basis (in each case, including securities of the Subsidiaries of the Company), or (iii) the direct or indirect acquisition by any Person or group of related Persons
(other than Parent and its Subsidiaries) of more than twenty percent (20%) of the shares of Company Common Stock then issued and outstanding.
(xiii)
Company Termination Fee
means a cash amount equal to $300,000,000.00.
(xiv)
Contract
means any contract, note, bond, mortgage, indenture, deed of trust, license, lease,
agreement, arrangement, commitment or other instrument or obligation that is legally binding, whether written or oral.
(xv)
Environmental Law
means any Law or common law (A) relating to pollution or the protection,
preservation or restoration of the environment (including indoor or outdoor air, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource), or any exposure to or Release
of, or the management of (including the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, sale, distribution, manufacture, notification, reporting, registration, importing or disposal of) any
Hazardous Materials or products containing Hazardous Materials or relating to human health and safety with respect to any Hazardous Materials or (B) that regulates, imposes liability (including for enforcement, investigatory costs, cleanup,
removal or response costs, natural resource damages, contribution, injunctive relief, personal injury or property damage) or establishes standards of care with respect to any of the foregoing.
(xvi)
ERISA Affiliate
means, with respect to any entity, trade or business, any other entity, trade or
business that is, or was at the relevant time, a member of a group described in Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is,
or was at the relevant time, a member of the same controlled group as the first entity, trade or business pursuant to Section 4001(a)(14) of ERISA.
(xvii)
Financing
means the debt financing incurred or intended to be incurred pursuant to the Commitment
Letter, including the offering or private placement of debt securities or borrowing of loans contemplated by the Commitment Letter and any related engagement letter.
(xviii)
Financing Sources
means the entities that have committed to provide or arrange or otherwise have
entered into agreements pursuant to the Commitment Letter or in connection with all or any part of the Financing described therein, or replacement debt financings, in connection with the transactions contemplated hereby, including the parties to any
commitment letters, joinder agreements, indentures or credit agreements entered pursuant thereto or relating thereto.
(xix)
Governmental Entity
means any federal, state, local or foreign government, any transnational
governmental organization or any court of competent jurisdiction, arbitral, administrative agency or commission or other governmental authority or instrumentality, domestic or foreign.
(xx)
Hazardous Materials
means all substances or materials defined or regulated as hazardous, a pollutant or
a contaminant or otherwise under any Environmental Law, including any regulated pollutant or contaminant (including any constituent, raw material, product or by-product thereof), petroleum or natural gas hydrocarbons or any liquid or fraction
thereof, asbestos or asbestos-containing material, polychlorinated biphenyls, any hazardous or solid waste, and any toxic, radioactive, infectious or hazardous substance, material or agent.
A-54
(xxi)
Indebtedness
means, with respect to any Person, without
duplication, as of the date of determination: (A) all obligations of such Person for borrowed money, including accrued and unpaid interest, and any prepayment fees or penalties, (B) all obligations of such Person evidenced by bonds,
debentures, notes or similar instruments, (C) all obligations of such Person issued or assumed as the deferred purchase price of property (including any potential future earn-out, purchase price adjustment, release of holdback or
similar payment, but excluding obligations of such Person incurred in the ordinary course of business), (D) all lease obligations of such Person capitalized on the books and records of such Person, (E) all Indebtedness of others secured by
a Lien on property or assets owned or acquired by such Person, whether or not the Indebtedness secured thereby have been assumed, (F) all obligations of such Person under interest rate, currency or commodity derivatives or hedging transactions
or similar arrangement (valued at the termination value thereof), (G) all letters of credit or performance bonds issued for the account of such Person, to the extent drawn upon, and (H) all guarantees of such Person of any Indebtedness of
any other Person other than a wholly owned subsidiary of such Person.
(xxii)
Intellectual Property
means all intellectual property and similar proprietary rights existing anywhere in the world associated with: (A) patents, including design patents and utility patents, and patent applications, including continuations, divisionals,
continuations-in-part, utility models, reissues or reexaminations and patents issuing thereon (collectively,
Patents
), (B) trademarks, service marks, trade dress, logos, corporate names, trade names and Internet domain names,
together with the goodwill associated with any of the foregoing, and all applications and registrations therefor (collectively,
Marks
), (C) copyrights (including such rights in software) and registrations and applications
therefor, and works of authorship (collectively,
Copyrights
), (D) designs, databases and data compilations, and (E) trade secrets and other proprietary and confidential information, including know-how, inventions
(whether or not patentable), processes, formulations, technical data and designs, in each case excluding any rights in respect of any of the foregoing that comprise or are protected by Patents (collectively,
Trade Secrets
).
(xxiii)
Intervening Event
means any material change, event, effect, occurrence, consequence or development
relating to the Company that (A) is unknown and not reasonably foreseeable as of the date hereof and (B) does not relate to any Company Takeover Proposal.
(xxiv)
IT Assets
means the computers, software and software platforms, databases, websites, servers,
routers, hubs, switches, circuits, networks, data communications lines and all other information technology infrastructure and equipment of the Company and its Subsidiaries that are required in connection with the operation of the business of the
Company and its Subsidiaries.
(xxv)
Liability
means any and all debts, liabilities and obligations,
whether fixed, contingent or absolute, matured or unmatured, accrued or not accrued, determined or determinable, secured or unsecured, disputed or undisputed, subordinated or unsubordinated, or otherwise.
(xxvi)
made available
to Parent and words of similar import means that, at 5:00 p.m. at least one Business
Day prior to the date hereof, the information or document (i) has been posted to the electronic data site maintained by the Company in connection with the transactions contemplated by this Agreement, (ii) has been included in any SEC
Document of the Company publicly filed with the SEC from and after November 1, 2014 and prior to the date hereof, or (iii) has been sent via email to Parents internal or external counsel.
(xxvii)
Material Adverse Effect
means, with respect to the Company, (a) any change, fact, effect,
event, occurrence or development that has a material adverse effect on the business, operations or financial condition of the Company and its Subsidiaries taken as a whole, excluding, however, the impact of (i) any changes or developments in
domestic or any foreign market or domestic, foreign or global economic conditions generally, including (A) any changes or developments in or affecting the domestic or any foreign securities, equity, credit or financial markets or (B) any
changes or developments in or affecting domestic or any foreign interest or exchange rates, (ii) changes in GAAP
A-55
or any official interpretation or enforcement thereof, (iii) changes in Law or any changes or developments in the official interpretation or enforcement thereof by Governmental Entities,
(iv) changes in domestic, foreign or global political conditions (including the outbreak or escalation of war, military actions, or acts of terrorism), including any worsening of such conditions threatened or existing on the date of this
Agreement, (v) changes or developments in the business or regulatory conditions affecting the industries in which the Company or any of its Subsidiaries operate, (vi) the announcement of this Agreement or the transactions contemplated
hereby (including the impact thereof on the relationships, contractual or otherwise, of the Company or any of its Subsidiaries with employees, labor unions, financing sources, customers, suppliers or partners), (vii) weather conditions or other
acts of God (including storms, earthquakes, tornados, floods or other natural disasters), (viii) the loss of business with customers that are or become major customers of Parent or its Subsidiaries, (ix) a decline in the trading price or
trading volume of the Companys common stock or any change in the ratings or ratings outlook for the Company or any of its Subsidiaries but not, in any case, the underlying causes thereof, (x) the failure to meet any projections, guidance,
budgets, forecasts or estimates, but not, in any case, including the underlying causes thereof, (xi) any action taken or omitted to be taken by the Company or any of its Subsidiaries at the written request of Parent, and (xii) any actions
or claims made or brought by any of the current or former stockholders of the Company (or on their behalf or on behalf of the Company) against the Company or any of its directors, officers or employees arising out of this Agreement or the Merger;
except, with respect to
clauses (i)
,
(ii)
,
(iii)
,
(iv)
,
(v)
and
(vii)
, to the extent that such impact is disproportionately adverse to the Company and its Subsidiaries, taken as a whole, relative to
others in the industry or industries in which the Company and its Subsidiaries operate.
(xxviii)
Net
Sales
means net sales, it being agreed that the calculation of net sales with respect to any asset, business or product line shall be measured by reference to the net sales for the corresponding asset, business or product line of the
Company (using the net sales associated therewith for the fiscal year ended October 30, 2015), regardless of which asset, business or product line is actually divested;
provided
,
however
, that the net sales associated with any
asset, business or product line of the Company or its Subsidiaries involved in the manufacture, distribution or sale of architectural coatings in Australia shall not count towards the $650,000,000.00 set forth in the definition of Triggering
Divestiture or the $1,500,000,000.00 set forth in
Section 5.7(d)
;
provided
,
further
, that the net sales associated with any asset, business or product line of Parent or its Subsidiaries involved in the manufacture,
distribution or sale of architectural coatings in Australia shall count towards the aforesaid $650,000,000.00 or the aforesaid $1,500,000,000.00.
(xxix)
Non-U.S. Company Benefit Plan
means each Company Benefit Plan that is maintained outside the
jurisdiction of the United States.
(xxx)
Order
means any charge, order, writ, injunction, judgment,
decree, ruling, determination, directive, award or settlement, whether civil, criminal or administrative.
(xxxi)
Parent Material Adverse Effect
means, with respect to Parent, any fact, change, event, occurrence or development that has a material adverse effect on Parents ability to timely consummate the transactions contemplated hereby
(including the Merger and obtaining the financing necessary to pay the Merger Consideration or any other Merger Amount).
(xxxii)
Permitted Lien
means (A) any Lien for Taxes not yet delinquent or that are being contested in
good faith by appropriate proceedings or for which adequate reserves have been established by the Company in accordance with GAAP, (B) vendors, mechanics, materialmens, carriers, workers, landlords,
repairmens, warehousemens, construction and other similar Liens (i) with respect to Liabilities that are not yet due and payable or, if due, are not delinquent or (ii) that are being contested in good faith by appropriate
proceedings and for which adequate reserves (based on good faith estimates of management) have been set aside for the payment thereof or (iii) arising or incurred in the ordinary and usual course of business and which are not, individually or
in the aggregate, material to the business operations of the Company and its Subsidiaries and do not
A-56
materially adversely affect the market value or continued use of the asset encumbered thereby, (C) Liens imposed or promulgated by applicable Law or any Governmental Entity with respect to
real property, including zoning, building or similar restrictions but only to the extent that the Company and its Subsidiaries and their assets are materially in compliance with the same, (D) pledges or deposits in connection with workers
compensation, unemployment insurance, and other social security legislation, (E) Liens relating to intercompany borrowings among a Person and its wholly owned Subsidiaries, (F) utility easements, minor encroachments, rights of way,
imperfections in title, charges, easements, rights of way (whether recorded or unrecorded), restrictions, declarations, covenants, conditions, defects and similar Liens, but not including any monetary Liens, that are imposed by any Governmental
Entity having jurisdiction thereon or otherwise are typical for the applicable property type and locality as do not individually or in the aggregate materially interfere with the present occupancy or use or market value of the respective Company
Owned Real Property or Company Leased Real Property or otherwise materially impair the business operations of the Company and its Subsidiaries, (G) Liens that have not had or would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.
(xxxiii)
Per Share Price
means the Baseline Per Share Price;
provided
that if and only if a Triggering Event occurs, the Per Share Price shall mean the Adjusted Per Share Price.
(xxxiv)
Person
means an individual, a corporation, a partnership, a limited liability company, an
association, a trust or any other entity, group (as such term is used in Section 13 of the Exchange Act) or organization, including a Governmental Entity and any permitted successors and assigns of such person.
(xxxv)
Release
means any actual or threatened release, spill, emission, discharge, leaking, pumping,
injection, deposit, disposal, dispersal, leaching or migration into the indoor or outdoor environment (including ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including the movement of
Hazardous Materials through or in the air, soil, surface water, groundwater or property.
(xxxvi)
Sanctioned
Country
means any of Crimea, Cuba, Iran, North Korea, Sudan and Syria.
(xxxvii)
Sanctioned
Person
means any Person with whom dealings are restricted or prohibited under the Sanctions Laws of the United States, the United Kingdom, the European Union, or the United Nations, including (A) any Person identified in any list of
sanctioned person maintained by (i) the United States Department of Treasury, Office of Foreign Assets Control, the United States Department of Commerce, Bureau of Industry and Security, or the United States Department of State; (ii) Her
Majestys Treasury of the United Kingdom; (iii) any committee of the United Nations Security Council; or (iv) the European Union; (B) any Person located, organized, or resident in, organized in, or a Governmental Entity or
government instrumentality of, any Sanctioned Country and (C) any Person directly or indirectly 50% or more owned or controlled by, or acting for the benefit or on behalf of, a Person described in
clause (A)
or
(B)
.
(xxxviii)
Sanctions Laws
means all Laws concerning economic sanctions, including embargoes, export
restrictions, the ability to make or receive international payments, the freezing or blocking of assets of targeted Person, the ability to engage in transactions with specified Persons or countries, or the ability to take an ownership interest in
assets of specified Person or located in a specified country, including any Laws threatening to impose economic sanctions on any Person for engaging in proscribed behavior.
(xxxix)
SEC Document
means all forms, documents and reports filed or furnished by the Company or any of its
Subsidiaries, including all exhibits thereto and documents incorporated by reference therein.
(xl)
Sensitive
Data
means cardholder data and sensitive authentication data that must be protected in accordance with the requirements of the Payment Card Industry Data Security Standard.
A-57
(xli)
Significant Subsidiary
has the meaning ascribed to it in
Rule 1.02(w) of Regulation S-X promulgated pursuant to the Exchange Act.
(xlii)
Substantive
Communication
means any communication relating to merits; remedies (including divestitures and potential divestiture buyers, any consent decree or other settlement agreement or any regulatory commission vote); timing agreement; or timing
of any significant decision or significant action in connection with any regulatory approval or clearance.
(xliii)
Tax
or
Taxes
means any and all federal, state, local or foreign taxes, imposts, levies or other similar assessments imposed by any Taxing Authority, including all net income, gross receipts, capital, sales, use,
ad valorem, value added, transfer, franchise, profits, inventory, capital stock, license, withholding, payroll, employment, social security, unemployment, excise, severance, environmental, stamp, occupation, premium, property (real or personal) and
estimated taxes, customs duties and other taxes of any kind whatsoever, including any and all interest, penalties, additions to tax or additional amounts imposed by any Governmental Entity with respect thereto.
(xliv)
Tax Return
means any return, declaration, election, report or similar filing (including any attached
schedules, supplements and additional or supporting material) required to be filed with respect to Taxes, including any information return, claim for refund, or declaration of estimated Taxes (and including any amendments thereof), or with respect
to or accompanying requests for the extension of time in which to file any such report, declaration, election, report or similar filing and including TD Form 90-22.1 (and its successor form, FinCEN Form 114).
(xlv)
Taxing Authority
means, with respect to any Tax, the Governmental Entity that imposes such Tax, and
the agency (if any) charged with the administration or collection of such Tax for such Governmental Entity.
(xlvi)
Top Customers
means those customers of the Company and its Subsidiaries that are the top 10 customers measured by dollar value of total sales for the twelve months ended October 30, 2015, and are set forth on
Section 3.22(a) of the Company Disclosure Schedule.
(xlvii)
Top Suppliers
means those suppliers of
the Company and its Subsidiaries that are the top 10 suppliers measured by dollar value of the total sales for the twelve months ended October 30, 2015, and are set forth on Section 3.22(b) of the Company Disclosure Schedule.
(xlviii)
Triggering Divestiture
means the divestiture, license, hold separate, sale or other disposition,
solely to the extent necessary to fulfill the conditions set forth in
Section 6.1(b)
(solely to the extent necessary under any Antitrust Law) or
Section 6.1(c)
, of or with respect to all of the assets, businesses or product
lines of the Company, Parent or any of their respective Subsidiaries representing, in the aggregate, in excess of $650,000,000.00 of Net Sales.
(xlix)
Triggering Event
shall be deemed to have occurred if and only if Parent is required pursuant to
Section 5.7
to take, or cause to be taken, or commit to take, or cause to be taken, any action constituting a Triggering Divestiture.
(l)
U.S. Company Benefit Plan
means, each Company Benefit Plan that is not a Non-U.S. Company Benefit Plan.
(li)
Willful Breach
means, with respect to any representation, warranty, agreement or covenant, an
action or omission where the breaching party knows such action or omission is, or would reasonably be expected to result in, a breach of such representation, warranty, agreement or covenant.
A-58
Index of Defined Terms
|
|
|
|
|
Acceptable Confidentiality Agreement
|
|
|
8.16(b)(ii)
|
|
Adjusted Option
|
|
|
2.3(a)
|
|
Adjusted Per Share Price
|
|
|
8.16(b)(i)
|
|
Adjusted RSU Award
|
|
|
2.3(b)
|
|
Affiliates
|
|
|
8.16(a)
|
|
Agreement
|
|
|
Preamble
|
|
Alternative Financing
|
|
|
5.12(d)
|
|
Antitrust Law
|
|
|
3.3(b)
|
|
Antitrust Laws
|
|
|
3.3(b)
|
|
Appraisal Provisions
|
|
|
2.1(b)
|
|
Baseline Per Share Price
|
|
|
8.16(b)(iii)
|
|
Book-Entry Shares
|
|
|
2.1(a)
|
|
Bribery Legislation
|
|
|
8.16(b)(iv)
|
|
Business Day
|
|
|
8.16(b)(v)
|
|
Business Plan
|
|
|
8.16(b)(vi)
|
|
Cancelled Shares
|
|
|
2.1(a)(ii)
|
|
Certificate
|
|
|
2.1(a)
|
|
Certificate of Merger
|
|
|
1.3
|
|
Closing
|
|
|
1.2
|
|
Closing Date
|
|
|
1.2
|
|
Code
|
|
|
8.16(b)(vii)
|
|
Collective Bargaining Agreement
|
|
|
3.14(a)
|
|
Commitment Letter
|
|
|
4.8(a)
|
|
Company
|
|
|
Preamble
|
|
Company 401(k) Plan
|
|
|
5.6(a)
|
|
Company Acquisition Agreement
|
|
|
5.3(e)
|
|
Company Adverse Recommendation Change
|
|
|
5.3(e)
|
|
Company Benefit Plan
|
|
|
8.16(b)(viii)
|
|
Company Board of Directors
|
|
|
Recitals
|
|
Company Common Stock
|
|
|
3.2(a)
|
|
Company Disclosure Schedule
|
|
|
Article III
|
|
Company Employees
|
|
|
5.6(a)
|
|
Company Equity Awards
|
|
|
8.16(b)(ix)
|
|
Company Financial Statements
|
|
|
3.4(b)
|
|
Company Information
|
|
|
8.16(b)(x)
|
|
Company Leased Real Property
|
|
|
3.8
|
|
Company Material Contracts
|
|
|
3.17(a)
|
|
Company Notes
|
|
|
5.12(f)
|
|
Company Option
|
|
|
2.3(a)
|
|
Company Organizational Documents
|
|
|
3.1(b)
|
|
Company Owned Real Property
|
|
|
3.8
|
|
Company Permits
|
|
|
3.7(b)
|
|
Company Product
|
|
|
3.21
|
|
Company PSU Award
|
|
|
2.3(b)
|
|
Company Recommendation
|
|
|
3.3(a)
|
|
Company Registered Intellectual Property
|
|
|
3.15(a)
|
|
Company Restricted Share
|
|
|
2.3(c)
|
|
Company RSU Award
|
|
|
2.3(b)
|
|
Company SEC Documents
|
|
|
3.4(a)
|
|
Company Severance Plan
|
|
|
5.6(a)
|
|
A-59
|
|
|
|
|
Company Superior Proposal
|
|
|
8.16(b)(xi)
|
|
Company Takeover Proposal
|
|
|
8.16(b)(xii)
|
|
Company Termination Fee
|
|
|
8.16(b)(xiii)
|
|
Confidentiality Agreement
|
|
|
5.2(c)
|
|
Continuation Period
|
|
|
5.6(b)
|
|
Contract
|
|
|
8.16(b)(xiv)
|
|
Copyrights
|
|
|
8.16(b)(xxii)
|
|
Credit Agreement
|
|
|
5.13
|
|
D&O Insurance
|
|
|
5.10(c)
|
|
Debt Offers
|
|
|
5.12(e)
|
|
Debt Offer Documents
|
|
|
5.12(f)
|
|
Definitive Debt Financing Agreements
|
|
|
5.12(a)
|
|
DGCL
|
|
|
1.1
|
|
Dissenting Shares
|
|
|
2.1(b)
|
|
Dissenting Stockholder
|
|
|
2.1(b)
|
|
DOL
|
|
|
3.9(a)
|
|
DTC
|
|
|
5.12(f)
|
|
Effective Time
|
|
|
1.3
|
|
End Date
|
|
|
7.1(b)
|
|
Enforceability Exceptions
|
|
|
3.3(a)
|
|
Environmental Law
|
|
|
8.16(b)(xv)
|
|
Equity Award Exchange Ratio
|
|
|
2.3(a)
|
|
ERISA Affiliate
|
|
|
8.16(b)(xvi)
|
|
Exchange Act
|
|
|
3.3(b)
|
|
Existing Credit Facility Termination
|
|
|
5.13(a)
|
|
Extended End Date
|
|
|
7.1(b)
|
|
FCPA
|
|
|
3.7(c)
|
|
Financing
|
|
|
8.16(b)(xvii)
|
|
Financing Conditions
|
|
|
4.8(b)
|
|
Financing Sources
|
|
|
8.16(b)(xviii)
|
|
First Extended End Date
|
|
|
7.1(b)
|
|
GAAP
|
|
|
3.4(b)
|
|
Governmental Entity
|
|
|
8.16(b)(xix)
|
|
Hazardous Materials
|
|
|
8.16(b)(xx)
|
|
HSR Act
|
|
|
3.3(b)
|
|
Indebtedness
|
|
|
8.16(b)(xxi)
|
|
Indemnified Parties
|
|
|
5.10(a)
|
|
Indemnity Agreement
|
|
|
5.10(a)
|
|
Insurance Policies
|
|
|
3.20
|
|
Intellectual Property
|
|
|
8.16(b)(xxii)
|
|
Intervening Event
|
|
|
8.16(b)(xxiii)
|
|
IRS
|
|
|
3.9(a)
|
|
IT Assets
|
|
|
8.16(b)(xxiv)
|
|
Law
|
|
|
3.7(a)
|
|
Laws
|
|
|
3.7(a)
|
|
Letter of Transmittal
|
|
|
2.2(c)
|
|
Liability
|
|
|
8.16(b)(xxv)
|
|
Lien
|
|
|
3.3(c)
|
|
Material Adverse Effect
|
|
|
8.16(b)(xxvii)
|
|
Marks
|
|
|
8.16(b)(xxii)
|
|
Merger
|
|
|
Recital
|
|
Merger Amounts
|
|
|
4.7(g)
|
|
A-60
|
|
|
|
|
Merger Consideration
|
|
|
Recitals
|
|
Merger Sub
|
|
|
Preamble
|
|
Multiemployer Plan
|
|
|
3.9(e)
|
|
Net Sales
|
|
|
8.16(b)(xxviii)
|
|
Non-U.S. Company Benefit Plan
|
|
|
8.16(b)(xxx)
|
|
Offering Documents
|
|
|
5.12(e)
|
|
Order
|
|
|
8.16(b)(xxix)
|
|
Original End Date
|
|
|
7.1(b)
|
|
Parent
|
|
|
Preamble
|
|
Parent Disclosure Schedule
|
|
|
Article IV
|
|
Parent Financial Statements
|
|
|
4.4(b)
|
|
Parent Material Adverse Effect
|
|
|
8.16(b)(xxxi)
|
|
Parent SEC Documents
|
|
|
4.4(a)
|
|
Parent 401(k) Plan
|
|
|
5.6(a)
|
|
Patents
|
|
|
8.16(b)(xxii)
|
|
Paying Agent
|
|
|
2.2(a)
|
|
Payment Fund
|
|
|
2.2(b)
|
|
PBGC
|
|
|
3.9(a)
|
|
Per Share Price
|
|
|
8.16(b)(xxxii)
|
|
Permits
|
|
|
3.7(b)
|
|
Permitted Lien
|
|
|
8.16(b)(xxxiii)
|
|
Person
|
|
|
8.16(b)(xxxiv)
|
|
Post-Closing Plans
|
|
|
5.6(b)
|
|
Proxy Statement
|
|
|
3.3(b)
|
|
Qualified Plan
|
|
|
3.9(c)
|
|
Qualifying Transaction
|
|
|
7.3(a)
|
|
Release
|
|
|
8.16(b)(xxxv)
|
|
Representatives
|
|
|
5.3(a)
|
|
Requisite Company Vote
|
|
|
3.3(a)
|
|
Sanctioned Country
|
|
|
8.16(b)(xxxvi)
|
|
Sanctioned Person
|
|
|
8.16(b)(xxxvii)
|
|
Sanctions Laws
|
|
|
8.16(b)(xxxviii)
|
|
Sarbanes-Oxley Act
|
|
|
3.4(a)
|
|
SEC
|
|
|
3.3(b)
|
|
SEC Document
|
|
|
8.16(b)(xxxix)
|
|
Second Extended End Date
|
|
|
7.1(b)
|
|
Second Request
|
|
|
5.7(c)
|
|
Securities Act
|
|
|
3.4(a)
|
|
Sensitive Data
|
|
|
8.16(b)(xl)
|
|
Significant Subsidiaries Organizational Documents
|
|
|
3.1(b)
|
|
Significant Subsidiary
|
|
|
8.16(b)(xli)
|
|
Specified Acquisition
|
|
|
5.1(c)
|
|
Specified Date
|
|
|
3.2(a)
|
|
Stock Purchase Program
|
|
|
2.3(d)
|
|
Stockholders Meeting
|
|
|
5.5
|
|
Subsidiaries
|
|
|
8.16(a)
|
|
Surviving Company
|
|
|
1.1
|
|
Takeover Statute
|
|
|
5.8
|
|
Tax
|
|
|
8.16(b)(xliii)
|
|
Tax Return
|
|
|
8.16(b)(xliv)
|
|
Taxes
|
|
|
8.16(b)(xliii)
|
|
Taxing Authority
|
|
|
8.16(b)(xlv)
|
|
A-61
|
|
|
|
|
Top Customers
|
|
|
8.16(b)(xlvi)
|
|
Top Suppliers
|
|
|
8.16(b)(xlvii)
|
|
Trade Secrets
|
|
|
8.16(b)(xxii)
|
|
Transaction Approvals
|
|
|
3.3(b)
|
|
Triggering Divestiture
|
|
|
8.16(b)(xlviii)
|
|
Triggering Event
|
|
|
8.16(b)(xlix)
|
|
U.S. Company Benefit Plan
|
|
|
8.16(b)(xl)
|
|
Willful Breach
|
|
|
8.16(b)(li)
|
|
[SIGNATURE PAGE FOLLOWS]
A-62
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered as of the date first above written.
|
|
|
THE VALSPAR CORPORATION
|
|
|
By:
|
|
/s/ Gary E. Hendrickson
|
Name:
|
|
Gary E. Hendrickson
|
Title:
|
|
Chairman and Chief Executive Officer
|
[Signature Page to the Agreement and Plan of Merger]
A-63
|
|
|
THE SHERWIN-WILLIAMS COMPANY
|
|
|
By:
|
|
/s/ John G. Morikis
|
Name:
|
|
John G. Morikis
|
Title:
|
|
President and Chief Executive Officer
|
|
VIKING MERGER SUB, INC.
|
|
|
By:
|
|
/s/ John G. Morikis
|
Name:
|
|
John G. Morikis
|
Title:
|
|
President and Chief Executive Officer
|
[Signature Page to the Agreement and Plan of Merger]
A-64
Annex B
CONFIDENTIAL
March 19, 2016
The Board of Directors
The Valspar Corporation
1101 South Third Street
Minneapolis, MN 55415
Members of the Board of Directors:
We understand that The
Valspar Corporation (Valspar) proposes to enter into the Agreement and Plan of Merger, dated March 19, 2016 (the Agreement), among Valspar, The Sherwin-Williams Company (Sherwin-Williams) and Viking Merger
Sub, Inc., a wholly owned subsidiary of Sherwin-Williams (Merger Sub), pursuant to which, among other things, Merger Sub will merge with and into Valspar (the Merger) and each outstanding share of the common stock, par value
$0.50 per share, of Valspar (Valspar Common Stock), other than Cancelled Shares and Dissenting Shares (each as defined in the Agreement), will be converted into the right to receive $113 in cash (the Non-Triggering Event
Consideration); provided that if and only if a Triggering Event (as defined in the Agreement) occurs, each outstanding share of Valspar Common Stock will be converted into the right to receive $105 in cash (the Triggering Event
Consideration, together with the Non-Triggering Event Consideration, the Consideration). The terms and conditions of the Merger are more fully set forth in the Agreement.
You have requested our opinion as to the fairness, from a financial point of view, to the holders of Valspar Common Stock of the Consideration, whether or not
a Triggering Event occurs, to be received by such holders in the Merger.
In connection with this opinion, we have, among other things:
|
(i)
|
reviewed certain publicly available business and financial information relating to Valspar;
|
|
(ii)
|
reviewed certain internal financial and operating information with respect to the business, operations and prospects of Valspar furnished to or discussed with us by the management of Valspar, including certain financial
forecasts relating to Valspar prepared by the management of Valspar (such forecasts, Valspar Forecasts);
|
|
(iii)
|
discussed the past and current business, operations, financial condition and prospects of Valspar with members of senior management of Valspar;
|
|
(iv)
|
reviewed the trading history for Valspar Common Stock and a comparison of that trading history with the trading histories of other companies we deemed relevant;
|
|
(v)
|
compared certain financial and stock market information of Valspar with similar information of other companies we deemed relevant;
|
|
(vi)
|
compared certain financial terms of the Merger to financial terms, to the extent publicly available, of other transactions we deemed relevant;
|
|
(vii)
|
reviewed a draft, dated March 19, 2016, of the Agreement; and
|
|
(viii)
|
performed such other analyses and studies and considered such other information and factors as we deemed appropriate.
|
In arriving at our opinion, we have assumed and relied upon, without independent verification, the accuracy and completeness of the financial and other
information and data publicly available or provided to or otherwise reviewed by or discussed with us and have relied upon the assurances of the management of Valspar that it is not
B-1
The Board of Directors
The Valspar Corporation
March 19, 2016
Page 2
aware of any facts or circumstances that would make such information or data inaccurate or misleading in any material respect. With respect to the Valspar
Forecasts, we have been advised by Valspar, and have assumed, that they have been reasonably prepared on bases reflecting the best currently available estimates and good faith judgments of the management of Valspar as to the future financial
performance of Valspar. We have not made or been provided with any independent evaluation or appraisal of the assets or liabilities (contingent or otherwise) of Valspar, nor have we made any physical inspection of the properties or assets of
Valspar. We have not evaluated the solvency or fair value of Valspar or Sherwin-Williams under any state, federal or other laws relating to bankruptcy, insolvency or similar matters. We have assumed, at the direction of Valspar, that the Merger will
be consummated in accordance with its terms, without waiver, modification or amendment of any material term, condition or agreement and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases
and waivers for the Merger, no delay, limitation, restriction or condition, including any divestiture requirements or amendments or modifications, will be imposed that would have an adverse effect on Valspar or the contemplated benefits to Valspar
of the Merger in any way meaningful to our analysis. We also have assumed, at the direction of Valspar, that that the final executed Agreement will not differ in any material respect from the draft of the Agreement reviewed by us.
We express no view or opinion as to any terms or other aspects of the Merger (other than the Consideration, whether or not a Triggering Event occurs, to the
extent expressly specified herein), including, without limitation, the form or structure of the Merger. Our opinion is limited to the fairness, from a financial point of view, of the Consideration, whether or not a Triggering Event occurs, to be
received by holders of Valspar Common Stock and no opinion or view is expressed with respect to any consideration received in connection with the Merger by the holders of any other class of securities, creditors or other constituencies of any party.
In addition, no opinion or view is expressed with respect to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to any of the officers, directors or employees of any party to the Merger, or class of
such persons, relative to the Consideration, whether or not a Triggering Event occurs. Furthermore, no opinion or view is expressed as to the relative merits of the Merger in comparison to other strategies or transactions that might be available to
Valspar or in which Valspar might engage or as to the underlying business decision of Valspar to proceed with or effect the Merger. In addition, we express no opinion or recommendation as to how any stockholder should vote or act in connection with
the Merger or any related matter.
We have acted as financial advisor to the Board of Directors of Valspar in connection with the Merger and will receive
a fee for our services, a portion of which is payable upon the rendering of this opinion and a significant portion of which is contingent upon consummation of the Merger. In addition, Valspar has agreed to reimburse our expenses and indemnify us
against certain liabilities arising out of our engagement.
We and our affiliates comprise a full service securities firm and commercial bank engaged in
securities, commodities and derivatives trading, foreign exchange and other brokerage activities, and principal investing as well as providing investment, corporate and private banking, asset and investment management, financing and financial
advisory services and other commercial services and products to a wide range of companies, governments and individuals. In the ordinary course of our businesses, we and our affiliates may invest on a principal basis or on behalf of customers or
manage funds that invest, make or hold long or short positions, finance positions or trade or otherwise effect transactions in equity, debt or other securities or financial instruments (including derivatives, bank loans or other obligations) of
Valspar, Sherwin-Williams and certain of their respective affiliates.
We and our affiliates in the past have provided, currently are providing,
and in the future may provide, investment banking, commercial banking and other financial services to Valspar and have received or in the future may receive compensation for the rendering of these services, including (i) having acted or acting
as joint
B-2
The Board of Directors
The Valspar Corporation
March 19, 2016
Page 3
lead arranger, joint bookrunner for, and/or a lender under, certain term loans, letters of credit, leasing and other credit facilities of Valspar (including
acquisition financing), (ii) having acted or acting as joint bookrunner and underwriter in connection with various debt offerings of Valspar and (iii) having provided or providing certain treasury and trade management services and products
to Valspar.
In addition, we and our affiliates in the past have provided, currently are providing, and in the future may provide, investment banking,
commercial banking and other financial services to Sherwin-Williams and have received or in the future may receive compensation for the rendering of these services, including (i) having acted or acting as administrative agent, joint lead
arranger, joint bookrunner for, and/or a lender under, certain leasing and other credit facilities of Sherwin-Williams, (ii) having acted or acting as joint bookrunner, underwriter and/or dealer manager for certain debt offerings of, and share
repurchases by, Sherwin-Williams, (iii) having provided or providing certain treasury and trade management services and products to Sherwin-Williams and (iv) having provided or providing certain derivatives and foreign exchange trading
services to Sherwin-Williams.
It is understood that this letter is for the benefit and use of the Board of Directors of Valspar (in its capacity as such)
in connection with and for purposes of its evaluation of the Merger.
Our opinion is necessarily based on financial, economic, monetary, market and other
conditions and circumstances as in effect on, and the information made available to us as of, the date hereof. It should be understood that subsequent developments may affect this opinion, and we do not have any obligation to update, revise, or
reaffirm this opinion. The issuance of this opinion was approved by our Americas Fairness Opinion Review Committee.
Based upon and subject to the
foregoing, including the various assumptions and limitations set forth herein, we are of the opinion on the date hereof that the Consideration, whether or not a Triggering Event occurs, to be received in the Merger by holders of Valspar Common Stock
is fair, from a financial point of view, to such holders.
Very truly yours,
/s/ MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
B-3
Annex C
CONFIDENTIAL
PERSONAL AND CONFIDENTIAL
March 19, 2016
Board of Directors
The Valspar Corporation
1101 South Third Street
Minneapolis, MN 55415
Ladies and Gentlemen:
You have requested our opinion as to the fairness from a financial point of view to the holders (other than The Sherwin-Williams Company
(Sherwin-Williams) and its affiliates) of the outstanding shares of common stock, par value $0.50 per share (the Shares), of The Valspar Corporation (the Company) of the Per Share Price (as defined in the
Agreement (as defined below)), whether or not a Triggering Event (as defined in the Agreement) occurs, to be paid to such holders pursuant to the Agreement and Plan of Merger, dated as of March 19, 2016 (the Agreement), by and among
Sherwin-Williams, Viking Merger Sub, Inc., a wholly owned subsidiary of Sherwin-Williams, and the Company.
Goldman, Sachs & Co. and its
affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman,
Sachs & Co. and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short
positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Sherwin-Williams, any of their respective affiliates and third parties, or any currency or
commodity that may be involved in the transaction contemplated by the Agreement (the Transaction). We have acted as financial advisor to the Company in connection with, and have participated in certain of the negotiations leading to, the
Transaction. We expect to receive fees for our services in connection with the Transaction, the principal portion of which is contingent upon consummation of the Transaction, and the Company has agreed to reimburse certain of our expenses arising,
and indemnify us against certain liabilities that may arise, out of our engagement. We have provided certain financial advisory and/or underwriting services to the Company and/or its affiliates from time to time for which our Investment Banking
Division has received, and may receive, compensation, including having acted as bookrunner in connection with the issuance of the Companys 3.30% Senior Notes due February 2025 (aggregate principal amount $250,000,000) and 4.40% Senior Notes
due February 2045 (aggregate principal amount $250,000,000) in January 2015; co-manager in connection with the issuance of the Companys 3.95% Senior Notes due January 2026 (aggregate principal amount $350,000,000) in July 2015; and dealer in
the Companys $450 million commercial paper program. We also have provided certain financial advisory and/or underwriting services to Sherwin-Williams and/or its affiliates from time to time, including acting as Sherwin-Williams financial
advisor in connection with its announced acquisition of Consorcio Comex S.A. de C.V. in September 2013 (which was subsequently withdrawn). We may also in the future provide financial advisory and/or underwriting services to the Company,
Sherwin-Williams and their respective affiliates for which our Investment Banking Division may receive compensation.
In connection with this opinion, we
have reviewed, among other things, the Agreement; annual reports to stockholders and Annual Reports on Form 10-K of the Company for the five fiscal years ended October 30, 2015; certain interim reports to stockholders and Quarterly Reports
on Form 10-Q of the Company; certain other communications from the Company to its stockholders; certain publicly available research analyst reports for the
C-1
Board of Directors
The Valspar Corporation
March 19, 2016
Page 2
Company; and certain internal financial analyses and forecasts for the Company prepared by its management, as approved for our use by the Company (the
Forecasts). We have also held discussions with members of the senior management of the Company regarding the past and current business operations, financial condition and future prospects of the Company; reviewed the reported price and
trading activity for the Shares; compared certain financial and stock market information for the Company with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent
business combinations in the coatings industry and in other industries; and performed such other studies and analyses, and considered such other factors, as we deemed appropriate.
For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the accuracy and completeness of all of the financial, legal,
regulatory, tax, accounting and other information provided to, discussed with or reviewed by, us, without assuming any responsibility for independent verification thereof. In that regard, we have assumed with your consent that the Forecasts have
been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. We have not made an independent evaluation or appraisal of the assets and liabilities (including any contingent,
derivative or other off-balance-sheet assets and liabilities) of the Company or any of its subsidiaries and we have not been furnished with any such evaluation or appraisal. We have assumed that all governmental, regulatory or other consents and
approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way meaningful to our analysis. We have assumed that the Transaction will be consummated on
the terms set forth in the Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to our analysis.
Our opinion does not address the underlying business decision of the Company to engage in the Transaction, or the relative merits of the Transaction as
compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. This opinion addresses only the fairness from a financial point of view to the holders (other than
Sherwin-Williams and its affiliates) of Shares, as of the date hereof, of the Per Share Price, whether or not a Triggering Event occurs, to be paid to such holders pursuant to the Agreement. We do not express any view on, and our opinion does not
address, any other term or aspect of the Agreement or Transaction or any term or aspect of any other agreement or instrument contemplated by the Agreement or entered into or amended in connection with the Transaction, including, the fairness of the
Transaction to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the amount or nature of any compensation to be paid
or payable to any of the officers, directors or employees of the Company, or class of such persons, in connection with the Transaction, whether relative to the Per Share Price, whether or not a Triggering Event occurs, to be paid to the holders
(other than Sherwin-Williams and its affiliates) of Shares pursuant to the Agreement or otherwise. We are not expressing any opinion as to the solvency or viability of the Company or Sherwin-Williams or the ability of the Company or Sherwin-Williams
to pay their respective obligations when they come due. Our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no
responsibility for updating, revising or reaffirming this opinion based on circumstances, developments or events occurring after the date hereof. Our advisory services and the opinion expressed herein are provided for the information and assistance
of the Board of Directors of the Company in connection with its consideration of the Transaction and such opinion does not constitute a recommendation as to how any holder of Shares should vote with respect to such Transaction or any other matter.
This opinion has been approved by a fairness committee of Goldman, Sachs & Co.
C-2
Board of Directors
The Valspar Corporation
March 19, 2016
Page 3
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the Per Share Price, whether or not a Triggering Event occurs, to be
paid to the holders (other than Sherwin-Williams and its affiliates) of Shares pursuant to the Agreement is fair from a financial point of view to such holders.
Very truly yours,
/s/ GOLDMAN, SACHS & CO.
C-3
ANNEX D
SECTION 262 OF THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE
§ 262 Appraisal rights
(a)
|
Any stockholder of a corporation of this State who holds shares of stock on the date of the making of a demand pursuant to subsection (d) of this section with respect to such shares, who continuously holds such
shares through the effective date of the merger or consolidation, who has otherwise complied with subsection (d) of this section and who has neither voted in favor of the merger or consolidation nor consented thereto in writing pursuant to
§ 228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholders shares of stock under the circumstances described in subsections (b) and (c) of this section. As used in this
section, the word stockholder means a holder of record of stock in a corporation; the words stock and share mean and include what is ordinarily meant by those words; and the words depository receipt
mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a corporation, which stock is deposited with the depository.
|
(b)
|
Appraisal rights shall be available for the shares of any class or series of stock of a constituent corporation in a merger or consolidation to be effected pursuant to § 251 (other than a merger effected pursuant
to § 251(g) of this title and, subject to paragraph (b)(3) of this section, § 251(h) of this title), § 252, § 254, § 255, § 256, § 257, § 258, § 263 or § 264 of this title:
|
|
(1)
|
Provided, however, that, except as expressly provided in § 363(b) of this title, no appraisal rights under this section shall be available for the shares of any class or series of stock, which stock, or depository
receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of the meeting of stockholders to act upon the agreement of merger or consolidation, were either: (i) listed on a national securities
exchange or (ii) held of record by more than 2,000 holders; and further provided that no appraisal rights shall be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its
approval the vote of the stockholders of the surviving corporation as provided in § 251(f) of this title.
|
|
(2)
|
Notwithstanding paragraph (b)(1) of this section, appraisal rights under this section shall be available for the shares of any class or series of stock of a constituent corporation if the holders thereof are required by
the terms of an agreement of merger or consolidation pursuant to §§ 251, 252, 254, 255, 256, 257, 258, 263 and 264 of this title to accept for such stock anything except:
|
|
a.
|
Shares of stock of the corporation surviving or resulting from such merger or consolidation, or depository receipts in respect thereof;
|
|
b.
|
Shares of stock of any other corporation, or depository receipts in respect thereof, which shares of stock (or depository receipts in respect thereof) or depository receipts at the effective date of the merger or
consolidation will be either listed on a national securities exchange or held of record by more than 2,000 holders;
|
|
c.
|
Cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a. and b. of this section; or
|
|
d.
|
Any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a., b. and c. of this section.
|
|
(3)
|
In the event all of the stock of a subsidiary Delaware corporation party to a merger effected under § 251(h), § 253 or § 267 of this title is not owned by the parent immediately prior to the merger,
appraisal rights shall be available for the shares of the subsidiary Delaware corporation.
|
D-1
|
(4)
|
In the event of an amendment to a corporations certificate of incorporation contemplated by § 363(a) of this title, appraisal rights shall be available as contemplated by § 363(b) of this title, and the
procedures of this section, including those set forth in subsections (d) and (e) of this section, shall apply as nearly as practicable, with the word amendment substituted for the words merger or consolidation, and
the word corporation substituted for the words constituent corporation and/or surviving or resulting corporation.
|
(c)
|
Any corporation may provide in its certificate of incorporation that appraisal rights under this section shall be available for the shares of any class or series of its stock as a result of an amendment to its
certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation or the sale of all or substantially all of the assets of the corporation. If the certificate of incorporation contains such a provision,
the procedures of this section, including those set forth in subsections (d) and (e) of this section, shall apply as nearly as is practicable.
|
(d)
|
Appraisal rights shall be perfected as follows:
|
|
(1)
|
If a proposed merger or consolidation for which appraisal rights are provided under this section is to be submitted for approval at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting,
shall notify each of its stockholders who was such on the record date for notice of such meeting (or such members who received notice in accordance with § 255(c) of this title) with respect to shares for which appraisal rights are available
pursuant to subsection (b) or (c) of this section that appraisal rights are available for any or all of the shares of the constituent corporations, and shall include in such notice a copy of this section and, if 1 of the constituent
corporations is a nonstock corporation, a copy of § 114 of this title. Each stockholder electing to demand the appraisal of such stockholders shares shall deliver to the corporation, before the taking of the vote on the merger or
consolidation, a written demand for appraisal of such stockholders shares. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the
appraisal of such stockholders shares. A proxy or vote against the merger or consolidation shall not constitute such a demand. A stockholder electing to take such action must do so by a separate written demand as herein provided. Within 10
days after the effective date of such merger or consolidation, the surviving or resulting corporation shall notify each stockholder of each constituent corporation who has complied with this subsection and has not voted in favor of or consented to
the merger or consolidation of the date that the merger or consolidation has become effective; or
|
|
(2)
|
If the merger or consolidation was approved pursuant to § 228, § 251(h), § 253, or § 267 of
this title, then either a constituent corporation before the effective date of the merger or consolidation or the surviving or resulting corporation within 10 days thereafter shall notify each of the holders of any class or series of stock of such
constituent corporation who are entitled to appraisal rights of the approval of the merger or consolidation and that appraisal rights are available for any or all shares of such class or series of stock of such constituent corporation, and shall
include in such notice a copy of this section and, if 1 of the constituent corporations is a nonstock corporation, a copy of § 114 of this title. Such notice may, and, if given on or after the effective date of the merger or consolidation,
shall, also notify such stockholders of the effective date of the merger or consolidation. Any stockholder entitled to appraisal rights may, within 20 days after the date of mailing of such notice or, in the case of a merger approved pursuant to
§ 251(h) of this title, within the later of the consummation of the tender or exchange offer contemplated by § 251(h) of this title and 20 days after the date of mailing of such notice, demand in writing from the surviving or resulting
corporation the appraisal of such holders shares. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holders
shares. If such notice did not notify stockholders of the effective date of the merger or consolidation, either (i) each such constituent corporation shall send a second notice before the effective date of the merger or consolidation notifying
each of the holders of any class or series of stock of such constituent corporation that are entitled to appraisal rights of the effective date of the merger or consolidation or
|
D-2
|
(ii) the surviving or resulting corporation shall send such a second notice to all such holders on or within 10 days after such effective date; provided, however, that if such second notice
is sent more than 20 days following the sending of the first notice or, in the case of a merger approved pursuant to § 251(h) of this title, later than the later of the consummation of the tender or exchange offer contemplated by §
251(h) of this title and 20 days following the sending of the first notice, such second notice need only be sent to each stockholder who is entitled to appraisal rights and who has demanded appraisal of such holders shares in accordance with
this subsection. An affidavit of the secretary or assistant secretary or of the transfer agent of the corporation that is required to give either notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the
facts stated therein. For purposes of determining the stockholders entitled to receive either notice, each constituent corporation may fix, in advance, a record date that shall be not more than 10 days prior to the date the notice is given,
provided, that if the notice is given on or after the effective date of the merger or consolidation, the record date shall be such effective date. If no record date is fixed and the notice is given prior to the effective date, the record date shall
be the close of business on the day next preceding the day on which the notice is given.
|
(e)
|
Within 120 days after the effective date of the merger or consolidation, the surviving or resulting corporation or any stockholder who has complied with subsections (a) and (d) of this section hereof and who
is otherwise entitled to appraisal rights, may commence an appraisal proceeding by filing a petition in the Court of Chancery demanding a determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time
within 60 days after the effective date of the merger or consolidation, any stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party shall have the right to withdraw such stockholders demand for
appraisal and to accept the terms offered upon the merger or consolidation. Within 120 days after the effective date of the merger or consolidation, any stockholder who has complied with the requirements of subsections (a) and (d) of this
section hereof, upon written request, shall be entitled to receive from the corporation surviving the merger or resulting from the consolidation a statement setting forth the aggregate number of shares not voted in favor of the merger or
consolidation and with respect to which demands for appraisal have been received and the aggregate number of holders of such shares. Such written statement shall be mailed to the stockholder within 10 days after such stockholders written
request for such a statement is received by the surviving or resulting corporation or within 10 days after expiration of the period for delivery of demands for appraisal under subsection (d) of this section hereof, whichever is later.
Notwithstanding subsection (a) of this section, a person who is the beneficial owner of shares of such stock held either in a voting trust or by a nominee on behalf of such person may, in such persons own name, file a petition or request
from the corporation the statement described in this subsection.
|
(f)
|
Upon the filing of any such petition by a stockholder, service of a copy thereof shall be made upon the surviving or resulting corporation, which shall within 20 days after such service file in the office of the
Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all stockholders who have demanded payment for their shares and with whom agreements as to the value of their shares have not been
reached by the surviving or resulting corporation. If the petition shall be filed by the surviving or resulting corporation, the petition shall be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall
give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving or resulting corporation and to the stockholders shown on the list at the addresses therein stated. Such notice shall also be
given by 1 or more publications at least 1 week before the day of the hearing, in a newspaper of general circulation published in the City of Wilmington, Delaware or such publication as the Court deems advisable. The forms of the notices by mail and
by publication shall be approved by the Court, and the costs thereof shall be borne by the surviving or resulting corporation.
|
(g)
|
At the hearing on such petition, the Court shall determine the stockholders who have complied with this section
and who have become entitled to appraisal rights. The Court may require the stockholders who have demanded an appraisal for their shares and who hold stock represented by certificates to submit their
|
D-3
|
certificates of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any stockholder fails to comply with such direction, the Court may
dismiss the proceedings as to such stockholder.
|
(h)
|
After the Court determines the stockholders entitled to an appraisal, the appraisal proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing
appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of any element of value arising from the accomplishment or expectation of the merger or consolidation, together with interest, if any, to
be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take into account all relevant factors. Unless the Court in its discretion determines otherwise for good cause shown, interest from the
effective date of the merger through the date of payment of the judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between
the effective date of the merger and the date of payment of the judgment. Upon application by the surviving or resulting corporation or by any stockholder entitled to participate in the appraisal proceeding, the Court may, in its discretion, proceed
to trial upon the appraisal prior to the final determination of the stockholders entitled to an appraisal. Any stockholder whose name appears on the list filed by the surviving or resulting corporation pursuant to subsection (f) of this section
and who has submitted such stockholders certificates of stock to the Register in Chancery, if such is required, may participate fully in all proceedings until it is finally determined that such stockholder is not entitled to appraisal rights
under this section.
|
(i)
|
The Court shall direct the payment of the fair value of the shares, together with interest, if any, by the surviving or resulting corporation to the stockholders entitled thereto. Payment shall be so made to each such
stockholder, in the case of holders of uncertificated stock forthwith, and the case of holders of shares represented by certificates upon the surrender to the corporation of the certificates representing such stock. The Courts decree may be
enforced as other decrees in the Court of Chancery may be enforced, whether such surviving or resulting corporation be a corporation of this State or of any state.
|
(j)
|
The costs of the proceeding may be determined by the Court and taxed upon the parties as the Court deems equitable in the circumstances. Upon application of a stockholder, the Court may order all or a portion of the
expenses incurred by any stockholder in connection with the appraisal proceeding, including, without limitation, reasonable attorneys fees and the fees and expenses of experts, to be charged pro rata against the value of all the shares
entitled to an appraisal.
|
(k)
|
From and after the effective date of the merger or consolidation, no stockholder who has demanded appraisal rights as provided in subsection (d) of this section shall be entitled to vote such stock for any purpose
or to receive payment of dividends or other distributions on the stock (except dividends or other distributions payable to stockholders of record at a date which is prior to the effective date of the merger or consolidation); provided, however, that
if no petition for an appraisal shall be filed within the time provided in subsection (e) of this section, or if such stockholder shall deliver to the surviving or resulting corporation a written withdrawal of such stockholders demand for
an appraisal and an acceptance of the merger or consolidation, either within 60 days after the effective date of the merger or consolidation as provided in subsection (e) of this section or thereafter with the written approval of the
corporation, then the right of such stockholder to an appraisal shall cease. Notwithstanding the foregoing, no appraisal proceeding in the Court of Chancery shall be dismissed as to any stockholder without the approval of the Court, and such
approval may be conditioned upon such terms as the Court deems just; provided, however that this provision shall not affect the right of any stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party to
withdraw such stockholders demand for appraisal and to accept the terms offered upon the merger or consolidation within 60 days after the effective date of the merger or consolidation, as set forth in subsection (e) of this section.
|
(l)
|
The shares of the surviving or resulting corporation to which the shares of such objecting stockholders would have been converted had they assented to the merger or consolidation shall have the status of authorized and
unissued shares of the surviving or resulting corporation.
|
D-4
THE VALSPAR CORPORATION
ATTN: CORPORATE SECRETARY
P.O. BOX 1461
MINNEAPOLIS, MN 55440
PRELIMINARY - DO NOT SUBMIT
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on [●], 2016. Have your
proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would
like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery,
please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone
to transmit your voting instructions up until 11:59 p.m. Eastern Time on [●], 2016. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return
it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,
Edgewood, NY 11717.
STOCKHOLDER MEETING REGISTRATION
To vote and/or attend the
meeting, go to the Register for Meeting link at
www.proxyvote.com.
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS FOLLOWS:
|
|
|
|
|
|
|
E09848-S44659
|
|
KEEP THIS PORTION FOR YOUR RECORDS
|
DETACH AND RETURN THIS PORTION ONLY